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College students diagnosed with Attention Deficit-Hyperactivity Disorder (ADHD) are at an 
increased risk of depression, anxiety, and lower academic self-efficacy as compared to college 
students not diagnosed with ADHD. Additionally, college students with ADHD diagnoses 
struggle to obtain effective treatment options for their ADHD symptoms. Specifically, 
pharmacological interventions are effective in mitigating ADHD symptoms; however, adverse 
effects of stimulant medications (i.e., increased/decreased appetite, headache) impact medication 
adherence in college students with ADHD. Neurofeedback is a non-invasive, drug-free 
intervention that uses the theories of biofeedback and cybernetics to increase self-regulation of 
brain functions.  
The purpose of this dissertation study was to examine differences in college student participants’ 
scores on inattention, hyperactivity, impulsivity, self-concept, depression, anxiety, and self-
efficacy measures over time when exposed to the neurofeedback intervention. The researcher 
employed a quasi-experimental, one group, time series design to explore differences in levels of 
symptomology in 11 participants over four assessment points. The results identified participants’ 
scores in inattention (p = .016), hyperactivity (p = .017), self-concept (p = .008), depression (p = 
.004), and anxiety (p = .018) significantly decreased of the course of the intervention (16 
neurofeedback sessions). Moreover, the participants’ self-reported levels of academic self-
efficacy increased significantly over time (p < .001). The findings for the current study provide 
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CHAPTER ONE: INTRODUCTION 
Approximately 6-8% of adults in the United State have a diagnosis of Attention Deficit 
Hyperactivity Disorder (ADHD). Moreover, 11% of children in the United States have an 
ADHD diagnosis with 66% of those with ADHD diagnoses retaining their symptoms into 
adulthood (Children and Adults with Attention Deficit Hyperactivity Disorder [CHADD], 2016; 
Faraone Biederman, & Mick, 2016). Children with ADHD are more likely to struggle 
academically and are more likely to be placed in exceptional education classes than children not 
diagnosed with ADHD (Barry, Lyman, & Klinger, 2002; Loe & Feldman, 2007). Further, 
children with ADHD show deficits in executive functioning which has been defined as the ability 
to maintain the cognitive abilities necessary to engage in goal-directed behavior, leading to a 
lack of planning, organizing, or problem solving (Biederman et al, 2004). In addition to issues 
with academic achievement and cognitive functioning, children with ADHD tend to struggle 
with social and emotional issues as well.   
Adults with ADHD face similar challenges and are at risk of higher levels of stress, work 
impairment, and marijuana dependence (e.g., Combs, Canu, Broman-Fulks, Rocheleau, & 
Nieman, 2015). Contrary to children, adults with ADHD are able to choose work environments 
conducive to their ADHD symptoms, thus coping with their symptomology by incorporating it 
into their daily lives. Many college students with ADHD are unable to cope with their ADHD 
symptoms in the same way as they are in an environment in which they are expected to manage 
excessive activity. Thus, college students need to find ways to mitigate their ADHD symptoms in 
order to adapt to the classroom environments in college. As a result, many college students with 
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ADHD have increased incidence of (a) social impairment, (b) sleep disorders, (c) depression, (d) 
suicidality, (e) anxiety, and (f) academic difficulties (Buchannan, 2011; Gaultney, 2014).  
Statement of the Problem 
Universities may have structures in place to assist college students diagnosed with 
ADHD such as classroom accommodations through student accessibility/disability services 
offices, counseling and mental health services through counseling and psychological services 
offices, and physical services and medication prescriptions through student health services 
offices. A specific issue with medication accessibility to college students involves a lack of 
willingness of psychiatric nurses and medical doctors at a university to prescribe medications to 
students with ADHD (Thomas, Rostain, Corso, Babcock, & Madhoo, 2016). Psychiatric nurses 
and medical doctors at a university reported that they felt comfortable that they could identify an 
individual with ADHD and could properly diagnose the disability; however, they were less 
comfortable with prescribing medication to the students and were more comfortable with 
referring the students to an outside practitioner for additional evaluation (Thomas, et. al, 2016). 
The challenge in receiving mediation can be an added barrier for college students to receive help 
for their ADHD symptoms as some college students may not have insurance that covers an 
outside practitioner, or may not be able to drive to an off campus site to get medication. Thus, 
college students with ADHD are in need of more accessible treatments for their ADHD. Another 
issue with pharmacological intervention for ADHD symptoms are side effects. Stimulant 
medications such as Ritalin or Adderall (most often used in the treatment of ADHD) carry with 
them side effects that range from drastic changes in appetite to headaches, leading to college 
students discontinuing their medication (Cunill, Castells, Tobias, & Capella, 2016) or self-
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medicating to cope with their ADHD symptoms. Thus, an intervention is needed to treat the 
symptoms of ADHD in college students without adverse side effects. 
Neurofeedback (NF) is different than pharmacological interventions in that the side 
effects of NF are limited to increased feelings of tiredness, and the benefits are long lasting. 
Meyers and Young (2012) noted that NF is a drug free, non-invasive intervention that should be 
given more attention in the counseling literature. In addition, NF has shown efficacy in 
mitigating ADHD symptoms in children with ADHD with Cohen’s d effect sizes ranging from 
.80 (Leins, Goth, Hinterberger, Klinger, Rumpf, & Strehl, 2007) to 2.08 (Duric, Assmus, 
Gundersen, & Elgen, 2012). The current study sought to add to the counseling and NF literature 
by expanding the research to adults with ADHD (a far less studied population), addressing the 
needs of college students with ADHD.  
Significance of the Study 
According to Ray and colleagues (2011), only six percent of the articles published in 
counseling journals explored the efficacy of counseling interventions. Thus, this study adds to 
the counseling literature by contributing to the intervention based research in the field as well as 
by providing a novel intervention for counselors to incorporate into research and practice. 
Providing research supporting the efficacy of NF may shift the overall attitude toward NF, 
generating more practical and research interest in it as an intervention. As college students with 
ADHD are also at higher risk of misusing stimulant medications for the purposes of cognitive 
enhancement and weight loss (Weyandt et al, 2014), providing evidence for a non-invasive and 
drug free alternative to stimulant medication may lessen the prevalence of stimulant medication 
abuse in college students with ADHD. 
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This study adds to the extant literature on NF with ADHD, depression, anxiety, and self-
efficacy by providing data on these constructs and how they change or remain the same over the 
course of 16 sessions of NF. Moreover, the current investigation also adds to the research on 
therapeutic interventions to assist college students with ADHD, addressing the gap in the 
literature of meeting the needs of this population by providing a non-invasive and drug free 
intervention for ADHD symptoms. The results of this study may spark future research on 
identifying a causal relationship between NF sessions and changes in ADHD symptomology. 
Specifically, implications for this research study include utilizing NF in conjunction with 
counseling. As NF focuses on the physiological factors associated with maladaptive behaviors in 
individuals, incorporating NF in addition to counseling may assist counselors in the 
psychotherapeutic process. Clients, especially with histories of trauma and neglect, may have a 
difficult time establishing a trusting relationship with their therapists and may be less willing to 
open up in counseling (Cohen, Mannarino, & Deblinger, 2006). However, utilizing NF with 
clients may increase feelings of calmness and relaxation, thus allowing clients to feel more 
comfortable with their counselors in session, allowing therapy to move faster. For example, 
Trauma Focused Cognitive Behavioral Therapy (TF-CBT; Cohen, Mannarino, & Deblinger, 
2006) is a modality of psychotherapy that is tailored to treat individuals who have experienced a 
significant trauma. TF-CBT is organized into stages in which counselors prepare clients to 
process their trauma by (a) providing psychoeducation about the physiological effects of trauma, 
(b) teaching relaxation techniques to self-regulate when emotions surrounding the trauma are 
high, and (c) developing coping skills to manage emotions surrounding the traumatic experience. 
Theoretically, NF may have the same effects on individuals suffering from trauma as the initial 
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stages of TF-CBT as the purpose of NF is to improve self-regulation within the brain. Counselors 
may utilize NF in addition to TF-CBT with children and adults who have experienced trauma to 
assist them in preparing to process their traumatic experience by “teaching” the brain to regulate 
itself with NF and by teaching coping skills through counseling. Once clients have established a 
foundation in which they are able to regulate their emotional arousal, they will be able to process 
their trauma in psychotherapy. 
Operational Definition of Terms 
In order to ensure the constructs observed in this study are consistent with those noted in 
the literature, the researcher has operationally defined the constructs of interest. The operational 
definitions of the key terms in this study are provided in the following sections, providing 
continuity throughout the document. Additionally, the following definitions will offer clarity of 
the terms. 
College Student 
 For the purpose of the study, the term College Student was used to describe an individual 
who is over the age of 18 and is enrolled in at least one class at an institution of higher education. 
Individuals who met the definition of college student were eligible to participate in the study. 
Individuals who were not enrolled in classes, were in high school, or were under the age of 18 
were not be eligible to participate in the study. Participants included individuals enrolled full 
time or part time in classes and were enrolled at a four-year institution or a community college or 
trade school. Recruitment occurred at colleges in the central Florida area and included two and 




 Neurofeedback refers to the process of providing feedback to the brain in order to 
manipulate brainwave activity. Neurofeedback involves measuring brainwaves through 
electrodes or electrode caps attached to the scalp, and providing audio or visual feedback to an 
individual based on their brainwave activity as it is measured by the electrodes. There are various 
neurofeedback types and systems; however, the system used in this study was the NeurOptimal 
2.0 system manufactured by the Zengar Institute (2013). Although the NeuOptimal system is 
similar to Z-Score Neurofeedback, which provides feedback based on brainwaves exceeding two 
standard deviations of the individual’s mean activity, the Zengar institute does not divulge the 
particulars of how the NeurOptimal system operates. The NeurOptimal system provided audio 
feedback in the form of slight interruptions in the music the participants listened to. Thus, for the 
purpose of this study, NF was defined as brainwave feedback per the NeurOptimal system 
operation protocol.  
Attention Deficit-Hyperactivity Disorder 
 Attention Deficit/Hyperactivity Disorder is a disorder characterized by inattention, 
hyperactivity or a combination of the two in children, adolescents, and adults. According to the 
DSM-5 (American Psychiatric Association, 2013), to meet the diagnostic criteria for ADHD, one 
must meet six or more symptoms of inattention, or six or more symptoms of hyperactivity with 
the symptoms being present before the age of 12. Additionally, the symptoms must be present in 
more than one environment, and interfere with quality of life. For the purpose of this study, 
ADHD diagnoses were verified by a treatment letter from a mental health professional. Further, 
ADHD symptoms were measured by participant self-reported responses on the Conner’s Adult 
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ADHD Rating Scale (CAARS). The CAARS measured ADHD symptom severity in four 
subscales: (a) inattention, (b) hyperactivity, (c) impulsivity, and (d) self-concept. The researcher 
used the subscale scores for each participant to measure their level of ADHD symptomology. 
Depression 
 Depression is a mood disorder characterized by persistent sadness and lack of energy. 
College students with ADHD are more likely to suffer from depressive symptoms than college 
students without ADHD diagnoses. Thus, the study measured depressive symptoms by 
participants’ scores on the Beck Depression Inventory II (BDI-II). The BDI was developed to 
match the DSM-IV diagnostic criteria for depression. The BDI consists of 21 items that each 
relate to the symptoms of depression. The higher participants score on the BDI, the higher their 
level of depressive symptoms (Beck, Steer, & Brown, 1988). 
Anxiety 
 Anxiety is characterized by excessive worry. College students with ADHD are more 
likely to suffer from symptoms of anxiety. Thus, the researcher measured anxiety symptoms with 
the Beck Anxiety Inventory (BAI; Beck & Steer, 1996). The BAI assesses the physical and 
cognitive symptoms associated with anxiety. The higher participants score on the BAI, the more 
symptoms of anxiety they possess (Beck & Steer, 1996).  
Academic Self-Efficacy 
 Generally, self-efficacy refers to one’s confidence in completing a specific task. 
Academic self-efficacy refers to the beliefs individuals have in their ability to complete academic 
tasks. As college students with ADHD are more likely to struggle academically and have lower 
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self-efficacy as a result, the researcher measured participant academic self-efficacy with the Self-
Efficacy for Learning Form Abridged (SELF-A). The SELF-A measures students’ beliefs in their 
ability to complete a list of academic tasks. The higher the individuals rate their confidence in 
completing the task, the higher their level of academic self-efficacy (Zimmerman & Kitsantas, 
2005). 
Methodology 
This study utilized a quasi-experimental time series design (Shadish, Cook, & Campbell, 
2002). Time series designs are characterized by multiple measures being made on the same 
variables over time. In the case of this study, a total of four data collection points (pre, mid, post, 
and follow-up) were made on the outcome variables (ADHD symptoms, depression, anxiety, and 
academic self-efficacy). Because there was only one group in this study, there was no random 
assignment nor was there random selection as participants self-selected to participate in the 
study, which made the study quasi-experimental (Shadish et al, 2002).  
The primary research question guiding this study was: Are there mean rank differences in 
college students’ scores on the Conner’s Adult ADHD Rating Scale (CAARS), the Beck 
Depression Inventory (BDI-II), the Beck Anxiety Inventory (BAI), and the Self Efficacy for 
Learning Form-Abridged (SELF-A) over time when receiving a NF intervention?  
Population and Sampling 
This study utilized random sampling with inclusion criteria (Gall, Gall, & Borg, 1996). 
Because all eligible participants in the study had equal chance of participating in the study, the 
sample was random. The target population, to which the researcher would hope to generalize 
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results of the study, was all college students in the state of Florida with ADHD. Moreover, 
because the participants are self-selecting to participate in the study, differences between the 
participants in the study and the target population also threatened external validity. For example, 
Pagan, Eaton, Turkheimer, and Oltmanns (2006) found that college students were more likely to 
participate in a research study if they were labeled by their peers as being needier or self-
sacrificing, suggesting that research participants may have specific personality traits that make 
them more likely to participate in a study. Therefore, individuals that choose to participate in 
research may have different characteristics than individuals choosing not to participate in 
research. Internal validity was threatened by treatment attrition. College students have busy 
schedules and missed NF sessions; therefore, they had to reschedule NF study sessions 
throughout the course of the study. If participants did not complete the total of 16 NF sessions, 
the ability to attribute change in participants’ assessment scores to NF as an intervention would 
have been weakened.  
Participants were students at universities in a Southeastern US state that had seen the 
recruitment flyers and/or were referred to the study by the Student Accessibility Services or 
Counseling and Psychological Services offices and had randomly selected themselves to 
participate in the study. Through screening criteria, interested students were assessed for 
eligibility for participation. Inclusion criteria for participation in the study included the 
following: (a) over 18 years of age; (b) enrolled at a college; (c) able to provide documentation 
of an ADHD diagnosis from a mental health professional; (d) no history of psychosis or 
psychotic disorders—verified in the treatment letter from the mental health professional and self-
report; (e) no recent emotional hospitalizations—within the past month, verified by self-report; 
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(f) not currently pregnant; (g) no implanted electrical medical device such as a pacemaker; (h) no 
severe skin allergies; and (i) is able to speak, read, and understand English as all of the 
assessments are in English.   
Recruitment 
To expand the potential participants in this study, the researcher recruited from multiple 
colleges in a Southeastern US metropolitan city. Recruitment methods included posting flyers in 
each college student disability services or equivalent office, emailing students via list serves, 
placing flyers in the resident halls, presenting at local mental health counselor meetings, placing 
flyers in the office of Wellness and Health Promotions, passing out flyers outside of Psychology 
classes, placing flyers in the student union break room, and obtaining referrals from the 
Counseling and Psychological Services office.  
As it was impossible to know for sure how many individuals were exposed to the study 
recruitment flyers, the researcher was unaware of and cannot report a response rate. However, in 
the 2014-2015 school year, there were 60,810 students enrolled at the large University in the 
southeastern United States. Statistically, between two percent and eight percent of college 
students are diagnosed with ADHD (Weyandt & Dupaul, 2013; Weyandt, Linterman, & Rice, 
1995); therefore, there were potentially between 1,216 and 4,865 students on campus diagnosed 
with ADHD. Over the course of the two semesters of recruitment, 18 students expressed interest 
in participating in the study. However, due to ineligibility, scheduling conflicts, and overall 
attrition, 11 students completed all 16 sessions and the 4 week follow up. 
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Data Collection Procedures 
Each round of data collection for the study was conducted over a total of 12 weeks with 8 
weeks of NF sessions and a 4 week post-NF follow-up. The timeline for the study was as 
follows: (a) there were two total semesters of data collection (Summer and Fall 2016); (b) 
recruitment was ongoing until the conclusion of NF sessions in the fall semester (12/4/16); (c) 
summer data collection began the week of 5/23/16 and fall data collection started the week of 
9/12/16. Midpoint assessments for each round of data collection occurred four weeks later and 
post assessments four weeks after the midpoint assessments; and (d) four weeks after the final 
NF session, participants came in for a follow-up assessment session in which they completed 
their assessments again. Participants attended a total of 16 sessions of NF over the course of 8 or 
more weeks with 1-2 sessions per week. Assessments were administered at the first, eighth, 
sixteenth session as well as at the four week follow-up meeting. In addition, $10.00 gift cards 
were given to participants at these four data collection intervals as well.   
Study Funding 
The Association for Assessment and Research in Counseling (AARC) 2016 Scholarship 
Grant provided funding for the gift card incentives, assessments, and printing costs. This grant 
was awarded to the researcher in the amount of $1,778.25 after the researcher submitted an 
application outlining the research protocol of the study. The purpose of this scholarship grant is 
to encourage research in the counseling field on assessment and client outcomes. Additionally, 
the NeurOptimal system to be used in this study was loaned to the researcher by the Zengar 
Institute for the purposes of conducting research. The researcher’s co-chair, a certified 
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neurofeedback professional, petitioned the Zengar Institute for a loaned machine for the purpose 
of the researcher’s dissertation study.  
Instrumentation 
The data collection packet included four measures: (a) the Conner’s Adult ADHD Report 
Scale Brief (Conners, Erhardt, & Sparrow, 1999), (b) the Beck Depression Inventory-II (Beck, 
Steer, & Brown, 1996), (c) the Beck Anxiety Inventory (Beck, & Steer, 1990), and (d) Self-
Efficacy for Learning Form-Abridged (SELF-A; Zimmerman & Kitsantas, 2005). In addition, the 
first data collection packet (first session) also included a psychosocial inventory, tracking the 
participants’ age, ethnicity, gender, and physical, emotional, and substance abuse histories. 
Conner’s Adult ADHD Report Scale Self-Report Short Form 
The Conner’s Adult ADHD Report Scale Self-Report Short Form (CAARS-S:S; 
Conners, Erhardt, & Sparrow, 1999) was developed in 1999, is a 26 item, Likert-type, self-report 
measure of ADHD symptoms. The CAARS was normed on a non-clinical sample of 1,026 adults 
ranging in age from 18 to 80 years old. The authors used ANOVAs to compare differences in 
CAARS scores based on age and gender. Because the authors found some significant differences 
in scores based on these factors, they are taken into consideration in the scoring of the measure.  
The version of the CAARS used in this study was the self-report, short form (CAARS-
S:S) as the researcher included four assessments and wanted to avoid testing fatigue by reducing 
the number of items participants completed. There are longer forms and observer forms 
available; however, for the purpose of this study, the most feasible version was the short, self-
report version. The CAARS has four subscales: (a) inattention, (b) hyperactivity, (c) impulsivity, 
and (d) self-concept. The internal consistency reliability of the CAARS is strong with subscale 
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alphas ranging from .80-.92. Test retest reliability (one month between administrations) yielded a 
correlation of > .8. The CAARS was compared to the Wender Utah Rating Scale, another ADHD 
scale, and showed a moderate relationship (subscale correlations ranged from r = .3-.6). 
Moreover, Conner’s and colleagues used the structured interview (based on the DSM-IV-TR) 
with the CAARS and the CAARS correctly identified ADHD diagnoses 87% of the time. The 
CAARS assessment has also been used in numerous studies on adults with ADHD, including 
studies evaluating the efficacy of NF on ADHD symptoms.  
Beck Depression Inventory-II  
The Beck Depression Inventory-II (BDI-II; Beck, Ward, Mendelson, Mock, & Erbaugh 
1961; Beck, Steer, & Brown, 1996) is a 21-item, self-report measure of depressive symptoms. 
The original BDI (Beck et al, 1961) items were based on 21 symptom attitude categories which 
were derived from Beck’s clinical observations of symptoms of depressed individuals. The BDI 
was normed on a clinical population of 400 outpatient and inpatient individuals at a University 
Hospital. These individuals were 60% female, and 64% White. Participants in this study were 
only categorized as either White or Black. The assessment was read aloud by the researchers, 
who recorded participants responses by circling the response the participant identified as most 
salient at the current moment for them. Participants were also interviewed by psychiatrists who 
had come to a consensus as to how to diagnose depression from the Diagnostic and Statistical 
Manual (DSM). The researchers found a significant relationship between each of the items on 
the inventory and the overall score (p < .01), indicating strong internal consistency and reliability 
of the measure. The researchers also compared participants’ self-report Depression Inventory and 
clinician administered Depth of Depression ratings and found a significant positive relationship 
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in symptom self-reported and clinician rated severity (p < .001), supporting sound validity with 
these data. 
The BDI-II is a revised version of the BDI that includes clearer statements and was 
created to make self-reporting easier for subjects. The BDI-II includes questions on suicidality 
which the research assistants were trained to scan for. If an individual provided an answer other 
than “0-I do not have any suicidal thoughts or plans”, the RA contacted the researcher and 
completed a SLAP assessment. If the participant needed to be placed under the Baker Act, 
Community Counseling and Research Center (CCRC) protocol would have been followed and 
UCF police would have been called to escort the individual to the nearest hospital. The reliability 
of the BDI is strong with an alpha >.8 and the authors compared the BDI to the Hamilton Rating 
Scale for Depression (HRSD) and the correlation was moderate (r = .6). The BDI has been 
widely used in the research on depression and in most studies utilizing NF to decrease depressive 
symptoms. 
Beck Anxiety Inventory  
The Beck Anxiety Inventory (BAI; Beck, & Steer, 1990) is a 21-item self-report measure 
of anxiety symptoms. The BAI was created from an 86 item pool that were drawn from extant 
anxiety scales including the Anxiety Checklist, the Physician’s Desk References Checklist, and 
the Situational Anxiety Checklist. The authors selected the 21 items for the BAI by conducting 
numerous rounds of item analysis including reducing items based on their similarity to one 
another and their validity after conducting a factor analysis. The BAI is scored by summing the 
total numbers correlating to the responses the participants choose. The larger the sum, the more 
symptoms of anxiety present. The internal consistency and test-retest reliability of the BAI is 
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sound with an alpha of .92 and test-retest correlation of .75. The authors compared the BAI to 
other measures of anxiety and found that there were moderate relationships amongst the 
measures (r = .5). Additionally, the authors sought to compare the BDI and BAI to ensure there 
was no overlap in the measures. As depression and anxiety may manifest in the same ways, the 
BDI and BAI are good to use together because they are independent of one another and each 
measure what they are intended to measure without overlap. Although most of the studies on NF 
and anxiety utilize specific anxiety disorder scales (e.g. the Yale-Brown Obsessive Compulsive 
Scale for Obsessive Compulsive Disorder), the BAI is often used with the BDI because of their 
construct reliability. 
Self-efficacy for Learning Form-Abridged  
The Self-efficacy for Learning Form (SELF-A; Zimmerman & Kitsantas, 2005) is a 19-
item self-report, Likert-type, measure of self-efficacy for self-regulated learning. That is, the 
SELF-A measures students’ perceived responsibility and ability to take control of their learning, 
including items that ask about students’ ability to take notes in class, or if they do not understand 
something, their ability to get the information they need. The answers are on a 100 point scale 
from 0—I definitely cannot do this, to 100—I definitely can do this. The authors have yet to 
complete reliability and validity analyses on SELF-A scale; however, they report that the 
communalities of the items in the factor analysis were all above .9, identifying that the items 
relate well to one another. Further, the authors compared students’ responses on the SELF to 
their teacher’s perceptions of the students’ self-efficacy and found a strong relationship between 
the students’ responses and the teacher’s perceptions, suggesting the measure is moderately 
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valid. The SELF-A encompasses the construct of self-efficacy for college students and has been 
normed on college students with ADHD. 
Data Analysis 
The researcher conducted a Friedman’s Analysis of Variance (ANOVA) for each of the 
dependent variables of interest. A Friedman’s ANOVA (Friedman, 1937; Friedman, 1940) was 
selected to analyze the data because the data collected did not meet the assumptions for a 
parametric analysis. The data did, however, meet the assumptions for a Friedman’s ANOVA 
which include the following: (a) one group is measures three or more times; (b) the group is a 
random sample from the population in that all eligible participants had equal opportunity of 
participating in the study; (c) the dependent variable is measured at the ordinal or continuous 
level; and (d) the sample does not need to be normally distributed (Daniel, 1990). The researcher 
used the inattention, hyperactivity, impulsivity and self-concept subscales of the CAARS:S-S; in 
addition to the BDI, BAI, and SELF-A total scores in the analyses for a total number of 7 
dependent variables on which the researcher ran Friedman’s ANOVAs.  
Ethical Considerations 
 The researcher obtained relevant approval from the University’s Institutional Review 
Board (IRB) and took additional precautions to ensure the safety of the participants in the study. 
As part of the IRB approval process, the researcher provided an explanation of the research study 
protocol, instrumentation, and recruitment documents for the board to review. Participants were 
made aware of the risks and benefits of participating in the study and were provided an informed 
consent document that outlined their rights as participants in the research study. Further, to 
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protect the privacy and confidentiality of the participants, the researcher assigned each 
participant an identification number that the researcher used rather than the participant’s name to 
identify the participant’s data. The researcher also kept the data collected in the study in a locked 
cabinet in the researcher’s locked office. Participants were able to withdraw from the study at 
any time. 
Limitations 
Shadish and colleagues (2002) note some potential threats to validity in this study, 
including maturation, alternative treatment, and the placebo effect. The threat of maturation calls 
into question whether the participants’ scores on the assessments would have changed even if 
they hadn’t been exposed to the intervention. Because Conners and colleagues (1999) conducted 
their test-retest reliability test with a month between the test and retest and found that the scores 
were stable across time, maturation may not be a threat to this study. However, a way to combat 
the threat of maturation in future studies would be by adding a control group for comparison. 
Alternative treatment (e.g., medication, counseling) was another threat to the validity of this 
study. One participant began taking medication in the middle of the study and that may have 
impacted the results of the participant’s assessments. Finally, participants may have expected to 
get better or felt socially obligated to get better and as a result, responded more positively on the 
assessments.  
Other limitations to this study include a lack of a control group. Shadish and colleagues 
(2002) state that causality is hard to determine with a one-group pretest-posttest design and 
suggest that a control group be added to increase the strength of the design. An additional 
limitation to the study is the sample size. Although a sample of 11 participants is sufficient to 
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conduct a Friedman test, such a small sample size may not accurately show differences in scores 
over time and limits the generalizability of the results. Future studies should incorporate larger 
samples to more effectively determine statistical significance. 
Conclusion 
 Chapter one has provided an overview of the study. The background of the study was 
discussed in relation to the problem the study addresses and the significance of the study. 
Further, the constructs that the study explored were introduced and operationally defined as they 
were measured in the study. An overview of the methodology of the study was provided. The 
data collection procedures including sampling, recruitment, instrumentation, and study protocol 
were discussed. Additionally, data analysis procedures, potential limitations, and ethical 




CHAPTER TWO: REVIEW OF THE LITERATURE 
Chapter two presents an overview of the existing literature relevant to college students 
with ADHD. Specifically, the challenges college students with ADHD face, and the effects of 
these challenges on their academic achievement is presented. Chapter two also provides a 
rationale for studying college students with ADHD, extant research on interventions that assist 
college students with ADHD, a critique of extant methods of reducing ADHD symptoms, and 
literature supporting neurofeedback (NF) as an effective intervention for reducing ADHD 
symptoms in college students with ADHD.  
The researcher met with a research librarian to thoroughly search the appropriate 
databases for the literature included in chapter two. The researcher searched PsychInfo, 
Academic Search Premier, ERIC, PubMed, Wiley Online Library, Taylor & Francis Journals, 
Sage Journals, Web of Science, Cochrane Library, and Science Direct. The researcher used the 
following keywords: Neurotherapy, Biofeedback, Attention Deficit Disorder with Hyperactivity, 
Depression (emotion), Anxiety, Academic Self-Concept, College Students, and Graduate 
Students. 
Introduction 
Approximately 6-8% of adults in the United State have a diagnosis of Attention Deficit 
Hyperactivity Disorder (ADHD; Kessler, 2006). Moreover, 11% of children in the United States 
have an ADHD diagnosis with approximately 66% of those with ADHD diagnoses retaining 
their symptoms into adulthood (Children and Adults with Attention Deficit Hyperactivity 
Disorder [CHADD], 2016; Faraone, Biederman, & Mick, 2016). Over time, the diagnosis of 
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ADHD has shifted from its introduction into the second edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-II) in 1968 as “Hyperkinetic Reaction of Childhood”; to its 
more contemporary “Attention Deficit-Hyperactivity Disorder” in the DSM-5. Moreover, before 
ADHD was a diagnosis, there were numerous documented examples of what is now classified as 
ADHD. One of the most popular examples of ADHD before it became a diagnosis was Heinrich 
Hoffmann’s “Fidgety Philip”. Hoffmann, a German physician, wrote the children’s story of 
Fidgety Philip which outlines the troubles of a child at a dinner table, whose parents try to 
convince him to be still. The story ends with Philip falling to the floor, toppling over the food 
that was on the table with him. Philip exhibited many of the characteristic symptoms of ADHD 
including hyperactivity and impulsivity. Other instances of ADHD-like symptomology appeared 
in the work of Sir George Frederic Still (1902) who studied children with a Defect of Moral 
Control which he defined as children who lack the “control of action in conformity with the idea 
of the good of all” (Still, 1992, p. 1008). Children with a defect of moral control were 
characterized as having excessive shamelessness, destructiveness, and also had issues with a 
delay of gratification; the last of which is a part of contemporary ADHD research. ADHD 
behaviors were also described as disorders of the brain. Tredgold (1908) observed inattentive and 
hyperactive behaviors in children who had brain damage early in life that led to learning 
difficulties, which was named Postencephalitic Behavior Disorder. Further, brain damage was 
attributed to hyperactive behaviors in children and thus a continuum was developed that 
described brain damage ranging in severity from diseases such as Cerebral Palsy to minimal 
brain damage. In the 1960s however, critics began to disapprove of the idea that brain damage is 
the only contributor to childhood hyperactive behaviors and argued that children who did not 
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have past brain damage or brain illnesses were still experiencing severe hyperactivity, thus 
leading to the disorder’s introduction into the DSM-II.   
In addition to the changes in the name of ADHD, the criteria for diagnosing ADHD has 
shifted throughout the revisions of the DSM. In its debut, ADHD (or “Hyperkinetic Reaction of 
Childhood”) was characterized by distractibility, restlessness, and over activity in young 
children. Additionally, the diagnostic criteria asserted that the disorder would usually diminish 
by adolescence. Further, as the DSM shifted into the third edition, the criteria for ADHD shifted 
as well. The focus of the disorder shifted from the hyperactive aspect of the disorder to the lack 
of attention. Thus, the American Psychiatric Association (1980) changed the name of the 
disorder to Attention Deficit Disorder for the DSM-III. Additionally, the DSM-III version of 
ADHD was the first to differentiate the presence of the disorder with or without hyperactivity. 
That is, hyperactivity no longer needed to be present in order to diagnose a child with ADD. The 
lack of hyperactivity as a major focus of diagnostic criteria in the DSM-III was different than the 
International Classification of Diseases (ICD-9), which continued to focus on hyperactivity as a 
major symptom of ADHD. The third edition of the DSM was also the first to introduce specific 
objective diagnostic criteria and cutoff scores for symptoms in addition to exclusion criteria, age 
of onset criteria, and criteria for duration of the condition. The fourth edition of the DSM (1994) 
drew from the research in the 1980s that identified different types of ADHD. It was in the DSM 
– IV that the three subtypes of ADHD (predominantly inattentive type, predominantly 
hyperactive-impulsive type, and combined type) were identified and distinguished from one 
another. As the DSM-IV was revised to the DSM-IV-TR in 2000, the symptoms for ADHD in 
the DSM and the ICD -10 were almost identical, however, the differences remain in the number 
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of symptoms necessary to provide a diagnosis of ADHD. Furthermore, the fifth version of the 
DSM (2013) was the first to address the persistence of ADHD into adulthood by providing 
wording of symptoms that could be expanded to adults’ workplaces rather than only school 
settings in childhood. The DSM-5 built upon the DSM-IV-TR criteria for ADHD diagnoses by 
providing a separate cutoff for symptom presentation in adults and adolescents than children. 
That is, children are required to meet six or more criteria to receive a diagnosis whereas adults 
and adolescents 17 and older are only required to meet five or more criteria. There are stark 
differences in the criteria for ADHD from its introduction in the DSM-II to the present DSM-5, 
these differences can be attributed to the research being conducted on individuals with ADHD 
and the expansion of knowledge about ADHD that comes as a result of the research.  
Faraone and colleagues (2016) conducted a meta-analysis on follow up studies examining 
the persistence of ADHD symptoms in children. Many of the studies included in this meta-
analysis found that a significant number of participants retained their ADHD symptoms over 
time. However, these studies utilized diagnostic criteria that ranged from the DSM-II to the 
DSM-IV, including a wide range of potential DSM criteria for participants to maintain. Although 
in Faraone and colleagues’ (2016) meta-analysis the authors found that children’s ADHD 
symptoms slightly decrease over time, it should be noted that the studies included in the analysis 
evaluated symptom retention through the lens of the DSM diagnosis criteria. As many diagnostic 
criteria for ADHD in earlier versions of the DSM are developmentally inappropriate for adults, 
the criteria used to evaluate the participants in the included studies may not have used 
developmentally appropriate criteria for assessing for ADHD in adolescents and adults; thus, 
reducing the likelihood that an adolescent or adult will meet the criteria long term. In addition, 
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Karam and colleagues (2015) conducted a follow up study on adults with ADHD (N = 344) over 
the course of seven years examining the persistence of ADHD symptomology. Unlike Faraone 
and colleagues’ findings, Karam and colleagues found that the majority (69%) of participants in 
the follow up study retained their ADHD symptoms and continued to meet DSM-IV criteria for 
ADHD in adulthood. These stark differences in findings may be attributed to differences in the 
diagnostic criteria used in each study. Nevertheless, the number of children and adults with 
ADHD is high considering the research on negative outcomes associated with ADHD.  
Children with ADHD are more likely to have poor grades, poor reading and math 
standardized test scores, and be placed in exceptional education classes (Loe & Feldman, 2007). 
Specifically, Barry and colleagues (2002) support the idea that students with ADHD struggle 
with academic achievement with their study on 66 children with ADHD. The researchers 
compared 33 children who met the DSM-IV criteria for ADHD (male, n = 21; female, n =12) to 
33 children without ADHD diagnoses (male, n = 15; female, n = 18) and found that the ADHD 
children showed lower scores on all academic subjects tests (basic skills t [65] =4.82, p < .001; 
reading t [65] = 3.60, p < .01; writing t [65] = 3.82, p < .001; and math t [65] = 4.21, p < .001). 
In addition to academic barriers, children with ADHD also have lower executive functioning 
(Biederman et al., 2004). That is, children with ADHD lack some cognitive abilities necessary 
for goal-directed behavior. Some examples of executive functions include planning and 
organizing, inhibiting an inappropriate response, working memory, cognitive flexibility, and 
problem solving with a future goal in mind. Children and adolescents with ADHD (n = 259), 
when compared to those without (n = 222) had significantly higher instance of executive 
functioning deficits (EFD) with more than double the number of participants with ADHD 
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exhibiting EFDs (33%) than those without (12%; χ2[1, 480] = 30.9, p < .01). Further, children 
with ADHD experience problems in relationships with their peers which are further perpetuated 
by their behavioral reactions to the problems experienced with peers (Hoza, 2007). As such, 
children with ADHD are faced with not only academic, but social and emotional challenges as 
well. Moreover, Currie, Stabile, and Jones (2014) examined the effects of pharmacological 
intervention on academic or emotional outcomes in children with ADHD and found that 
although children in Canada showed a sharp increase in stimulant medication use, these children 
did not show improvement in academic or emotional functioning. Although 30 - 47% of children 
diagnosed with ADHD take medication (Froehlich, Lanphear, Epstein, Barbaresi, Katusic, & 
Kahn, 2007), it is concerning that medications may not address the social and academic 
challenges faced by children with ADHD.  
Similarly, adults with ADHD face their own challenges and are at risk for higher levels of 
stress (Combs, Canu, Broman-Fulks, Rocheleau, & Nieman, 2015), functional impairment at 
school or work, conduct disorder, and marijuana dependence. Moreover, adults with late-onset 
ADHD—that were not diagnosed as a child—are likely to show lower prevalence of 
externalizing problems, and higher Intelligence Quotients (IQ) than those diagnosed in childhood 
(Agnew-Blais, Polanczyk, Danese, Wertz, Moffitt, & Arseneault, 2016). However, adults with 
ADHD often develop coping skills to deal with their hyperactive symptomology. As adults have 
more control of their surroundings, they are better able to choose environments in which their 
ADHD symptoms are not as problematic (Weiss & Weiss, 2004). Children with ADHD have 
issues in the classroom, where they are expected to hinder their activity, and pay attention to the 
teacher. Adults with ADHD are able to choose their work environments and may choose 
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environments that fit their needs. College students are in classrooms and are expected to pay 
attention and manage excessive activity. Specifically, college students with ADHD face unique 
challenges and have more difficulty with organization, setting goals, social impairment, and 
sleep than college students not diagnosed with ADHD (Buchannan, 2011; Gaultney, 2014). In a 
study examining overall wellbeing of college students with ADHD, Buchannan (2011) compared 
wellbeing scores of college students who had reported a prior diagnosis of ADHD (n = 34) and 
those who did not (n = 283). The researcher found that students reporting an ADHD diagnosis 
scored significantly lower on overall wellbeing (t [315] = 3.6, p < .001), perceptions of 
environmental mastery (t [315] = 2.3, p < .05), personal growth (t [315] = 3.4, p < .001), purpose 
in life (t [315] = 4.6, p < .001), and self-acceptance (t [315] = 2.1, p < .05) than those who did 
not report an ADHD diagnosis with the latter four variables being subscales of the total 
wellbeing scale. It should be noted that the results for purpose in life are consistent with the 
extant literature on college students with ADHD. Further, Gaultney (2014) administered a survey 
to freshman college students on their sleep patterns and their ADHD symptomology and found 
that college students with ADHD diagnoses reported less sleep during the weekday than college 
students without ADHD (t [1084] = -2.1, p < .05). In addition, Fedele and colleagues found that 
gender differences exist in college students with ADHD in that women in college with ADHD 
experience more inattentive symptoms and have more problems with home life, social life, 
education, money management, and daily life activities (Fedele, Lefler, Hartung, & Canu, 2012).  
Depression in College Students with ADHD 
Most salient in the literature on college students with ADHD is the prevalence of 
depression, anxiety, and problems with academic achievement. Specifically, Harrison and 
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colleagues (2013) found that college students experiencing stress, depression, and anxiety at high 
levels are more likely to exhibit ADHD symptomology; thus, making misdiagnosis on college 
campuses common due to the comorbidity and similarity in expression with ADHD, depression, 
anxiety, and stress. The authors stress the importance of assessing for depression, anxiety, and 
academic stressors in college students who exhibit ADHD symptoms. Further, Kearns and 
Ruebel (2011) examined emotional regulation in adults with ADHD. The researchers found that 
there are gender differences in ADHD presentation in adults with women scoring higher on 
negative emotion scales (as defined by the Attention-Deficit Scales for Adults; ADSA-Emotive 
Scale) than men. Additionally, irrespective of gender, the researchers found that college students 
with ADHD scored higher on negative emotion (F [2,170] = 7.29, p < .01; η2 = .07). The results 
of these studies further support the evidence that college students with ADHD score different on 
measures of executive functioning, depression, and anxiety, than those without ADHD.  
Specifically, the literature on depression in college students with ADHD further supports 
the notion that college students with ADHD are in need of support for their depressive 
symptoms. An example of such literary support includes Patros and colleagues’ (2013) study on 
college students with depression and hyperactive and inattentive symptoms. The authors 
surveyed college students on their ratings of depression, suicidal ideation, self-harm attempts, 
and hyperactive/inattentive behaviors and found that students with more hyperactive and 
inattentive behaviors were more likely to have more severe depression scores and greater 
prevalence of suicidal thoughts (t [1054] = 3.89, p < .001, R2 = .25) and suicide attempts (t 
[1054] = 3.74, p < .001, R2 = .12). These results identified a strong correlation between suicidal 
behaviors and ADHD symptoms. Similarly, Van Eck, Ballard, Hart, Newcomer, Musci, and 
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Flory (2015) sought to add to these findings by addressing specific mechanisms that contribute to 
suicidal ideation in college students with ADHD. These authors found through path analysis that 
depression was a significant mediator of the association between ADHD and suicidal ideation 
with approximately 33% of the variance in the relationship between ADHD and suicidal ideation 
being accounted for by depression. Further building upon the depression in college students with 
ADHD literature, Meinzer and colleagues (2015) found that ADHD and depressive symptoms 
are positively related (r = .44, p < .01). Moreover, they found that parental involvement in terms 
of maternal and paternal warmth, autonomy, and involvement are significant mediators for 
depression in college students with ADHD.  
Contrastingly, Nelson and Gregg (2012) examined college students with ADHD and 
college students with Dyslexia. Dyslexia is a learning disorder that makes it hard for an 
individual to read. Similar to ADHD, Dyslexia is not a result of delayed development or a lack of 
intelligence; however, academic achievement in children with ADHD and dyslexia may be more 
difficult. The researchers found no significant differences in depression and anxiety scores 
between clinical groups (college students with ADHD and dyslexia) and the nonclinical group 
(college students without a diagnosis of ADHD nor dyslexia). These results are in stark contrast 
to the results of other studies in this area. A potential limitation of this study that may have 
impacted the findings is a lack of a formal validation process for the diagnoses. The researchers 
used self-report assessments and self-reports of ADHD and Dyslexia diagnoses, they may not 
have found differences in the groups in depression and anxiety because the participants may not 
have met the full criteria for the disorders they reported having.  
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Anxiety in College Students with ADHD 
In addition to increased prevalence of depression and suicidal ideation, college students 
with ADHD are at higher risk for anxiety (Anastopoulos et al, 2016). Schatz and Rostain (2006) 
conducted a review of the literature on comorbid anxiety and ADHD. The authors reported 
differences in presentation of ADHD symptomology when comorbid anxiety is present and when 
it is not. Compared to individuals without comorbid anxiety, those with comorbid ADHD and 
anxiety showed higher levels of aggressiveness in childhood (Brown, 2000), lower levels of self-
esteem (Brown, 2000), decreased working memory (Tannock & Schachar, 1995), decreased 
incidence of Conduct Disorder (MTA Cooperative Group, 1999), and increased prevalence of 
sluggish cognitive tempo (Carlson & Mann, 2002; Hartman, Willcutt, Rhee, & Pennington, 
2004). It should be noted, that the studies examined in Shatz and Rostain’s literature review 
included children rather than adults; thus, challenges, adults with comorbid anxiety and ADHD 
may differ from challenges children face. 
Specifically, college students with ADHD have greater incidence of test anxiety and 
anxiety surrounding academic achievement (Nelson, Lindstrom, & Foels, 2014; Prevatt, Dehili, 
Taylor, & Marshall, 2015). Jarrett (2016) examined anxiety and ADHD in college students as it 
relates to executive functioning and found that students with comorbid anxiety and ADHD 
showed less executive functioning—as defined by problem solving, time management, emotion 
regulation, restraint, and motivation—than students with ADHD and anxiety separately. Using 
structural equation modeling, the results identified deficits in executive functioning were most 
closely related to inattention and hyperactive/impulsive symptoms and anxiety. 
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 Specifically, test anxiety saturates the college student with ADHD literature. Hembree 
(1988) conducted a meta-analysis on the construct of test anxiety and found that test anxiety has 
a relationship to self-esteem, fears of evaluation, and other forms of anxiety. Supporting the 
relationship between anxiety and self-esteem, Dan and Raz (2015) examined ADHD, test 
anxiety, and self-esteem in female college students with ADHD. The authors matched 25 college 
students with ADHD to 30 control participants and administered questionnaires based on the 
constructs of self-esteem and test anxiety. Participants with ADHD reported higher levels of test 
anxiety (t [53] = 5.98, p < .001; d = .63). Further, participants with ADHD reported lower levels 
of self-esteem than the control group (t [53] = -4.33, p < .001; d = .5). The results of this study 
provide support for the relationship between ADHD symptoms, anxiety, and low self-esteem in 
college students. 
 In addition, Lewandoski, Gathje, Lovett, and Gordon (2013) examined differences 
between college students with ADHD and those without in their reading skills, and anxiety 
during a high stakes test. The researchers found that although there were no significant 
differences between groups on reading skills, students with ADHD presented with higher test 
anxiety (t [218] = 5.93, p < .001; d = 0.85) and perceived themselves as having more difficulty in 
reading the questions (t [218] = 5.66, p < .001; d = 1.05) than their peers without ADHD 
diagnoses. The results identified that although college students with ADHD perceive themselves 
as having more difficulty reading during a test, their scores were similar to those who do not 
have ADHD; further supporting the idea that college students with ADHD have lower self-
efficacy and self-esteem than those who do not. Moreover, these findings also identified that 
college students with ADHD have higher test anxiety than their peers without ADHD diagnoses.  
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Prevatt and colleagues (2015) expanded the literature on college students with ADHD by 
examining the impact of anxiety on college students with ADHD. The researchers found that 
college students with ADHD reported higher levels of anxiety than those without ADHD. 
Moreover, the college students with ADHD that reported higher anxiety expressed that their 
anxiety is more closely related to their academic factors like studying or test taking, (F [1, 300] = 
30.00, p < .01; d = 0.68) than life in general. In addition to Prevatt and colleagues’ findings, 
Nelson and colleagues (2014) found that college students with ADHD present with higher levels 
of overall anxiety as well as test anxiety. The findings reported above provide further support for 
the premise that college students with ADHD are not only in need of generalized anxiety 
support, but academic anxiety support as well.  
Finally, in a large multi-site study comparing college students with ADHD to those 
without any comorbid disorders, Anastopoulos and colleagues (2016) collected data on ADHD 
symptomology, mood disorders (anxiety and depression), and externalizing behavior 
(Anastopoulos, et al, 2016). Symptomology was assessed using the ADHD Rating Scale, Self-
Report and Parent Report scales, Semi-Structured Interview for Adult ADHD, Beck Anxiety 
Inventory, Beck Depression Inventory, and the Externalizing Behavior Rating Scale. Overall, 
55% of the ADHD group exhibited comorbidity, significantly more than the non-ADHD group 
(11%; χ2 [1] = 96.1, p < .001). Moreover, 31% of the ADHD group showed evidence of two or 
more comorbid disorders, being more prevalent than the non-ADHD group in which only 4% 
showed evidence of two or more non-ADHD disorders (χ2 [1] = 58.3, p < .001). Further, anxiety 
disorders were more prominent in the ADHD group as well (χ2 [1] = 51.6, p < .001) with 28.6% 
of participants with ADHD presenting with anxiety disorders as compared to 3.6% of the non-
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ADHD group. Anxiety disorders included generalized anxiety disorder, panic disorder, social 
phobia, and anxiety disorder not otherwise specified. This study’s findings adds to the literature 
by illuminating the breadth of anxiety disorders college students with ADHD may face and 
expanding the literature to include forms of anxiety in addition to test anxiety. 
Academic Achievement in College Students with ADHD 
In addition to increased prevalence of depression and anxiety in college students with 
ADHD, academic achievement and self-efficacy is yet another area in which college students 
with ADHD struggle. Academic self-efficacy is defined as judgements of one’s capabilities to 
achieve academic or educational tasks (Bandura, 1977). Tabassam and Grainger (2002) further 
supported the idea that self-efficacy may contribute to academic achievement. The researchers 
examined the differences in scores on academic self-concept, academic attributional styles, and 
academic self-efficacy beliefs in elementary school students with Learning Disabilities (LD), and 
comorbid ADHD and LD. They found that both the LD and LD/ADHD groups scored lower on 
the self-efficacy assessments than students not diagnosed with ADHD or LD (F [2, 166] = 18.43, 
p < .001). However, there were no differences between the LD/ADHD and LD only groups. 
These findings identified that even from a young age, students with ADHD struggle with self-
efficacy as it pertains to academic achievement. Academic self-efficacy has a positive 
relationship to grades and achievement throughout one’s development (Caprara, et al, 2008). 
Thus, children with lower academic self-efficacy are likely to retain their low academic self-
efficacy into adulthood (Zimmerman, 1995). Additionally, in a study on the academic self-
efficacy of adolescents with ADHD, Major, Martinussen, and Weiner (2012) found that students 
with ADHD had lower academic self-efficacy (as measured by the SELF; Zimmerman & 
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Kitsantas, 2007) than students without ADHD. Further, female students with ADHD showed the 
lowest academic self-efficacy of the groups (F [3, 51] = 6.46, p < .01; η2 = .26). Male 
adolescents with ADHD had lower academic self-efficacy than females without ADHD but 
higher academic self-efficacy than females with ADHD.  
As noted, college students with ADHD are at higher risk of failing classes, withdrawing 
from courses, and dropping out of degree programs than students without ADHD (Blase et al, 
2009; Heiligenstein et al, 1999; Weyandt & DuPaul, 2013). Moreover, Dupaul and colleagues 
(2015) examined the differences in self-rated academic achievement in college students with and 
without ADHD. The researchers found that students with ADHD showed lower academic self-
ratings than those without ADHD (F [3, 12335] = 66.61, p < .001; η2 = .016). Of course, the 
symptoms associated with ADHD (i.e., inattention, hyperactivity, impulsivity) make academic 
achievement difficult for students. However, the literature on ADHD and academic achievement 
has shifted to include other factors such as study skills and self-efficacy for learning as potential 
covariates in the relationship between ADHD and academic success in students. Advokat and 
colleagues (2011) found that college students with ADHD, when compared to college students 
without ADHD, have similar study habits, yet, the students with ADHD had lower high school 
and college grade point averages (GPAs), withdrew from more classes, and had lower American 
College Test (ACT) scores. Turnock, Rosen, and Kaminski (1998) examined the differences in 
academic coping behaviors of students with ADHD and those without. They found that college 
students with higher ADHD symptomology used fewer academic coping behaviors than those 
without ADHD (F [7, 135] = 10.47, p < .001; R2 = .35). Additionally, expanding Turnock and 
colleagues’ findings, Norwalk and colleagues (2009) found that higher ADHD symptomology 
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related to lower career decision making self-efficacy (r = -.27, p < .001), academic adjustment (r 
= -.32, p < .001), and study skills (r = -.25, p < .001), suggesting that various factors, including 
academic self-efficacy, may influence academic achievement in college students with ADHD.  
Additionally, it should be noted that there exists literature supporting differences between 
the subtypes of ADHD (inattentive and hyperactive/impulsive) and academic achievement with 
inattentive symptoms predicting academic impairment better than hyperactive symptoms in 
adults (Frazier, Youngstrom, Glutting, & Watkins, 2007; Rogers, Hwang, Toplak, Weiss, & 
Tannock, 2011). However, other studies examining the effects of inattentive and hyperactive 
symptoms on academic achievement show that both inattentive symptoms and hyperactivity in 
children influence academic achievement (Loe & Feldman, 2007; Merrell & Tymms, 2001). The 
difference between the former and the latter being that the former studies included adult samples 
while the latter included children in their samples; which is important to note as 
hyperactive/impulsive symptoms in adult ADHD are less reported (Millstein, Wilens, 
Biederman, & Spencer, 1997). 
Interventions for the Treatment of ADHD   
 In light of the aforementioned challenges and negative outcomes associated with ADHD, 
helping professionals utilize various interventions to help mitigate the symptoms of ADHD. 
Researchers have long been testing the efficacy of interventions to assist children, adolescents 
and adults with ADHD. Extant literature on the treatments for ADHD vary from interventions 
like hypnosis to stimulant medication. The following section presents the literature on treatment 
options for individuals with ADHD. 
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 Medication is the most common form of treatment for ADHD in children and adults. 
Cunill, Castells, Tobias, and Capella (2016) conducted a meta-regression on studies utilizing 
placebo controlled designs to assess the efficacy of medication on ADHD symptoms. The 
authors found that: (a) medications are effective in reducing ADHD symptoms, (b) participants 
in studies where concurrent psychotherapy was offered showed better improvements, (c) 
individuals who received medications were more likely to discontinue their medication than 
those in placebo groups, and (d) medications were associated with more side effects than placebo 
groups. These themes reported in Cunil and colleagues’ study are supported by other researchers 
as well. 
 Prince and colleagues (2006) noted that stimulant medications are the most often used 
form of treatment for ADHD symptom management in adults. Extant research identifies that 
ADHD symptoms may be a result of imbalanced neurotransmitters (such as dopamine) in the 
brain (Preston, O’Neal, & Talaga, 2010). Stimulant medications address the imbalance of 
dopamine in the brain by inhibiting dopamine reuptake. That is, when neurons release dopamine 
into a synapse to be absorbed by other neurons, the stimulant medications bind to the neurons to 
prevent the dopamine from being absorbed back into its neuron of origin, thus creating more 
dopamine in the brain. There are four classes of stimulant medications that are used to treat 
ADHD: (a) Methylphenidate, (b) Dextroamphetamine, (c) Amphetamines, and (d) 
Lisdexamphetamine (Preston, et al., 2010). When prescribed to treat ADHD, each of these 
medications may be prescribed in an immediate-release or an extended-release form. The main 
effects of stimulant medications include increased attention and concentration. Additionally, 
Alpha-2 andregenic agonists such as clonidine and guanfacine may be used to treat irritability 
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and impulsivity in children with ADHD. Further, because depression is often comorbid with 
ADHD in children, antidepressants such as Wellbutrin and Strattera may be prescribed. Only 
antidepressants whose mechanisms of action increase dopamine or norepinephrine in the brain 
may be effective on ADHD symptoms. For example, antidepressants that are classified as 
selective serotonin reuptake inhibitors (SSRIs) do not have the same effects on ADHD 
symptoms as antidepressants that inhibit the reuptake of dopamine. One stimulant medication 
that shows potential in having a longer duration of effect than most stimulants is 
Lisdexamfetamine dimeslyate (LDX). DuPaul and colleagues (2011) conducted a double-blind, 
placebo controlled crossover study on the effects of LDX in college students with ADHD. 
Twenty-four college students with ADHD and 26 students without ADHD participated in the 
study. Treatment began with a one week baseline which included no medication, in the following 
four weeks, participants were administered a placebo, and LDX in 30, 50, and 70mg doses, each 
for one week. Control participants did not receive LDX at all and only participated in the 
baseline phase. The researchers found significant differences in ADHD symptom presentation 
(as measured by the CAARS) between baseline assessment and with each dosage of LDX. 
Inattention scores were significantly lower (F [4, 84) = 8.88, p < .001; η2 = .30) as well as 
hyperactivity (F [4, 84) = 14.7, p < .001; η2 = .41) and ADHD Index (F [4, 84) = 10.9, p < .001; 
η2 = .34). Other researchers (e.g., Adler, et al, 2008; Brams, Giblin, Gasior, Gao, & Wigal, 2011; 
Faraone, Spencer, Kollins, Glatt, & Goodman, 2011; Findling, et al., 2011) support the efficacy 
of LDX in reducing ADHD symptoms as well.  
 Another prescribed and researched medication for ADHD symptoms is methylphenidate 
(MPH). Researchers have found that MPH is effective in reducing ADHD symptoms in adults 
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(Bouffard, Hechtman, Minde, & Iaboni-Kassab, 2003; Kooij, Burger, Boonstra, Van der Linden, 
Kalma, & Buitelaar, 2004; Rosler, Fischer, Ammer, Ose, & Retz, 2009; Spencer, et al, 2005). 
Although the efficacy of MPH has been researched at length, there are no studies that 
specifically explore the efficacy of MPH in college students. 
Additionally, Weyandt and colleagues (2014) conducted a systematic review of the 
literature on the efficacy of stimulant medications on ADHD symptoms. They found that 
medications such as methylphenidate, amphetamines, and LDX are effective in reducing ADHD 
symptoms in adolescents and adults with ADHD. However, Weyandt and colleagues also 
explored the phenomenon of stimulant medication misuse in adolescents and adults with and 
without ADHD. Depending on the population studied, prevalence of stimulant misuse is between 
1.7% and 55%. Individuals at higher grade levels tend to misuse stimulant medications at a 
higher rate which is alarming when considering college students with ADHD. Arria and 
colleagues reported that 26.7% of college students with ADHD overuse their medications and 
15% use other individuals’ medications in order to increase attention and help them stay up all 
night (Arria, Caldeira, O’Grady, Vincent, Johnson, & Wish, 2008). In addition to the increased 
likelihood of stimulant medication misuse, another issue with pharmacological intervention is 
long term effects. Craig and colleagues (2015) evaluated the long term effects of stimulant 
medication when used to treat ADHD. The researchers reviewed the key articles on long term 
outcomes associated with medication and ADHD. They found that although stimulant 
medication is effective when used as prescribed in the short term, long-term randomized trials 
have not been done, thus limiting the ability to determine how effective stimulant medications 
are in treating ADHD longitudinally.  
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Craig and colleagues (2015) brought to light another issue pertaining to using medication 
to reduce ADHD symptoms. The authors state that short term use of medication is beneficial 
when the medication is taken as prescribed. Medication adherence is a common challenge in 
adolescence as youth tend to gravitate toward independence and prefer not to take medication for 
ADHD (Meaux, Hester, Smith, & Shoptaw, 2006). Langberg and Becker (2012) reviewed the 
literature on stimulant medication in youth with ADHD and found that from nine studies, 
stimulant medication is effective in improving academic achievement in children with ADHD. 
However, they found that the studies included in the review had major limitations including the 
protocol for measuring medication adherence. They call for more stringent forms of measuring 
medication adherence in studies and more research on medication adherence in children with 
ADHD. More research is also needed in adults with ADHD and medication adherence as there is 
a dearth in the literature on this topic. Additionally, Gau and colleagues (2006) conducted a 
study on 307 children with ADHD examining their medication adherence patterns and their 
reasons for not adhering to medication. They found that 25.7% of the children involved in the 
study had poor medication adherence. The researchers then sought to determine the reasons for 
the children not adhering to their medication routines. They found that 72.7% of children 
reported forgetting to take their medications as their primary reason, with 20% reporting that a 
lack of effect of the medication led to them discontinuing, and, 12.7% of children refused to take 
their medication. 
 Moreover, Gould and Doucette (2016) examined reasons why college students with 
ADHD do not adhere to their medications. They found that college students with ADHD are 
more likely to take their medication on weekdays because of their beliefs that the medication 
38 
 
helps with schoolwork. Additionally, they found that students attributed forgetfulness and side 
effects to their lack of medication adherence on weekends. McCarthy (2014) reviewed the 
literature on overall stimulant medication adherence in individuals with ADHD. She found that 
the beliefs about medication had a large effect on adherence in adolescents and adults with 
ADHD. Similar to Gould and Doucette (2016), participants in the studies McCarthy reviewed 
expressed that the pros of taking medication include a reduction in ADHD symptomology, 
increased productivity at school/work, and improved social relationships. However, the cons 
reported by the participants in the reviewed studies included the physical side effects associated 
with stimulant medications, stigma associated with medication use, and the inconvenience of 
taking medications.  
While medication is the most common form of treatment for ADHD symptoms in adults 
and children, the Multimodal Treatment Study of Children with ADHD (MTA group) suggest 
that medication, paired with psychotherapy, is the most beneficial in reducing ADHD symptoms 
(MTA Cooperative Group, 1999). However, between 1987 and 1997, children receiving 
medication and psychotherapy decreased the number of psychotherapy sessions and increased 
stimulant prescriptions (Olfson, Gameroff, Marcus, & Jensen, 2003). With that said, adults with 
ADHD are often referred for psychotherapy services due to comorbid anxiety and depression, or 
substance abuse (Faraone, et. al, 2000). They types of psychotherapy offered to adults with 
ADHD varies as presenting concerns may differ within this population. The most common form 
of psychotherapeutic treatment for adults with ADHD are cognitive and behavioral therapies. 
Safren and colleagues (2005) explored the efficacy of a Cognitive Behavioral Therapy (CBT) 
therapeutic intervention with 31 adults with ADHD who were also concurrently taking 
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medication during the CBT intervention (Safren, Otto, Sprich, Winett, Wilens, & Biederman, 
2005). The researchers randomly assigned participants to either the CBT or non CBT groups. All 
participants continued taking their medication as prescribed regardless of assigned group. They 
found that participants in the CBT group showed greater improvements in self-report (F [1, 27] = 
10.54, p < .01) and evaluator reported (F [1, 28] = 8.72, p < .01) ADHD symptomology. Thus, 
supporting the notion that combined medication and psychotherapy is more beneficial than 
medication alone. Further, Wilens and colleagues (1999) evaluated 26 charts of adults with 
ADHD receiving Cognitive Therapy (CT) and taking medication as prescribed for their ADHD 
symptoms. They found that 69% of the participants were “improved” or “much improved” after 
24 sessions of CT. 
 Further, Costello and Stone (2012) call for the use of positive psychology with college 
students with ADHD. The authors assert that helping professionals in higher education should 
utilize positive psychology principles to improve self-efficacy by focusing on students’ strengths. 
Although it is important to emphasize students’ strengths to increase self-efficacy, positive 
psychology may not assist in the mediation of the specific ADHD symptoms of impulsivity and 
inattention in college students. To address specific ADHD symptoms in college students, 
researchers utilize more cognitive and behavioral interventions. For example, Eddy and 
colleagues (2015) evaluated the efficacy of a CBT protocol for ADHD in four college students 
(Eddy, Canu, Broman-Fulks, & Michael, 2015). The researchers utilized a CBT protocol that 
included eight sessions with four modules. The purpose of the CBT intervention was to provide 
psychoeducation about ADHD, introduce skills to manage attention span and distractibility 
issues, and adapt cognitive patterns contributing to the maladaptive symptoms of ADHD. The 
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participants overall showed marked improvement in their inattention and hyperactivity as 
evidenced by a mean score reduction on the Conner’s Adult ADHD Rating Scale (CAARS) of 
8.25. Additionally, the participants showed an increase on the self-concept scale of the CAARS, 
providing evidence that CBT can help in reducing ADHD symptoms and increasing self-concept 
in college students with ADHD. Although there were only four participants in Eddy and 
colleagues’ study, the promising results provide evidence for a future randomized control trial 
(RCT) on the efficacy of CBT as an intervention for ADHD symptoms in college students. 
 Moreover, Fleming, McMahon, Moran, Peterson, and Dreessen (2015) conducted a small 
scale RCT on the efficacy of a Dialectical Behavioral Therapy (DBT) group intervention for 
college students with ADHD. Building upon Philipsen and colleagues’ research on the efficacy 
of DBT with adults with ADHD, Fleming and colleagues sought to apply DBT to college 
students with ADHD. Dialectical Behavioral Therapy was designed to be used to treat Borderline 
Personality Disorder (BPD), Philipsen (2006) argues that because ADHD and BPD have some 
similar behavioral components (i.e., impulsivity, emotion regulation), DBT may also be effective 
in treating ADHD symptoms in adults. Specifically, a DBT skill group intervention may be 
useful with this population because of its integration of mindfulness and behavioral strategies 
that may increase attention and decrease impulsivity in college students with ADHD (Philipsen, 
2006). Fleming and colleagues assessed ADHD symptoms in a treatment and control group pre 
and post the nine session DBT intervention. They found that at post assessment, the control 
group—which received self-guided skills training handouts—did not differ significantly than the 
treatment group (F [1, 31] = 2.29, p = .14; d = .55). However, participants in the DBT group 
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showed greater improvement at the three month follow up assessment than the control group 
with a large effect size (F [1, 31] = 5.82, p < .05; d = .81).  
 Yet another form of psychotherapeutic intervention posed by Anastopoulos and King 
(2015) is a group therapy intervention that incorporates Cognitive Behavioral Therapy as well as 
mentoring for college students with ADHD to mitigate their symptoms and improve daily 
functioning. Participants were provided eight weeks of 90 minute group CBT sessions after 
which, the participants met with mentors for 30 minutes each week. The CBT group sessions 
included psychoeducation about ADHD, skills training to help mitigate issues with inattention 
and impulsivity, and time management/ organization strategies. The mentoring sessions included 
a mentor providing campus resources to individuals and as well as monitoring the student’s 
understanding of ADHD symptoms and progress in learning the skills from the group sessions. 
Additionally, the mentors assisted the students in applying the skills they learned in group to 
their daily lives. The researchers found significant improvements in inattentive symptoms (t [42] 
= 4.81, p < .001; d =.76), and total ADHD symptoms (t [42] =3.8, p <.001; d = .60).  
The aforementioned studies provide evidence of the efficacy of cognitive and behavioral 
interventions with ADHD in college students. Although psychotherapy provides a holistic 
solution to the social and emotional challenges of ADHD in college students, CBT does not 
address the physiological aspect of ADHD. As such, college students may learn the skills 
necessary to regulate their impulsivity; however, counselors may not be aware of how the 
neurological aspects of ADHD play a role in therapy. Meyers and Young (2012) acknowledge 
neurofeedback (NF) as an intervention that addresses the physiological complexities of mental 
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disorders while also providing an avenue through which counselors may integrate neuroanatomy 
and neuroscience into clinical counseling practice.  
Neurofeedback as a Treatment for Mental Disorders 
Neurofeedback (NF), also called neurotherapy, is a clinical application of neuroscience in 
which the basic principles of biofeedback and cybernetics are combined. Biofeedback is the 
monitoring of an automatic bodily function in order to raise awareness of the function and assist 
an individual in gaining control of that function. In NF, the bodily function being observed is the 
brain’s electrical activity. Cybernetics is the study of automatic control systems in machines and 
living things. In NF, the automatic control system being studied is the autonomic nervous system 
(ANS) in the brain, the ANS is responsible for controlling bodily functions such as breathing and 
the heartbeat. Thus, neurofeedback is a form of monitoring the automatic systems in the brain 
and providing feedback to the brain in order to increase self-regulation of brain functioning 
(Gunkelman & Johnstone, 2005).  
The brain self-regulates blood flow to certain areas through the dilation and constriction 
of blood vessels. An increase in blood flow to a particular area of the brain has been shown to 
directly relate to the electrical activity in that area of the brain. Therefore, Electroencephalogram 
(EEG) activity is directly regulated by the brain itself. Consequently, maladaptive behaviors may 
manifest in an individual whose EEG patterns are dysregulated. Specifically, in individuals with 
ADHD, Chabot and Serfontein (1996) found that EEG activity characterized by insufficient 
alpha and/or theta wave activity in the frontal lobe was more prominent in children and adults 
with ADHD than in those without ADHD. The frontal lobe is located at the front of the brain and 
is one of the latest lobes to reach maturity. Additionally, the frontal lobe is mostly associated 
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with logic, reasoning, attention, focus, planning, motivation, and short term memory. Moreover, 
alpha and theta brainwaves are associated mostly with relaxation, memories, and emotions. An 
excess or deficiency of alpha or theta wave activity can lead to difficulties in attention, 
concentration, problem solving, and relaxation. Thus, an electrical dysregulation in the frontal 
lobe, specifically with alpha and theta wave imbalance, provides physiological support for the 
inattentive and hyperactive behaviors associated with ADHD.  
As has been established by Sterman (2000) in his early 1960’s research, it is possible to 
train the brain to regulate EEG activity. The brain’s electrical activity is a form of behavior, and 
by providing feedback to the brain on its dysregulated behavior, clinicians may condition the 
brain to regulate its behavior, thus mitigating the symptoms associated with the dysregulated 
behavior. The purpose of NF is to determine what the deficits or excesses are in an individual’s 
EEG activity, and provide feedback to the brain to remediate the discrepancies. Clinicians collect 
quantitative EEG (qEEG) data of the individual’s brain activity to interpret and develop an 
individualized NF training protocol for the individual. Clinicians may compare the qEEG data 
from a client to a large external database (available from the Journal of Neurotherapy, 2003) to 
determine which brainwave frequencies should be targeted in NF training. However, there are 
some types of NF (i.e., sLORETA Z-Score training) that have combined the NF training with the 
database comparison of qEEG scores in a seamless process. In Z-Score NF training software, 
individuals’ qEEG scores are continuously being compared to a database of qEEG scores from 
individuals who are similar in demographics. When an individual’s brainwave activity is 
different than the database determined norm, the NF system provides feedback to the brain 
through visual or auditory avenues. The audio and visual feedback allows the brain to become 
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aware of how it is dysregulated so that it may function in a more regulated manner. Specifically, 
clinicians may target “problem areas” for individuals that are related to their symptomology. For 
example, individuals with ADHD may receive NF protocols that target frontal alpha/theta 
activity as research shows that individuals with ADHD have dysregulated activity in that area. 
Arnold (1999) conducted a systematic literature review on the existing research on 
alternative treatments for ADHD. In this review, the author listed a total of 23 alternative 
treatments to medication for ADHD and the research supporting the treatments as well as the 
limitations of the treatments. Of the 23 alternative treatments, EEG biofeedback (also called 
neurofeedback) was included on the list and rated as “3: promising prospective data, lacking 
important control trials with trends suggesting further exploration” (p. 38) on a rating scale from 
one to six, with six representing treatments that “should be considered established treatment for 
the appropriate subgroup” (p. 38). It should be noted, however, that Arnold’s review was 
completed in 1999. Since then, numerous controlled trials have been conducted and have shown 
the efficacy of NF on ADHD symptoms in numerous populations.  
Neurofeedback as a Treatment for Depression 
College students with ADHD are at risk of experiencing depression at a higher rate than 
college students without ADHD (Nelson & Gregg, 2012). Much of the research on NF efficacy 
has been conducted on small samples. Case studies and single case designs populate much of the 
neurofeedback literature (Decker, Roberts, & Green, 2014; Gracefire & Durgin, 2012; 
Hammond, 2003; Leddick, 2011); however, the results of studies on the efficacy of NF in the 
depression literature are promising. Hammond (2005) reviewed the NF and depression literature 
and concluded that NF has the potential to reduce depressive symptoms by training the functions 
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in the brain that contribute to depression. Researchers have theorized that depressive symptoms 
are a result asymmetry in frontal alpha wave activity (Davidson, 1998, Henriques & Davidson, 
1991). As such, when utilizing NF with individuals with depression, researchers have 
incorporated NF protocols that target frontal alpha asymmetry (Hammond, 2000; Rosenfeld, 
1997). 
Baehr, Rosenfeld, and Baher (2001) examined the efficacy of NF on depressive 
symptoms in adults, including exploring the impact of alpha–theta neurofeedback on alpha 
asymmetry. This study incorporated participants that had been provided at least 27 
neurofeedback sessions prior to the data collection. The authors collected Beck Depression 
Inventory (BDI; Beck, Steer, & Garbin, 1988) scores from each participant before and after the 
NF intervention as well as either one, three, or five years after the participant completed NF 
sessions. The participants in this study included three adult individuals, one male (one year 
follow-up), and two females (three and five years follow-up). BDI scores were compared from 
pre NF to post NF and from pre to follow up. The differences in the scores were calculated and 
the authors found that participants retained their BDI scores from their posttest to the follow-up, 
providing evidence that the effects of NF can last as long as five years. 
Building upon this research by including a pretest, Cheon and colleagues (2015) 
conducted a one group pretest posttest quasi-experiment examining the effects of NF on adult 
psychiatric patients’ symptomology. This study included adult 77 psychiatric patients with a 
DSM – IV diagnosis of a mental disorder, patients with a diagnosis of any personality disorder   
were excluded from the study. The researchers used an audio-visual NF model in which the 
feedback for participants was provided in the form of an increase in scores and graphs on a 
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computer game. They trained beta and SMR audio-visually while training alpha-theta activity 
with audio feedback only. The purpose of the training was to reduce alpha and increase theta and 
beta activity. Approximately half of the participants in the study received more than 10 sessions 
of NF (n = 39), with 25 participants receiving more than 20 sessions of NF. Of the 77 
participants in the study, 19 participants presented with depressive disorders; however, all 
participant data were analyzed together regardless of symptomology. The authors utilized the 
Clinical Global Impression-Severity scale which provided a broad overall objective rating of 
treatment effectiveness on a 7-point scale. Thus, no specific psychiatric disorder was examined, 
rather, the overall functioning of participants was assessed. The team of researchers each rated 
the participants on the scale and the interrater reliability was good (κ > .9). Additionally, for a 
subjective measure of outcomes, the researchers utilized the Hill-Castro Checklist for a rating of 
symptom improvement. The Hill-Castro Checklist provides a broader view of patient functioning 
by providing a percentage rather than a cutoff score. The researchers used a paired t test to 
examine the effect of NF on the participants by comparing pre and post CGI and Hill-Castro 
scores on PASW (statistical analysis software). They found a significant decrease in CGI scores 
after treatment (p < .001, no effect size reported). It should be noted that although only 22 
participants completed the pre and post Hill-Castro assessments, they reported improvements in 
depression, anxiety, self-esteem, hostility, attention, and hyperactivity scales of the Hill-Castro 
(all p < .001) but not for other scales.  
Further into the depression and NF literature, Cheon, Koo and Choi (2016) investigated 
the effects of NF on depressive symptoms and electrophysiological disturbances in 20 adults 
(female n = 16, male n = 4) with DSM-IV-TR diagnoses of Major Depressive Disorder (MDD). 
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This study builds upon Baer and colleagues’ (2001) study by including a pre- and post-test while 
also examining the effects of NF on depression specifically in an adult population. The 
participants in this study were diagnosed by trained psychiatrists using the DSM-IV Structured 
Clinical Interview for Depression. Individuals were not excluded from participation if they were 
taking medications but were not allowed to begin a new medication regimen over the course of 
the study. The authors used one total hour of beta and alpha training to increase beta activity (30 
minutes) and reduce alpha activity (30 minutes). Participants attended training sessions 2-3 times 
per week for eight weeks. Assessments (Hamilton Depression Rating Scale, HAM-D; Hamilton 
Anxiety Rating Scale, HAM-A; Beck Depression Inventory, BDI; and Clinical Global 
Impression-Severity, CGI:S) were administered at the baseline (pre), four week (mid), and eight 
week (post) time points. The researchers conducted a Repeated Measures ANOVA on the PASW 
statistical software and found significant improvements in HAM-D, HAM-A, BDI, and CGI-S 
scores (p < .005, no effect size reported). BAI scores did not significantly change but were 
approaching significance (p = .01; Bonferroni adjusted α = .005). The results indicate that 
individuals who are provided a NF intervention over the course of eight weeks are likely to 
improve in their depression scores. However, a limitation of this study is its lack of a control 
group, preventing the authors from stating causality or generalizing their results.  
Choobforoushzadeh and colleagues (2014) sought to expand the NF efficacy research to 
individuals who have been diagnosed with Multiple Sclerosis (MS) who have also experienced 
significant depression and fatigue. The researchers utilized a comparison group (treatment as 
usual, TAU) experimental design with 24 participants in an Iranian Hospital. Participants in the 
treatment group received two sessions of NF each week for a total of eight weeks. The 
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researchers used a similar NF protocol as Choi and colleagues (2011). Procomp 2 Infiniti NF 
system was used to train the increase of theta activity and the decrease of alpha activity with 
reinforcement of 15-18hz beta activity. Feedback was administered in the form of a videogame 
with audio and visual feedback. When beta activity was higher than the predetermined threshold 
and alpha or theta was lower than the threshold, participants were rewarded by the game being 
active, if the game was not active, that was indication that the beta, alpha, or theta waves were 
out of the training range. Assessments included the Expanded Disability Status Scale (EDDS; 
only administered at the first session to confirm MS symptom severity), Fatigue Severity Scale, 
and the Depression Subscale of Hospital Anxiety and Depression Scale (HADS). Each of these 
assessments were administered pre, post, and two months after the end of NF sessions (follow 
up). The researchers conducted a Repeated Measures ANOVA to determine if there were 
differences in the assessment scores over time between groups. They found that there is a 
difference between pre to post to follow up in depression scores for the treatment group (F [2, 
21] = 6.5, p < .005), and there is a difference between treatment and control group scores on the 
assessments for pre, post, and follow up for interaction of group and time (F [2, 21] = 13.7, p < 
.005). The mean differences indicated that the treatment group improved whereas the control 
group scores remained stable across time. The largest improvement was from pre to post 
assessments in the treatment group, but both groups were stable between post and follow up. The 
authors reported a small effect size (d = .29), indicating that the means of the treatment group 
were not largely (but statistically significantly) different than the means of the comparison group. 
Thus providing evidence that the intervention made a significant impact on depression and 
fatigue in adults with MS and that NF has the potential to improve depression in adults. 
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To build further upon the depression literature, Choi and colleagues (2011) addressed the 
limitation of Cheon and colleagues’ study by implementing a comparison group in their study 
design examining the effects of alpha-wave NF on depressive symptoms. The researchers 
conducted five weeks of mid-frontal alpha targeted NF using the Procomp Infinity asymmetry 
protocol. The goal of this protocol is to increase right mid-frontal alpha activity and decrease left 
mid-frontal alpha activity to reduce asymmetry in alpha frequencies across the brain. After the 
treatment group finished their NF sessions, they were provided additional practice sessions to 
help them practice retaining their mental states without the assistance of the NF protocol. The 
comparison group in this study received psychoeducation sessions in which they were 
administered assessments and provided an interpretation of their results. The participants in the 
comparison group were also provided psychoeducation on their depressive symptoms. The 
authors utilized the HAM-D (clinician-rated and verified by two other psychologists) as an 
objective form of assessment. Subjectively, the authors administered the Daily Stress Scale, 
Automatic Thought Questionnaire-Positive, ATQ-P, Automatic Thought Questionnaire-Negative, 
ATQ-N, and the BDI-II to assess participant levels of depression. To analyze the data gathered, 
the researchers conducted a Repeated Measures ANOVA on the pre and post scores of the 
assessments. There were no significant pre-training differences between the treatment and 
control groups; however, they found a significant difference in BDI-II, ATQ-N, and HAM-D 
scores over time (BDI-II, F [1, 20] = 6.87, p < .05; ATQ-N, F [1, 20] = 6.02, p < .05; HAM-D, F 
[1, 20] = 5.96, p < .05). The BDI-II and ATQ-P data did not meet did not meet parametric 
assumptions for a post hoc test, so they used Mann Whitney U tests for each group individually. 
Post hoc tests determined that the scores in the treatment and control group were significantly 
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different (ATQ-N, t [21] = -2.27, p < .05; HAM-D, t [21] = -2.70, p < .05; BDI-II U = 31, p < 
.05; ATQ-P U = 32.5, p < .05; no effect sizes reported). The results identified that NF may be 
effective in decreasing depression in adults with depression when compared to psychoeducation. 
It should be noted that there are no NF and depression studies in the counseling literature and 
that the psychoeducation provided in this study was provided by psychologists rather than 
counselors. Meyers and Young (2012) further state the need for more research on NF in the 
counseling literature.  
Overall, the literature on depression and depressive symptom reduction with NF is scarce. 
Further, there is no literature specifically on the efficacy of NF in college students with 
depression, let alone college students with comorbid depression and ADHD. However, the 
research that exists shows that NF, regardless of specific protocol, has the potential to reduce 
depressive symptoms in adults. The current study seeks to build on the depression and NF 
literature by examining changes in depressive symptoms in college students with ADHD, a 
population that has not yet been examined in the literature.  
Neurofeedback as a Treatment for Anxiety  
Moore (2000) conducted a review of the literature on Electroencephalogram (EEG) NF 
and its use with anxiety symptoms. The literature review included studies that focused on the 
four most studied types of anxiety, including Generalized Anxiety Disorder, Phobic Anxiety, 
Obsessive Compulsive Disorder, and Post-Traumatic Stress Disorder. Moore concluded after 
reviewing the literature on NF and anxiety that the research on NF and anxiety shows promise. 
Of the eight studies included in this review, the largest sample was 18 in Garrett and colleagues' 
(1976) study with Phobic Anxiety. Glueck and Stroebel’s (1975) study on Obsessive Compulsive 
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Disorder (OCD) had the least number of participants with a sample of four. Most of the protocols 
in the review used NF protocols to increase alpha and theta activity and most reported 
statistically significant increase in targeted brainwave activity. Clinical outcomes included 
decreases in test anxiety (Garrett & Silver, 1976; p < .001), decrease in rumination in OCD 
(Mills & Solyom, 1974; 22% increase in alpha levels for one of four participants), and decrease 
in the need for pharmacological intervention (Peniston, 1991; χ2 = 23.26, p < .05, participants in 
the treatment group significantly reduced their medicine use over the course of NF treatment). 
The results of these studies show that NF has the potential to be effective in decreasing 
symptoms of anxiety and the need for medication in individuals with anxiety.  
Hammond (2003) conducted case studies on two individuals with Obsessive Compulsive 
Disorder (OCD) diagnoses. Both 25 years old, the male and female participants were given the 
Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and Padua Inventories before and after their 
respective NF sessions. The female participant received 21 sessions of NF using Hammond’s 
depression protocol. The male participant, who also had an ADHD diagnosis, received 93 total 
NF sessions, 44 of which specifically targeted beta activity. The results are significant in that 
they are comparable to effects found in pharmacological intervention studies in which the most 
commonly used medication for OCD (clomipramine) was shown to produce a 1.33 SD 
improvement in participants on the Y-BOCS (Ackerman & Greenland, 2002). With that being 
said, the female participant experienced a 3.7 SD improvement and the male participant 
experienced a 3.0 SD improvement on pre and post Y-BOCS scores, suggesting that NF was 
more effective than clomipramine in reducing anxiety symptoms in these two individuals. 
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However, the design of this study does not allow the researchers to state causation nor are the 
researchers able to generalize these findings to other adults with anxiety. 
In addition, Gracefire and Durgin (2012) completed a study including three individuals 
who presented with anxiety. Each participant received NF in the form of 19 point Z score Low-
Resolution Electromagnetic Tomography (LORETA) training. That is, the clinicians measured 
brain activity using an electrode cap with 19 points for measuring electrical activity in the brain. 
LORETA training is specifically different and more sophisticated than from other forms of NF in 
that it includes a three-dimensional representation of brainwave activity. The researchers 
measured participant brain activity at their most problematic areas. That is, qEEG data were 
recorded and reviewed after the completion of NF sessions. Participant 1 (a 30 year old female 
taking clonazepam for Generalized Anxiety Disorder symptoms) was experiencing excessive 
activity at 21hz before NF. By the end of one NF session, the participants 21hz activity 
decreased from 3.32 SD to 2.31 SD. Moreover, Participant 2 (29 year old female with severe 
social anxiety) showed a decrease in hibeta activity after two 20 minute sessions from 2.96 SD to 
1.67. Finally, Participant 3 (a 36 year old male presenting with concerns with rumination) 
completed one 20 minute session of NF, in which his hibeta activity decreased from 3.12 SD to 
2.27 SD. These results identified the efficacy of NF in regulating brain wave patterns; however, 
they are more anecdotal in nature and lack the statistical, internal, and external validity necessary 
to draw valid conclusions from the data.  
Moreover, the results of Gracefire and Durgin’s (2012) study contradict the findings of 
Kluetsch and colleagues (2014) who found that a single session of NF does not decrease anxiety 
in participants. In this study, the researchers sought to identify if one session of NF was related 
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to significant changes in anxiety in individuals with PTSD. In this study, the researchers 
recruited 21 adults with diagnoses of PTSD as a result of childhood sexual or physical abuse. 
The STAI was administered to gauge the levels of anxiety pre and post an MRI guided NF 
session. In this session, participants were scanned via MRI to assess their EEG oscillations, 
provided one session of EEG NF, and scanned again after the EEG NF. Additionally, the 
participants received the STAI after the session. The researchers found through a paired t test 
that there were no significant pre to post session STAI score differences (p > .05); however, there 
was an increase in calmness at the end of the session (t = 2.72, p < .05). These results could be 
expected due to the fact that participants may not report differences on the STAI after only one 
session of NF. The differences between these two studies is that in the first study, anxiety was 
measured by self-report and quantitative EEG data whereas the latter study did not incorporate 
EEG data and defined anxiety through the results of the STAI measure. The difference in these 
studies results indicate that although there may be physiological changes that occur after one or 
two sessions of NF, participants may not be aware of the changes after one session.  
Kerson and colleagues (2009) utilized NF protocol that reduced frontal asymmetry in 
eight adult participants. Excessive alpha wave activity in the frontal lobes of the brain are related 
to rumination, depression, excessive worry, and repetitive thinking. Frontal asymmetry describes 
the phenomenon of an imbalance in alpha wave activity in the frontal lobes of the brain, which 
can lead to an increase in symptoms of anxiety and depression. The participants (five women and 
three men) all presented with multiple generalized anxiety behaviors or a diagnosis of 
Generalized Anxiety Disorder. Additionally, the participants were screened for the presence of 
high alpha activity and asymmetry in frontal sites. The State-Trait Anxiety Inventory (STAI) was 
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administered before the beginning of NF sessions, one week after the NF sessions ended, and at a 
6 month follow up. The researchers utilized suppression training and asymmetry training with a 
19 point EEG protocol. Participants were instructed to reduce alpha wave activity by 10%. Audio 
feedback was given to the participants in the form of nine tones indicating the magnitude of their 
activity. That is, higher pitch of the sound the participants heard was related to higher the alpha 
activity. Additionally, visual feedback was provided by a line on a screen representing EEG 
channels. The researchers used a one way ANOVA to compare the scores of the STAI from pre 
to post, and from pre to follow up. The researchers found that state anxiety was significantly 
different when compared pre and post to follow up (F [3, 21] = 13.9, p < .001). Trait anxiety was 
also significantly different when comparing pre and post to follow-up (F [3, 21] = 15.51, p < 
.001). Overall, the researchers did not find significant differences from pre to post assessment, 
but the findings indicate that the participants experienced a significant change in state and trait 
anxiety between pre assessment and follow up. The researchers did not report the mean scores 
for each STAI assessment point. The results provide evidence that NF has an effect on state and 
trait anxiety in adults.  
 The aforementioned studies investigating the effects of NF on anxiety in adults are 
limited, with most of the current literature utilizing case study or designs with a very small 
sample. Although the extant literature provides support that NF may be effective in reducing 
anxiety symptoms, further research needs to be conducted with larger sample sizes that include 
demographically diverse individuals. It should be noted, however, that the studies reviewed show 
that NF has shown efficacy in reducing anxiety symptoms in adults and may, have the same 
efficacy in reducing anxiety in college students with ADHD.  
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Neurofeedback as a Treatment for ADHD 
ADHD is a common disorder in childhood that research has shown is characterized by 
maladaptive EEG patterns in the brain. The fact that maladaptive EEG patterns play a role in 
ADHD symptomology supports the rationale for NF to be used as a treatment for ADHD as NF 
directly addresses and alters EEG brainwave patterns. Lubar and Shouse in a seminal study 
(1976) sought to examine the effects of EEG neurofeedback in boys with Hyperkinetic Disorder 
(the DSM-II diagnosis for ADHD). Based on the theory that Sensorimotor Rhythm (SMR) is 
both trainable and directly related to relaxation and reduction in muscle tension (Chase and 
Harper, 1971); Lubar and Shouse sought to reduce over activity in boys with hyperkinetic 
disorder by training SMR with NF. The researchers found that using NF to train SMR activity in 
the brain reduced over activity and distractibility in boys with hyperkinetic disorder. 
Vernon and colleagues (2004) noted that research should address identifying the best 
mode of feedback (auditory, visual, combined) to produce results in this population, identifying 
which training protocol is best, and identify if training procedures have different effects on the 
different types of ADHD (inattentive, hyperactive, combined). However, the extant research on 
NF and ADHD in children is somewhat contradictory and there is a need for more 
methodologically sound studies on the efficacy of NF and ADHD, specifically in college student 
populations. The following is a review of the recent and relevant literature on the efficacy of NF 
in children and adults with ADHD. 
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Neurofeedback as a Treatment for ADHD in Children 
Unlike studies conducted on NF and anxiety and depression, much of the NF and ADHD 
literature, especially with children, includes experimental or quasi-experimental designs with 
control or comparison groups. Bakhshayesh and colleagues (2011) sought to answer the research 
question of if NF was more effective than EEG biofeedback in reducing ADHD symptoms in 
children through a randomized controlled trial. Their sample consisted of 38 children with the 
International Classification of Diseases (ICD) diagnosis for ADHD (either Hyperkinetic 
Disorder, ICD-9; or Attention Deficit Disorder without Hyperactivity, ICD-10). The ICD is the 
diagnostic manual used in Germany, where this study was conducted, and there are few 
differences between the ICD and DSM – IV criteria for ADHD. Participant ages ranged from six 
to fourteen years old (M = 9.32, SD = 1.92). Much like other studies on individuals with ADHD, 
participants were allowed to continue their medication as prescribed, with the caveat that parents 
were asked to keep medications stable throughout the course of treatment. Children were 
randomly assigned to the NF and EEG biofeedback groups and were not informed about the 
specific differences between groups. The Structured Clinical Interview was used to determine a 
diagnosis and ensure there were no comorbid disorders. Neurofeedback trainings were held two 
to three times per week (30 mins per session) for a total of 30 sessions (for both groups). 
Additionally, all parents met with a psychotherapist twice a month for four total sessions 
receiving psychoeducation. Outcome assessments in this study included the Structured Clinical 
Interview for the DSM-IV, parent and teacher rating scales of the German ADHD Rating Scale, a 
paper and pencil attention test, nonverbal intelligence tests, continuous performance tests, and 
standardized behavioral observations in the classrooms. The authors found that there were no 
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significant differences between the groups at the outset of the study. They also found that three 
children did not complete the study due to loss of motivation or protocol violation. Two 
ANOVAs were completed, one comparing the groups to one another (between) and one 
comparing pre vs post treatment (within). The researchers found that parent report scores on the 
German ADHD Rating Scale in both groups significantly decreased over time (total score F [1] = 
12.59, p < .001). However, there was a difference between the NF group and the EEG 
biofeedback group in which the NF group total ADHD scores improved with a moderate to large 
effect size (d = -.77) with a p value approaching significance (p = .06). For the paper and pencil 
attention test, again, there was no significant difference in scores amongst treatment groups but 
all participants scores increased as a result of time (total concentration scores F [1] = 31.75, p < 
.001). These results identified that NF protocol may not make a difference and that NF and EEG 
biofeedback are effective in reducing ADHD symptoms and increasing concentration regardless 
of training protocol.  
Bink, Nieuwenhuizen, Popma, Bongers, and van Boxtel, (2015) also utilized a 
comparison group in their study design; however, rather than comparing NF protocols, the 
researchers compared NF and medication (n = 45) to medical or behavioral treatment as usual 
(TAU; n = 26) group in adolescents with ADHD. The subjects in this study were 71 male 
adolescents. Inclusion criteria was as follows: (a) spoke Dutch as their native language, (b) were 
between ages 12 and 24, (c) had a DSM-IV-TR diagnosis of ADHD, (d) had an Intelligence 
Quotient above 80. Comorbid disorders including Autism Spectrum Disorder (ASD) did not 
exclude participants from the study. Exclusion criteria included psychotic disorders, and 
neurological disorders. Because there are sex differences in the EEG spectra of male and female 
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adolescents with ADHD which would have created an uncontrollable variable, this study did not 
include female participants. Treatment as usual included participants taking their medications as 
prescribed or continuing behavioral interventions including CBT or other supportive counseling 
for the individual or family. Adherence to this treatment was verified by self-report after 
questioning. Neurofeedback was provided over 25 weeks for a total of 40 total sessions at 30 
minutes each. Although not all participants completed the same amount of sessions, 37 
participants completed at least 19 sessions. A Biofeedback Certification International Alliance 
(BCIA) certified psychologist trained the psychologists that conducted the sessions. The aim of 
the NF protocol used in the study was to increase sensorimotor rhythm (SMR) activity, which is 
strongly associated with motor activity. SMR typically increases in states of immobility and 
relaxation, and according to the authors, individuals with ADHD may benefit from increasing 
their SMR activity. Further, the NF protocol in this study aimed to decrease theta, alpha, and 
electromyographic (EMG) activity. Electromyographic activity is measured by the electric 
activity in muscles, thus a reduction in EMG would theoretically relate to an increase in 
relaxation. Medication type (χ2 = 2.48, p = .63) and dose (F [1, 32] = .57, p = .46) were not 
different between groups at the outset of the study. In addition, there were no differences 
between the pre-medicated and the non-medicated participants in either group based on Global 
Assessment Functioning (GAF) scores or behavioral measures. The researchers found that in 
both groups, the ADHD rating scale (inattention F = 31.57, p < .001; η2 = .31; 
hyperactive/impulsive F = 13.01, p < .001; η2 = .16), Youth Self Report (F = 12.35, p < .001; η2 = 
.15), and Childhood Behavioral Checklist (F = 12.08, p < .001; η2 = .18) scores decreased over 
time with no difference between groups. There was also no difference between medicated and 
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non-medicated participants as it pertains to the changes in assessment scores. These findings 
identify that NF paired with medication is just as effective as medication and psychotherapy in 
reducing ADHD symptoms over time. This study did not, however, examine the sole effects of 
NF on ADHD symptoms in participants as the treatment group was receiving medication as well 
as NF training. 
Escolano and colleagues (2014) conducted a pilot study specifically utilizing NF with 
children with ADHD. Participants included 20 children diagnosed with ADHD using the DSM – 
IV criteria based on semi-structured interview with the parents using the Structured 
Developmental History portion of the Behavior Assessment System for Children (BASC). 
Participants were not on medication and were not in psychotherapy for at least one month before 
starting the study. The final sample included 17 participants after three participants did not 
complete the study (combined type ADHD n = 10, inattentive type ADHD n = 7). The training 
procedures for this study included 18 sessions of NF over the course of two months with two or 
three sessions per week with each training session lasting a total of 20 minutes. The focus of the 
protocol was to increase upper alpha activity in the frontal sites, each session was recorded and 
used to inform the protocol for the next session. The Behavioral Assessment System for Children 
Parent Rating Scales (BASC-PRS) and the Conners Parent Rating Scales Revised were used as 
outcome measures in the study. After conducting a t test of pre and post scores on the 
assessments, the researchers found a significant difference in pre and post scores (externalizing 
problems, t [16] = 3.52, p < .005; d = .85; internalizing problems, t [16] = 4.12, p < .001; d = 
1.00) for the BASC-PRS. No change was found in adaptive skills of the BASC. These results 
identified that NF has the potential to positively impact parent reports of internalizing and 
60 
 
externalizing behaviors in children with ADHD. Because this study had a small sample size and 
only one group, the external validity (ability of the authors to generalize their findings) is 
threatened; however, the large effect sizes indicate that the treatment had a notable influence on 
the pre to post change in scores. 
Similar to Escolano and collegues’ pilot study which used parent report measures to 
assess differences in participants’ ADHD symptomology, Duric, Assmus, Gundersen, and Elgen, 
(2012) utilized parent report measures to assess differences in ADHD symptoms as a result of 
NF training in children and adolescents. However, the researchers conducted a three group 
Randomized Control Trial (RCT) with one group taking medication (n = 31), one group provided 
NF (n = 30), and one combined NF and medication group (n = 30). The sample in this study 
included a total of 91 children aged six to eighteen in a Child and Adolescent Mental Health 
clinic in Norway. Participants met the ICD 10 criteria for an ADHD diagnosis and received 30 
sessions of NF which included receiving visual feedback in the form of a videogame or movie. 
The purpose of the NF was to increase beta activity and decrease theta activity. These sessions 
lasted for 40 minutes, three times per week. Medication was administered as a twice daily dose 
of one milligram of methylphenidate. Assessments occurred at the baseline and one week after 
the end of NF sessions. The assessment used in this study included the Clinician’s Manual for 
Assessment of Disruptive Behavior Disorders – Rating Scale for Parents (Barkley, 1997). In 
addition, a medical exam was conducted at the outset of the study to exclude physiological 
explanation of ADHD symptoms. With no differences between the groups at the baseline, 
parents reported effects of treatments over time in attention and hyperactivity (p < .001). 
However, there was no difference in scores over time between groups. Thus, these findings 
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provide evidence that NF is just as effective in treating ADHD symptoms in children as 
methylphenidate based on parent reports. It should also be noted that the NF group did show 
almost double pre to post change in attention compared to the other groups (NF t1-t2 = 3.1, 
medication only group t1-t2 = 1.5, NF and medication t1-t2 = 1.1), this difference in pre to post 
change was not statistically significant. 
Gonzalez-Castro, Cucli, Rodriguez, Garcia, and Alvarez (2015) sought to compare NF 
and medication in children with ADHD. One hundred thirty-one total participants between ages 
eight and eleven were split into four groups (control/no medication nor NF, n = 33, NF only, n = 
33, medication only, n = 34, combined NF and medication, n = 31). Inclusion criteria included an 
IQ above 80 and an ADHD diagnosis from participants’ own neuropediatrician. The authors did 
not specify whether the participants were randomly assigned or if they self-selected into their 
groups. Pretreatment assessment included the Tests of Variables of Attention (TOVA), Attention 
Deficit Hyperactivity Disorder Adult Assessment Scale (EDAH), and a Quantified EEG 
spectrum. The authors did not explain the specific NF protocol used in the study; however, the 
authors explained that the NF specialist modified the goals and thresholds for each participant, 
and the participants experience feedback through a videogame. Sessions spanned three months 
with three sessions per week, each session lasting 15 minutes. Participants in the groups in which 
medication was administered were given methylphenidate which was administered in doses 
based on the clinical judgement of the neuropediatricians for each individual participant based on 
age and weight. After the three months of treatment based on group assignment, assessments 
were re-administered to participants. It should be noted that the pretreatment TOVA scores were 
significantly different amongst groups (Wilks’ λ = 0.691, F [18, 339] = 6.906, p < 0.001). So, the 
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researchers controlled for TOVA scores by including the pre TOVA score as a covariate in the 
posttreatment analyses. The authors found differences between the control group and 
neurofeedback groups (p < .001) and between the control group and combined groups (p < .005). 
However, there was no difference the control group and medication only group (p = 0.128). The 
NF and medication group obtained more benefits, while the NF group improved more in 
executive control than the medication only group. These results identified that NF and 
medication may together provide benefits for children with ADHD, and NF may be more 
effective than medication in improving executive functioning in this population. 
The research on the efficacy of NF and ADHD symptoms in children is limited; however, 
it is more robust than the literature on NF and adults with ADHD. Moreover, of the few studies 
conducted with adults, even fewer include college students with ADHD in the population.  
Neurofeedback as a Treatment of ADHD in Adults  
 White, Hutchens, and Lubar (2005) suggested that NF is effective in reducing ADHD 
symptoms in adults from what they found by using brain imaging to compare brains of Adults 
with (n = 10) and without ADHD (n = 10) during a task. Participants aged 21-47 (ADHD group), 
and 22-44 (control group) met the following inclusion criteria: (a) a score higher than 85 on a 
vocabulary test; (b) no history of neurological or psychotic disorder; and (c) no head injury, 
substance abuse, or learning disability. Participants with ADHD who were taking medication 
were evaluated 12 hours after taking their medication. Participants in the control group were not 
able to take any medications with the exception of birth control pills. Participants wore electrode 
caps with 19 channels to measure brainwave activity while they completed the Paced Auditory 
Serial Addition Task (PASAT), Wisconsin Card Sorting Test (WCST), and the Integrated Visual 
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and Auditory Continuous Performance Test (IVA) after being attached to the EEG. Independent t 
tests were used with a Bonferroni adjusted alpha (α = .005) to examine the difference between 
groups on the tasks. The groups did not differ based on demographic variables with the exception 
of participants with ADHD having higher inattentive and hyperactive/impulsive symptoms. 
However, there was a significant difference in performance on the PASAT (t [18] = 5.46, p < 
.001) between the control group (M = 157.7, SD = 21.26) and the ADHD group (M = 94.9, SD = 
29.51). These results identified that adults with ADHD have more difficulty with attention, 
information processing, and memory than do adults without ADHD. Moreover, the authors 
found that adults with ADHD had increased upper alpha activity during the IVA performance 
test and that increased theta/beta performance during the IVA test was related to poor attention. 
Thus, the results supported the extant NF protocols that target theta/beta and alpha bands 
(Hammond, 2000).  
Of the extant research on utilizing NF with Adults with ADHD, Mayer and colleagues 
are at the forefront. Mayer, Wyckoff, Schulz, and Strehl (2012) investigated the effects of Slow 
Cortical Potential (SCP) NF on ADHD in adults. Slow Cortical Potentials in the brains of adults 
with ADHD has been shown to have a relationship with cognitive and behavioral performance 
(Birbaumer, Elbert, Canavan, & Rockstroh, 1990). Thus, NF targeting SCP in adults with ADHD 
may improve short-term memory and attention. Mayer and colleagues sought to provide 
evidence of SCP NF in a total of 20 adults (with ADHD n = 10; without ADHD n = 10). 
Participants in the control group were matched in age, gender, and IQ. In order to be included in 
the study, participants with ADHD met the cutoff score of 18 on an ADHD self-rating scale 
(ADHD-SB), which is a subscale of the German Assessment Battery for ADHD; participants in 
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the control group scored less than 18. Participants in the ADHD group were administered the 
ADHD-SB—which included inattention, hyperactive, and overall ADHD symptomology 
subscales—and the Beck Depression Inventory (BDI) before receiving 15 NF sessions (1-3 times 
per week). Participants were also administered the same assessments (ADHD-SB, and BDI) at 
the conclusion of their NF sessions. The researchers found a reduction in ADHD symptom total 
scores (t [9] = 2.653, p < .05; Cohen’s d = -.73), attention (t [9] = 3.597, p < .05; d = -.56), 
impulsivity (t [9] = 2.395, p < .05; d = -.6). It should be noted that not only were there reductions 
in symptoms in the ADHD group, but that the effect sizes are also moderate to large, suggesting 
that NF has a moderate to large effect on ADHD symptoms in adults with ADHD in comparison 
to a control group of adults without ADHD.  
Mayer and colleagues (2015) sought to answer the research question of whether SCP NF 
is effective in treating ADHD symptoms in adults’ long term. Adults between 18 and 60, 
meeting DSM-IV criteria for ADHD inattentive hyperactive or combined type participated in the 
study. Stimulant medication was allowed during participation in the study; however, participants 
were required to not take their medication within 24 hours of beginning their NF session. 
Additionally, participants were required to maintain their medication regimen throughout the 
course of treatment. Participants were initially screened over the phone, then mailed a packet of 
assessments and the informed consent. After the consent and assessments had been mailed, 
participants completed a diagnostic interview with the researchers and began NF sessions. The 
participants attended 30 sessions of NF and were assessed on ADHD symptoms in every 5th 
session with the German Assessment Battery for ADHD. After 15 sessions, participants took a 
three week break from sessions, after which, they returned for another 15 sessions and a follow 
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up assessment 6 months later. Although none of the participants dropped out of the study during 
the treatment phase, there was attrition between posttest and follow up. The researchers do not 
report how many participants began the study; however, they report that they only received 
follow up data from 18 participants. The researchers found reductions in self-rated scores on the 
self-report German ADHD test battery scores from pre to post (t [23] = 5.85, p <.000; d = 1.40) 
and observer reports of ADHD symptoms (t [17] = 3.87, p < .001; d = 0.57). Further, self-report 
symptoms of ADHD reduced over 25% in 14 participants with 6 participants no longer meeting 
diagnostic criteria for ADHD. Symptoms for depression (t [23] = 4.81, p < .001; d = 0.93), state 
anxiety (t [23] = 2.192, p < .05; d = 0.51) and trait anxiety (t [23] = 4.25, p < .001; d = 0.87) 
decreased as well. 
Neurofeedback as a Treatment for ADHD in College Students 
Surprisingly, there is limited research examining the efficacy of NF with college students 
with ADHD. However, the following studies were conducted with college students, although the 
participants do not have ADHD, the researchers found that NF was effective in improving 
attention in a college sample.  
Rasey, Lubar, McIntyre, Zoffuto, and Abbott, (1995) conducted a study on the effects of 
NF on attention in college students. Participants in this study included seven undergraduate 
students between 18 and 45 years of age who classified themselves as a freshman or sophomore. 
Participant grade point averages (GPAs) were between 2.0 and 2.5 and participants did not have 
a learning disorder nor a history of EEG biofeedback training. Over the course of the study three 
participants dropped out, leaving the researchers with four participants. Screening sessions for 
participants included the Integrated Variables of Attention (IVA), Quantitative EEG assessment, 
66 
 
and the Wechsler Adult Intelligence Scale- Revised (WAIS-R). Participants received a mean 
number of 20 sessions using a protocol designed to increase beta activity (16 - 22hz) and inhibit 
high theta and low alpha activity (6 - 10hz). Participants were provided both visual and auditory 
feedback. For IVA scores, the researchers found that participants one and two increased by 2.2 
and 3.73 SD and participants three and four increased by -.93 and .13 SD respectively on the Full 
Attention Quotient. The researchers’ classified participants one and two as “Learners” and 
participants three and four as “Non-Learners” based on improvements on the IVA and 
improvements in reaction time on the IVA. The results identified that some college students can 
learn to increase EEG activity and attention based on the measures used in the study, whereas 
some students may not. The researchers attribute the “Non-Learners” inability to make progress 
to the limited number of sessions, they explain that if the participants had more sessions, they 
may have experienced more positive effects of NF.  
Further, Fritson and colleagues (2007) examined the effects of NF in a sample of college 
students. Participants included 16 nonclinical college students and 16 control group participants 
with ages ranging from 19 to 38. Criteria for participation in this study included no current 
diagnosis of a mental disorder, no history of a psychotic disorder, no prior EEG biofeedback, no 
current medications for a mental disorder, and no history of epilepsy. The treatment group 
participants were all female, whereas the control group contained four males. Although all 
participants were told they were receiving NF, only the treatment group received NF and audio 
feedback. Control group participants were told that they were receiving NF; however, the NF 
system was in the “off” position and the participants did not receive any audio feedback. All 
participants received a baseline session lasting 12 minutes and subsequent twice weekly sessions. 
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Total, including the baseline session, the participants received 20 sessions of NF over the course 
of 12 weeks with each session lasting 20-25 minutes. Originally, there were 39 participants, 
however seven participants dropped out due to scheduling conflicts. Data gathered from the 
participants that did not complete the NF sessions were not used in the analysis. The protocol 
used for the treatment group was designed to increase task performance by training low beta 
activity to 12-15hz. Assessments used in this study include a demographics form, the Integrated 
Variables of Attention + Plus (IVA + Plus), the Kaufman Brief Intelligence Test 2 (KBIT 2), the 
Wide Range Intelligence Test (WRIT), Self-Efficacy Questionnaire, Brief Mood Introspection 
Scale, and the Beck Depression Inventory-II (BDI-II). The researchers found a main effect of 
training/time-pre to post (Wilks's λ = .74) but there was no difference between groups (Wilks's λ 
= .95) nor was the interaction significant (Wilks's λ =.99). The treatment group did show an 
improvement in response control as measured by the IVA scores (F [1, 30] = 6.66, p < .015). The 
treatment group also showed greater improvements than the control group in the IVA subscales 
of Response Control Auditory Quotient, (F [1, 30] = 4.97, p < .05), and Response Control Visual 
Quotient, (F [1, 30] = 6.83, p < .05). Moreover, the researchers did not find a difference in pre to 
post scores on the BDI, Mood scale, total IQ or Emotional IQ scales. The fact that they didn't 
find a difference in BDI scores could be attributed to the characteristics of the population. 
Therefore, because the participants in the study were non-clinical college students, they may not 
have had significant issues with their mood to begin with. Despite the obvious need for an 
alternative intervention for college students with ADHD, there have been no studies conducted 
examining the effect of NF in reducing ADHD symptoms in college students, providing further 




 Chapter two reviewed the relevant literature as it pertains to negative outcomes 
associated with ADHD in adults and college students. With college students facing increased 
precedence of depression, anxiety, and lower academic self-efficacy, they are in need of 
treatment options that address their unique needs. Additionally, this review of the literature 
identified treatment options of college students with ADHD; providing a critique of the efficacy 
and feasibility of current treatment options such as CBT and pharmacological intervention. 
Although medication and therapy are effective in reducing ADHD symptoms, there are some 
limitations to each. Medication includes inherent difficulties in adherence and adverse side 
effects, while psychotherapy does not address the physiological aspect of ADHD. In answering 
Meyers and Young’s (2012) call for incorporating NF in counseling as a means by which 
counselors can understand and treat the physiological aspect of mental disorders, an argument 
was made for the use of NF as an effective form of treatment in decreasing depression, anxiety, 





CHAPTER THREE: METHODS 
 The purpose of this study was to investigate the effects of neurofeedback training on 
college students with ADHD diagnoses symptoms of ADHD (as measured by the Conner’s Adult 
ADHD Rating Scale [CAARS-S:S; Conners, Erhardt, & Sparrow, 1999]), symptoms of 
depression (as measured by the Beck Depression Inventory-II [BDI-II; Beck Ward, Mendelson, 
Mock, & Erbaugh, 1961; Beck, Steer, & Brown, 1996]), anxiety symptoms (as measured by the 
Beck Anxiety Inventory, [BAI; Beck, Epstein, Brown, & Steer, 1988]), and academic self-
efficacy (as measured by the Self-Efficacy for Learning Form-Abridged [SELF-A; Zimmerman 
& Kitsantas, 2005]). Specifically, this investigation attempted to determine if participants scores 
on the BDI, BAI, and CAARS-S:S would decrease, and the scores on the SELF-A would 
increase over time after 16 sessions of neurofeedback.  
 The research methods chapter provides a description of the research design and protocols 
for the study. Threats to validity (i.e., statistical conclusion, internal, construct, and external) are 
discussed in addition to mechanisms that were implemented to mitigate these threats to validity. 
Additionally, data collection procedures including population, sample, recruitment, incentives, 
and screening criteria are described. Moreover, data collection assessments and the rationale for 
selecting instruments and their respective psychometric properties is presented. The 
neurofeedback (NF) training protocol and study timeline is also reviewed. Data analysis 
procedures are presented along with ethical considerations and potential limitations of the study. 
Research Design 
 This study used a quasi-experimental, time-series design (Gall, Gall, & Borg, 2007; 
Shadish, Cook, & Campbell, 2002). A time-series research design is a quasi-experimental 
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research design involving one group that is repeatedly tested while exposed to the experimental 
treatment (Fraenkel, Wallen, & Hyun, 2012; Gall et al., 2007). Participants received 16 total 
sessions of the NF training intervention over the course of eight to ten weeks. There were four 
data collection points within the study, including (a) baseline data collection conducted prior to 
the intervention, (b) midpoint data collection after eight sessions (four weeks) of the 
intervention, (c) post data collection occurred after the intervention (the end of session 16), and 
(d) follow-up data collection four weeks after the final intervention session. 
Threats to Validity 
 Validity in research refers to the veracity of the claim the study is asserting. That is, the 
ability of a researcher to assert causal claim in an experimental or quasi-experimental study 
design (Murname & Willett, 2010). Threats to validity may be addressed in the development of a 
study, with researchers accounting for threats to validity by incorporating methodological 
mechanisms to account for specific threats to validity. Shadish and colleagues (2002) noted that 
researchers may design studies that are methodologically sound and address potential limitations 
of the study before the data are collected. Additionally, researchers may increase validity by 
accounting for covariates after the data have been collected during the statistical analysis. In 
order to design a sound study, researchers first identify threats to validity, determine if the threats 
are plausible, and put mechanisms in place to address these threats. Not all threats to validity 
may be mitigated by incorporating methodological factors, thus statistical adjustments may need 
to be made in order to strengthen the validity of a study. Moreover, when attempting to mitigate 
one threat to validity, researchers may run into problems with other threats to validity. For 
example, addressing the threat of homogeneity of treatment implementation may lessen the 
71 
 
external validity in that it may not be feasible to implement the treatment the exact same way 
across settings and populations, thus it is not generalizable (Murname & Willett, 2010). The 
following section presents four aspects of validity (i.e., statistical conclusion, construct, internal, 
and external) as well as strategies in which the researcher tried to mitigate these threats in the 
study.  
Statistical Conclusion Validity 
 Statistical conclusion validity addresses whether a relationship between the independent 
variable (IV) and dependent variable (DV) exists based on the statistics used in the analysis. In 
experimental and quasi-experimental research, the most common form of testing the relationship 
between an IV and DV is null hypothesis significance testing (NHST). In NHST, researchers 
place most of the emphasis on whether or not one can reject or accept a null hypothesis (i.e., the 
difference in mean scores before and after an intervention is zero). The issue with only 
considering the p value is that the size of the effect of the treatment on the scores is often 
neglected. Lipsey and Wilson (1993) note that researchers should report effect sizes as well as 
confidence intervals in order to accurately describe the effects of treatment in an experiment or 
quasi-experiment. An effect size is the magnitude of the effect of the treatment whereas the p 
value provides researchers with the ability to correctly state that the findings are not due to error 
or chance. That is, the higher the p value, the more likely a researcher will incorrectly identify a 
covariation between the treatment and the effects the outcome. Some specific threats to statistical 
validity include (a) low statistical power, (b) violated assumptions of statistical tests, (c) 
unreliability of treatment implementation, and (d) restriction of range (Shadish et al, 2002).  
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Low Statistical Power  
Statistical power refers to the ability of a statistical test to detect relationships in a sample 
as well as correctly identify this relationship. If a study has low power, the risk of identifying a 
relationship between variables that does not exist (type I error) or failing to identify a 
relationship when one actually exists (type II error) increases. Further, effect size estimates may 
be less accurate, that is, confidence intervals will be wider indicating that the true value of the 
effect size may fall between a larger range of values. Low power often occurs in experimental 
designs, thus causing experimental researchers to falsely reject null hypotheses (Shadish et al., 
2002). Because of the increased likelihood of type I and II error in experimental designs, it is 
important that researchers report effect sizes and power when reporting the results of a statistical 
analysis (Shadish et al., 2002).  
 This study was quasi-experimental in nature, and thus, it is probable that low statistical 
power may have been a threat to the validity of this study. Additionally, due to the small sample 
size (N = 11), statistical power was low. However, the researcher reported effect sizes in the 
form of positive and negative ranks as a measure of the power of the results.  
Violated Assumptions of Statistical Tests  
Each type of statistical procedure has its own set of assumptions that need to be met in 
order for the results of the procedure to be accurate. Assumptions for the Friedman ANOVA 
statistical procedure include the following; (a) that one group is measured at three or more 
different occasions, (b) the group is a random sample of the population, (c) the dependent 
variable is measured at the ordinal or continuous level, and (d) the data do not need to be 
normally distributed. The first three assumptions were met as the study was designed. The study 
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design included one group of subjects with assessments at four time points throughout the study. 
Additionally, the participants were randomly sampled from the population and randomly self-
selected to participate in the study. Due to the small sample in the current study, the data were 
not normally distributed. The data do not need to be normally distributed for the Friedman’s 
ANOVA; thus, the assumption of normality did not need to be met in this study. 
Unreliability of Treatment Implementation  
Unreliability of treatment implementation refers to the inconsistency of the treatment 
when it is administered to participants in the study. Inconsistent treatment implementation may 
decrease the effect size of an intervention, begging the need for additional design mechanisms to 
increase power (i.e., larger sample size). However, in some studies, the intervention may need to 
be tailored to each individual subject. In this study, treatment fidelity was not a plausible threat 
to validity as the NF software automatically provides the exact same amount of NF training to 
each participant. Treatment fidelity may have become an issue if participants missed NF 
sessions. Each participant was scheduled for 16 total sessions of NF training; however, if 
participants did not attend all 16 sessions, treatment implementation may have been a plausible 
threat to validity (Shadish et al, 2002). In October, 2016, during the fall semester round of data 
collection, Hurricane Matthew made landfall in Florida making attending sessions on October 6th 
dangerous. The researcher canceled the study sessions on that date, pushing data collection 
further than eight total weeks; however, each participant received a total of 16 sessions while 
participating in the study. An exception to this occurred when a mistake by an RA caused one 
participant to receive 17 sessions of NF training instead of 16; Nevertheless, all participants 
received at least 16 sessions of NF. 
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Restriction of Range  
Restriction of range refers to a lack of variation in the IV or DVs. Restriction of IVs may 
occur when the researcher is only evaluating two possible outcomes of the treatment or 
comparing two similar treatment interventions. Restriction of DVs may occur when the ceiling 
effect or floor effect occurs. The ceiling effect occurs when participants’ scores on the 
instruments at baseline assessment cluster on the high end of the scale. The floor effect occurs 
when participants’ scores on the instruments at baseline cluster around the lower end of the scale. 
If the researcher seeks to evaluate an increase or decrease in scores on an assessment but the 
scores at baseline are already on the highest or lowest end of the assessment scale, a significant 
change will not be observable due to a lack of variation in the scores at the outset (Shadish, et. 
al., 2002). 
Participant scores on the Beck Depression Inventory-II and the Beck Anxiety Inventory 
were relatively low at the outset of the study. For example, of the 11 total participants, 6 
participants scored in the “mild” category (total score < 9) on the BAI. Further, seven of the 
eleven participants scored in the “minimal” range on the BDI-II (total score < 13).  Restriction of 
range is a probable threat to validity, especially in the depression and anxiety constructs for this 
study, as participants may not present with impairments on the depression, anxiety, or academic 
self-efficacy variables. Theoretically, college students with ADHD are more likely to suffer from 
higher prevalence of depression and anxiety with lower levels of academic self-efficacy. 
However, some college students with ADHD may not be impaired by depression, anxiety and/or 




 Internal validity refers to the ability of a causal inference to be made between the IV (i.e., 
time, or the intervention) and the DV (i.e., assessment scores). That is, does the IV cause changes 
in the DV? The term causality is most important when considering internal validity. Though 
similar to statistical conclusion validity, internal validity differs from statistical conclusion 
validity in that the former refers to a lack of alternative explanations for changes in the DVs 
whereas the latter refers to the confidence a researcher has in the veracity of the statistical 
findings. A major threat to internal validity is ambiguous temporal precedence. Researchers may 
not confidently state causality if cause does not precede effect. A strategy to mitigate the threat 
of ambiguous temporal precedence is implementing a pretest, or a measure of the outcome 
variables, before implementing the treatment in order to more confidently attribute change in the 
outcome variables to the treatment. Other examples of threats to internal validity that are relevant 
to this study include (a) history, (b) regression to the mean, (c) attrition, and (d) testing (Gall et 
al., 2006).  
History  
History refers to events that occur within the course of the intervention that may possibly 
effect the outcome variables (Shadish et al, 2002). If participants began taking medications or 
attending psychotherapy sessions while receiving NF training sessions, any changes in the 
outcome variables may have been attributed to the medications or the psychotherapy rather than 
the NF training intervention. The researcher asked participants at the outset of the study what 
they were implementing to treat their ADHD symptoms on the Psychosocial Inventory. 
Additionally, the researcher asked that participants disclose if they began a new treatment for 
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their ADHD symptoms while participating in the study. During the course of the study, one 
participant disclosed that they began taking medication soon after beginning the study and was 
unsure whether to attribute positive changes they had noticed to the NF or to their medication. 
This participant beginning medication around the same time as NF training sessions threatened 
the internal validity of the findings for this one participant because the researcher cannot state 
with complete certainty that the changes in scores on the assessments were due solely to the NF 
training intervention. 
Additionally, the researcher conducted multiple rounds of data collection at different time 
periods (i.e., Summer 2016 and Fall 2016), events may have occurred that influenced the 
participants’ moods, motivation, and scores on the instruments. For example, in June of 2016, a 
tragic mass shooting occurred in Orlando, Florida that could have affected the moods of the 
participants in the summer round of data collection. Participants who completed their 
assessments the week following the shooting may have responded more severely on the 
depression and anxiety scales due to heightened feelings of sadness and anxiety following the 
shooting. Specifically, one participant reported feeling sadder and crying more, but attributing 
the sadness and crying to the shooting rather than overall feelings of depression. Moreover, 
Hurricane Matthew made landfall in October of 2016 during the fall semester round of data 
collection. No participants reported being directly harmed or affected by the Hurricane, but if the 
hurricane had affected participants (i.e; destroyed their property) they may have responded 
differently to their assessments. 
Further, differences in the time the participant received the intervention (i.e., Fall or 
Summer semester) may have impacted the participants’ reaction to the intervention. That is, 
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there may have been some factors that affected the impact of the intervention based upon the 
time of year. For example, students that take summer courses and participated in the summer 
round of data collection may have been more motivated than students who take courses within 
the academic school year. However, Marshall and colleagues (2012) found that students who 
completed a course in their major were equally as successful in their subsequent coursework as 
those who completed their major coursework in the fall or spring semester. Thus, Marshall and 
colleagues’ finding identified that students who take summer courses are not different than those 
students who do not take summer courses.   
Regression to the Mean  
Regression to the mean, or regression artifacts, refers to the tendency for extreme scores 
on a measure to naturally gravitate toward the mean score (Shadish et al, 2002). When 
administering an assessment numerous times to the same participants, regression to the mean is 
more likely to occur. Further, when participants present with extreme scores at the outset, 
regression to the mean is also more probable. As the study utilized four data collection points 
with the same participants, whose scores may be extreme due to the selection process—that is 
participants are expected to have high ADHD symptomology scores, a natural decrease in scores 
was possible.  
Attrition  
Attrition is defined by research participants discontinuing their participation in the study 
or failing to complete the outcome measures. In a pretest-posttest design, the purpose of the 
outcome measures is to provide data from which the researcher can make inferences about the 
impact of the treatment intervention (Murnane & Willett, 2010). If there are no outcome 
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measures, the researcher’s ability to determine a change in scores from pretest to posttest is 
diminished. The researcher was contacted by 23 total students (over the course of the summer 
and fall semesters) to participate in the study. Two participants were ineligible because they were 
not currently enrolled in classes at a college. Three individuals did not show up for their first 
sessions and did not respond to the researcher’s attempts to contact them to reschedule. Four 
potential participants did not have time in their schedules to participate in summer or fall. One 
potential participant called the researcher but did not answer when the researcher attempted to 
contact them again. Two participants expressed interest, and began sessions but did not complete 
all of their sessions due to one participant starting a new class and not being able to come in for 
sessions and the other participant reported feeling more tired than usual after having started the 
NF sessions. Thus, due to their fatigue, they did not want to continue with the study. 
Further, it is also important for researchers to assess the reasons and characteristics of 
participants who do not complete the outcome measures. That is, if all of the participants that did 
not complete the outcome measures share a common characteristic, that characteristic may 
provide more information about the sample of participants and the relationship of that 
characteristic to the intervention or outcome measures. Thus, the characteristic may interfere 
with the researcher’s ability to state cause by limiting the outcome data.  
Testing and Instrumentation  
Testing refers to any changes in an individual such as practice effects, familiarity, or 
fatigue that cause changes in assessment responses that may be falsely attributed to treatment 
effects (Gall et al, 2006). Similarly, instrumentation refers to changes in the instruments that 
affect the outcome. Although testing and instrumentation may seem similar in that they are both 
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related to the outcome measure, they are different in that the former focuses on changes in the 
individual that affect outcomes whereas the latter focuses on changes in the assessment that 
affect outcomes. Nevertheless, instrumentation was not a plausible threat in this study as all of 
the instruments were the same for all participants. Testing, however may have been a probable 
threat to validity due to the fact that participants in the study were administered the assessments 
four times over the course of the study.      
Construct Validity 
 Constructs in research are important in that they set the parameters of what concepts will 
be studied and how these concepts will be measured. Without a solid definition of the constructs 
of interest, researchers may be unable to develop clear methods of assessing the constructs and as 
a result, the ability of the researcher to assert a relationship between constructs is weakened. 
Further, well defined constructs allow researchers to interpret their findings as they relate to 
other relevant constructs. Due to the implications constructs have on the interpretation of 
research, it is important to thoroughly define constructs of interest as well as the measures used 
to gather data on the constructs. If constructs are not well defined or mislabeled, the findings of a 
study may not be relatable to other similar concepts in the literature. That is, the research 
findings may be misinterpreted and implications may be incorrect. To address this threat to 
construct validity, the researcher incorporated measures that assess each of the constructs of 
interest in a comprehensive manner (Shadish et al, 2002). The researcher understands that the 
instruments utilized in the study may not fully assess all symptoms of ADHD, depression, 
anxiety, and academic self-efficacy; however, the specific construct validity of each instrument 
is presented in the instrumentation section below. 
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Construct validity refers to the validity of the means by which the researcher is measuring 
the constructs of interest. That is, construct validity relates to how well the DVs actually 
represent the constructs of interest. Construct validity is the veracity of the explication of the 
constructs involved in the study (Shadish et al, 2002). For example, in this study, college 
students with ADHD were the population being studied and as such, ADHD and college students 
are constructs that must be defined for the purposes of this study. As delineated in the sampling 
section of this chapter, participants were diagnosed with ADHD by a mental health professional 
and were enrolled in at least one course at an institute of higher education in the central Florida 
area. Further, construct validity can be threatened in various ways. Shadish and colleagues 
(2002) outline 14 specific threats to construct validity. As some of these threats were not 
plausible in this study (i.e., reactive self-report changes, compensatory equalization, 
compensatory rivalry, resentful demoralization, and treatment diffusion), because they are 
specific to experimental designs with more than one group, they will not be described at length 
in this section. Additionally, treatment sensitive factorial structure and reactivity to the 
experimental situation are not plausible in the current study and are not discussed in this section. 
The threats to construct validity that are possible include construct confounding, mono-method 
bias, mono-operation bias, experimenter expectancies, and novelty and disruption effects 
(Shadish et al, 2002).  
Construct Confounding  
The threat of construct confounding refers to the possibility of constructs being inherently 
grouped within the constructs of interest in the study (Shadish et al, 2002). That is, researchers 
may observe or label a specific construct as a construct of interest in the study without 
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accounting for other constructs that may play a role in their construct of interest. The other 
constructs that play a role in the constructs of interest would be the confounding constructs and 
may affect the validity of the observed construct of interest. For example, in this study, it is 
possible that the participants that presented with high levels of depression may have attributed 
their depressive symptoms to different factors (e.g., bereavement, trauma, finances, etc.). Thus, it 
would have been incorrect for the researcher to assume that the construct of depression in this 
study is the same for all participants. 
Mono-operation/Monomethod Bias  
Mono-operation bias refers to the lack of multiple forms of defining a construct. That is, 
mono-operation bias may occur when a researcher uses only one operational definition of a 
construct, thus failing to address other potential facets of the construct (Shadish et al, 2002). This 
study operationally defined the constructs of interest by utilizing one measure per construct. A 
limitation to using only one measure per construct is that the researcher may fail to assess all 
aspects of the constructs in one assessment. Similarly, monomethod bias occurs when all 
outcome measures are the same in their method of recording responses. In the current study, all 
of the outcome measures were self-report, which limited the quality of the responses provided. 
As ADHD is a majorly behavioral disorder (American Psychiatric Association, 2013), observer 
report measures may have been beneficial in providing more information about the subjects’ 
symptomology. 
Experimenter Expectancies  
Experimenter expectancies refers to the expectations researchers have that the treatment 
interventions they are providing is effective. Researchers may influence research participants by 
82 
 
telling them that the intervention will be effective, thus increasing participants’ expectations that 
the intervention will be effective. As a result, the novelty or disruption effect occurs. Novelty or 
disruption effect refers to the excitement or expectations that are associated with a novel 
intervention. Contrarily, the disruption effect occurs when participants react negatively to the 
intervention introduced. Experimenter expectancies and the novelty effect may have played a 
role in this study as participants were expected and encouraged to research the intervention being 
provided. As most individuals are unfamiliar with NF and are curious about how it works, in 
order to gain trust and buy-in from the participants, the researcher encouraged participants to 
research NF as an intervention for ADHD. Most research on NF is promising, and the 
manufacturers of the NF system used in this study list a number of benefits of NF on their 
website. Therefore, participants may have been made aware of the potential benefits of NF and 
developed an expectation that NF would be effective in reducing their ADHD symptoms; thus, 
creating a placebo effect and threatening the validity of the study (Shadish et al, 2002). 
External Validity 
 External validity refers to the ability of the researcher to generalize the results of a study 
across individuals, treatment settings, across treatment types, and across outcomes. 
Generalizability is important in experimental research because it strengthens the claims of 
causality or relationships among variables presented by allowing researchers to apply their 
findings to other individuals, settings, treatments, or outcomes (Shadish et al, 2002). Considering 
external validity in a study is important before collecting data as some issues of generalizability 
may be addressed methodologically. For example, a researcher may increase external validity by 
intentionally recruiting participants that represent a diverse background in a specific domain. 
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That is, if socioeconomic status (SES) may play a key role in how an intervention may affect the 
outcome in an experiment, the researcher may seek to recruit participants from varying SES 
levels to show that the intervention effects are similar regardless of SES. The threats to external 
validity that are plausible in the proposed study include the interaction of the causal relationship 
with units, treatment variations, outcomes, and settings (Shadish et al, 2002).  
Interaction of the Causal Relationship with Units  
As explained in the previous section, there may exist some specific factors that may 
interfere with the effects of the intervention on the research subjects in the sample. The threat of 
the interaction of the causal relationship with units refers to the possibility that the causal 
relationship may only occur with the populations in the study sample. That is, the results of a 
study are not generalizable to individuals who were not subjects in the study. To mitigate the 
threat of a lack of generalizability across individuals, the researcher sought to include subjects 
from diverse backgrounds in terms of age, ethnicity, gender, and ADHD subtype (Murnane & 
Willett, 2010).  
Interaction of Causal Relationship over Treatment Variations 
The threat of generalizability based on treatment variations refers to the ability of a 
researcher to manipulate the treatment while maintaining the same causal relationship (Murnane 
& Willett, 2010). In the study, NF as a treatment was administered as a total of 16 sessions over 
the course of at least eight weeks, with no more than two sessions in one week. Because the 
treatment is standardized across participants, the researcher is not able to generalize the results to 
include variations of the treatment. However, although the threat to external validity is increased 
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by standardizing the treatment, the researcher chose to sacrifice external validity to improve the 
statistical conclusion validity of the study by increasing treatment fidelity. 
Interaction of Causal Relationship with Outcomes  
Treatments or interventions in experimental research may show a cause-and-effect 
relationship with the researcher’s constructs of interest (Murnane & Willett, 2010). However, the 
ability of a researcher to generalize the cause and effect relationship across outcome measures 
increases external validity. The current study sought to assess the interaction of the potential 
relationship between NF and ADHD symptoms as well as other constructs (i.e., depression, 
anxiety, and academic self-efficacy). Thus, the findings of the study may provide external 
validity in its ability to generalize a potential relationship across numerous outcomes. 
Interaction of Causal Relationship Across Settings  
As the current study was conducted on the campus of a large metropolitan university in 
the Southeastern United States with participants from the surrounding area, the researcher was 
not able to generalize the results of the study across settings and locations. If the researcher were 
to include multiple settings across the United States, the ability to generalize the results would 
increase. However, participants in the study were students of multiple universities in one state. 
Thus, the researcher can generalize the results of the study to include students from the 
universities represented in the sample (Murnane & Willett, 2010).  
Procedures 
 In order to begin recruitment of participants and collecting data for the study, the 
researcher sought approval from the university’s Institutional Review Board (IRB). The IRB 
application included essential information for the study including a rationale for conducting the 
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study, data collection procedures, data analysis plan, and potential risks and benefits for 
participants. Additionally, the study materials including recruitment materials and data collection 
instruments were included as well. All data were collected at the university’s Community 
Counseling and Research Center (CCRC). Permission was granted from the CCRC director to 
utilize one room in the CCRC for the research study. 
Population and Sample 
 This study utilized convenience sampling with an inclusion criteria (Gall et al., 1996). As 
this study sought to include participants from a specific population (college students with 
ADHD), it was not logical for the researcher to randomly sample all adults or all college 
students. Thus, inclusion criteria delineating ADHD diagnoses was also important in the 
sampling process. Sampling is important in quantitative research as the individuals who 
participate in the study should ideally represent the population. The target population, the 
population to which the researcher would ideally hope to generalize results of the study, was all 
college students in the United States with ADHD. The researcher will only be able to generalize 
results to the accessible population which included college students who participated in the study 
from the participating universities. Participants were students at universities in one Southeastern 
state that saw the recruitment flyers and/or were referred to the study by the Student 
Accessibility Services or Counseling and Psychological Services offices and had randomly 
selected to participate in the study. Through screening criteria, interested students were assessed 
for eligibility for participation. Inclusion criteria for participation in the study included the 
following: (a) over 18 years of age; (b) currently enrolled at a college; (c) able to provide 
documentation of an ADHD diagnosis from a mental health professional; (d) no history of 
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psychosis or psychotic disorders—to be verified in the treatment letter from the mental health 
professional and self-report; (e) no recent emotional hospitalizations—within the past month, to 
be verified by self-report; (f) not currently pregnant; (g) did not have an implanted electrical 
medical device such as a pacemaker; (h) did not have severe skin allergies; and (i) was able to 
speak, read, and understand English as all of the assessments were in English. 
Intervention 
The study was conducted over at least 12 weeks with 8-10 weeks of NF sessions 
(depending on the semester—fall semester participants’ sessions lasted longer due to canceled 
sessions) and a 4 week post-NF follow-up. The tentative timeline for the study was as follows: 
(a) there were two total semesters of data collection (Summer and Fall 2016); (b) recruitment 
was ongoing throughout the fall semester; (c) summer data collection began the first week of the 
Summer 2016 semester with midpoint assessments four weeks later and post assessments four 
weeks after the midpoint assessments; and (d) four weeks after the final NF session, participants 
came in for a follow-up assessment session in which they completed the assessments again. 
Participants attended a total of 16 sessions of NF over the course of 8-10 weeks with 1-2 sessions 
per week. Assessments were administered at the first, eighth, sixteenth, and fourth week follow 
up sessions. In addition, $10.00 gift cards were provided at these four data collection intervals. 
Research assistants (RAs) were trained to conduct the NF sessions in the study. The 
research assistants were recruited from the university’s counselor education program and were 
Master’s level counseling students. Research assistants expressed written interest via email to the 
researcher explaining their interest in joining the research team and their availability to devote 
time to the study. The researcher then met with the prospective research assistants to provide an 
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overview of the researcher’s expectations of the RAs, as well as answer any questions the RAs 
had about joining the research team. If potential RAs were available to dedicate six to eight 
hours each week to the study, and were able to complete CITI training, they were asked to join 
the research team. Once the invitation was accepted, the RAs needed to provide proof of 
professional liability insurance, CITI training, and obtain an IRB account. RAs were then trained 
by the researcher’s co-chair, a certified NF professional, on how to conduct NF sessions. The RA 
training lasted two total days in which the RAs learned about the NF system, watched a 
demonstration of how the NF system works, and practiced conducting a NF session. The 
researcher then created an RA schedule outlining the days and times the RAs were expected to 
conduct NF sessions for participants. 
The first session consisted of the research assistant, or primary researcher, explaining to 
the participants the informed consent for the study. The informed consent outlined that the 
participants’ participation in the study was voluntary and they could withdraw from the study at 
any time they desired. Further, the informed consent provided an outline of the benefits and risks 
associated with participation in the study. According to CCRC policy, when exempt research is 
conducted in the clinic (and the participants do not have to sign the informed consent, as is the 
case with this study), participants must sign an additional form stating that they have received a 
copy of the study’s informed consent. The purpose this additional form is to ensure that each 
participant of research conducted in the CCRC has received a copy of an informed consent. 
Moreover, the Zengar institute, the manufacturers of the NeurOptimal NF system that was 
loaned to the researcher’s co-chair for the purpose of this study, also required study participants 
to sign an informed consent. The purpose of this informed consent was to ensure that the 
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participant understood that the NeurOptimal system is not a medical device and that results may 
vary from participant to participant. In addition to the three informed consent forms, the 
participants also completed a psychosocial inventory. The psychosocial inventory was three 
pages total and included questions about participants’ emotional history (i.e., history of mental 
illness or hospitalization due to mental illness), physical health history, and other basic 
demographics (gender, race, age, etc.). The purpose of the psychosocial inventory was to gather 
demographic information from the participant as well as confirm and screen again for psychotic 
symptoms such as hallucinations. Finally, the participants completed the four assessments 
(CAARS-S:S, BDI, BAI, and SELF-A) and once they completed those assessments they 
received 15 minutes of NF training and a $10 gift card at the end of the session. The first session 
of NF was always 15 minutes, every other session after the first session lasted 33.5 minutes.  
In subsequent sessions, participants were greeted in the CCRC waiting room by the 
researcher or the research assistant conducting the session and guided to the designated research 
room where they were “hooked up” to the NF system and received 33.5 minutes of NF training. 
“Hooking up” the participant to the NF machine involved attaching a total of five sensors to the 
participants’ ears and temples. These sensors “listened” to the participants’ brainwaves and 
transmitted that information to a laptop equipped with the Neuroptimal software. Because the 
Zengar Institute does not delineate the particulars of how the software works, neither the 
researcher nor the RAs was qualified to explain exactly what was happening in session that was 




NeurOptimal monitors the electrical activity of your brain, reminding your brain about 
what it’s actually doing so your brain can function more optimally. When brain activity 
shows signs of turbulence, the music within the NeurOptimal NF software is 
momentarily interrupted. This subtle cue alerts your brain that it is operating inefficiently. 
With repeated training sessions, the brain learns to “reset” itself and function more 
smoothly. All of this learning is non-invasive and happens outside your conscious 
awareness. Over time, NeurOpitmal adjusts itself automatically in response to your 
brain’s activity, individualizing the training microsecond by microsecond to your own 
brain’s functioning. (Zengar, 2016, retrived from: http://www.zengar.com/the-brain-
neuroptimal)  
 Neurofeedback training sessions lasted for 33.5 minutes as this is the standard length of 
time for sessions in the NeurOptimal software; the system automatically stopped itself when the 
session was over. According to NeurOptimal guidelines, participants may read, sleep, text, study, 
etc. as long as they did not talk or chew as the facial movements involved in that may have 
interfered with the readings of the sensors. At the end of the session, the RA removed and 
cleaned the sensors, shut down the NF machine, and asked the participant if they had noticed any 
changes since their last session. The RA then escorted the participant out of the research room 
and to the bathroom (to clean the electrode paste from their temples) or back through the CCRC 
waiting room. As a common effect of NF is a feeling of being tired, the RAs suggested that if 
participants were feeling particularly tired, they sit in the waiting room of the CCRC for 10-15 
minutes before leaving. After each session, the RAs completed a research note which contained a 
section for what the participant reported as well as a section for what the RA observed in session. 
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The RA wrote whatever the participant reported as noticeable changes from their last session 
(e.g. “I’m feeling more alert”, or “I can study better”). In addition, the RA wrote on the note any 
things they notice that was different about the participant (ex: participant showed up late, was 
more/less fidgety than usual, etc.). The purpose of the research notes was to allow the researcher 
to keep track of the participant reported changes as well as ensure the sessions are being 
conducted in a structured way by all of the RAs.  
In assessment sessions (sessions one, eight, and sixteen), the participants were greeted as 
usual and guided back to the research room where they received 33.5 minutes of NF. After the 
NF session, the RA administered the four assessments to the participant (CAARS-S:S, BDI, 
BAI, and SELF-A). It should be noted that participants completing their assessments after 
receiving NF may have impacted their responses on the assessments. That is, participants may 
have felt less anxious, for example, directly following their NF session; thus, impacting their 
responses on the BAI. As the participants completed these same assessments in their initial 
session, the researcher did not anticipate the participants having many questions about the 
assessments. However, if the participants had questions while completing the assessments, the 
RA’s were able to answer the questions as they were informed in their training on how the 
participants are supposed to complete the assessments. If the RA was unable to answer the 
participant’s question regarding the assessment, the RA contacted the researcher or the 
researcher’s co-chair to answer the question. The participants completed the assessments after 
the NF training in each assessment session (with the exception of the very first session and the 
follow-up) to ensure that each participant had received the exact same amount of NF when they 
completed their assessments. Participants also received a $10.00 gift card at the end of their first, 
91 
 
eighth, sixteenth, and follow up sessions. Follow-up sessions lasted approximately 30 minutes, 
the researcher administered the assessments and allowed the participants to ask any follow up 
questions they had about the study. Although participants that participated in the pilot study were 
allowed to participate in the first round of data collection, participants were not able to continue 
sessions once they finished their NF sessions in the summer semester. 
Funding 
 The current study was funded by a Scholarship Research Grant provided through the 
Association for Assessment and Research in Counseling (AARC). AARC is a division of the 
American Counseling Association (ACA) dedicated to the advancement of outcome research and 
instrument development in the counseling profession. The AARC 2016 Scholarship Research 
Grant was awarded to the researcher in the amount of $1,775.25 to cover the cost of participant 
incentives, instrumentation, and supplies necessary to conduct the research study.  
Instrumentation 
 The data collection packets included four measures: (a) the Conner’s Adult ADHD Rating 
Scale (CAARS-S:S; Conners et al, 1999), (b) the Beck Depression Inventory-II (BDI-II; Beck et 
al, 1996), (c) the Beck Anxiety Inventory (BAI; Beck et al, 1988), and (d) the Self-Efficacy for 
Learning Form-Abridged (SELF-A; Zimmerman & Kitsantas, 2005). These packets were 
administered at the four data collection points of the study. In the first data collection point, 
participants also completed a Psychosocial Inventory, which included demographic information 
as well as physical health, emotional health, and substance abuse history. For an abridged 




 The Psychosocial Inventory was adapted from the Psychosocial Inventory used in the 
university’s CCRC for client intake sessions. The CCRC version of the Psychosocial Inventory 
was revised to address issues related to the study population. That is, some items on the 
questionnaire were reworded or changed to gather information from the participants that was 
relevant to the study. The Psychosocial Inventory included questions about the participants’ 
demographic information (i.e., age, gender, ethnicity, contact information) in addition to brief 
questions about the participant’s main concerns as it relates to their ADHD symptoms and what 
they are currently doing to manage their ADHD symptoms. Additionally, the psychosocial 
inventory included questions about participants’ physical health history (i.e., present and past 
illnesses, presence of an electronic medical implanted device, or skin allergies). Moreover, to 
screen for current suicidal behaviors or substance abuse, the psychosocial inventory included 
questions about emotional history and substance abuse. 
The Conner’s Adult ADHD Rating Scale  
The Conner’s Adult ADHD Report Scale Self-Report Short Form (CAARS-S:S; Conners, 
Erhardt, & Sparrow, 1999) was developed in 1999, is a 26 item, Likert-type, self-report measure 
of ADHD symptoms. The version of the CAARS being used in this study is the self-report, short 
form (CAARS-S:S). There are longer forms and observer forms available; however, for the 
purpose of this study, the most feasible version was the short, self-report version. The CAARS 
has four subscales: inattention, hyperactivity, impulsivity, and self-concept.  The CAARS was 
normed on a non-clinical sample of 1,026 adults ranging in age from 18 to 80 years old. Gender 
and age were assessed for their relationship to overall CAARS scores in the nonclinical sample. 
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As such, the authors found significant differences based on gender and age on the inattention 
subscale with men scoring higher than women, (CAARS-S:L, F [1, 1018] = 13.24, p < .001; 
CAARS-S:S, F [1,1018] = 4.66, p < .05). Individuals aged 18 - 29 scored higher than the other 
age groups on the CAARS-S:L (F [3, 1018] = 4.10, p < .01), and the CAARS-S:S, (F [3, 1018] = 
4.34, p < .01). On the hyperactivity subscale, men scored higher than women on the CAARS-S:L 
(F [1, 1018] = 8.27, p < .005) and the CAARS-S:S (F [1,1018] = 8.82, p < .005), lower scores 
were found in older age groups on the CAARS-S:L (F [3, 1018] = 14.79, p < .001) and the 
CAARS-S:S (F [3, 1018] = 19.08, p < .001). On the impulsivity subscale 18 to 29 year olds 
scored higher than the other age groups on the CAARS-S:L (F [3, 1018] = 5.59, p < .001), and 
the CAARS-S:L (F [3, 1018] = 5.86, p < .001). Finally, on the self-concept subscale women 
scored higher than men on the CAARS-S:L (F [1, 1018] = 19.32, p < .001) and the CAARS-S:S 
(F [1,1018] = 18.23, p < .001). Because of these gender and age differences in the normative 
sample, the scoring and interpretation of the CAARS forms take into consideration the 
respondents age and gender. 
Internal consistency reliability of the CAARS is strong with the majority of the alpha 
coefficients above α = .80. For the self-report measures of the CAARS the alpha coefficients 
ranged from α = .66 (males, hyperactive/impulsive symptoms) to α = .90 (males, 
hyperactivity/restlessness-CAARS-S:L). These strong coefficients suggest that there are strong 
relationships between the items on each of the subscales in the CAARS forms for both males and 
females of all ages. Further, Conners and colleagues reported the test-retest reliability of the 
CAARS forms. Participants were administered the CAARS forms initially and then re-
administered the assessments either two weeks or four weeks later. For the two week 
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reassessment (n = 50), responses on each of the subscales were significantly correlated (p < .05) 
with correlations ranging from r = .85 to r = .95, suggesting that results of the assessments are 
stable over time. Further, the four week reassessment (n = 61) showed strong correlations 
between r = .80 and r = .91 (p < .05).  
Conners and colleagues (1995) assessed the discriminant and construct validity of the 
CAARS scales. Discriminant validity addresses the assessments ability to distinguish the 
construct it is meant to measure from other similar constructs. To establish discriminant validity, 
the researchers compared scores on the CAARS between individuals that met DSM-IV-TR 
criteria for ADHD (n = 39) to a control group that did not meet ADHD criteria (n = 40). They 
found that the group of adults with ADHD diagnoses scored higher on inattention (t [38] = 8.62, 
p < .001), hyperactivity (t [38] = 4.55, p < .001), impulsivity (t [38] = 2.84, p < .01), and 
problems with self-concept (t [38] = 5.32, p < .001) than those who did not meet ADHD criteria 
(Erhardt, Epstein, Conners, Parker, & Sitarenios, 1999). Moreover, discriminant function scores 
correctly classified individuals as having ADHD or not 85% of the time. These findings 
identified strong validity in that the CAARS assessments measure what they intend to measure. 
To test the relationship between childhood symptoms of ADHD and current adulthood 
symptoms, the researchers compared participants’ scores on the Wender Utah Rating Scale 
(WURS; Ward, Wender, & Reimherr, 1993) to CAARS scores. The WURS assesses 
retrospective ADHD symptomology in adults. Correlations the subscales ranged from r = .37 to r 
= .67, showing a moderate correlation between childhood ADHD symptoms and adulthood 
ADHD symptoms. Moreover, Conner’s and colleagues used the structured interview (based on 
the DSM-IV-TR) with the CAARS and the CAARS correctly identified ADHD diagnoses 87% 
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of the time. The CAARS assessment has also been used in numerous studies on adults with 
ADHD, including studies evaluating the efficacy of NF on ADHD symptoms. 
The Beck Depression Inventory-II 
The Beck Depression Inventory-II (BDI-II; Beck, Ward, Mendelson, Mock, & Erbaugh 
1961; Beck, Steer, & Brown, 1996) is a 21-item, self-report measure of depressive symptoms. 
The original BDI (Beck et al, 1961) items were based on 21 symptom attitude categories which 
were derived from Beck’s clinical observations of symptoms of depressed individuals. The BDI 
was normed on a clinical population of 400 outpatient and inpatient individuals at a University 
Hospital. These individuals were 60% female, and 64% White. Participants in this study were 
only categorized as either White or Black. The assessment was read aloud by the researchers, 
who recorded participant’s responses by circling the response the participant identified as most 
salient at the current moment for them. The researchers found a significant relationship between 
each of the items on the inventory and the overall score (p < .01), indicating strong internal 
consistency and reliability of the measure. The researchers also compared participants’ self-
report Depression Inventory and clinician administered Depth of Depression ratings and found a 
positive relationship in symptom self-reported and clinician rated severity (p < .001), supporting 
strong validity with these data. 
The BDI-II is a revised version of the BDI that includes clearer statements and was 
created to make self-reporting easier for subjects. Moreover, the BDI-II was edited to match the 
DSM-IV diagnostic criteria for depression. Beck and colleagues provided psychometric data on 
the BDI-II from a sample of 500 outpatients representing both suburban and urban locations. The 
outpatient sample included individuals who had all been diagnosed according to the DSM-III or 
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DSM-IV criteria. Additionally, a sample of 120 college students served as a normative group to 
which the researchers compared the scores from the clinical (outpatient) group. Internal 
consistency reliability of the BDI is strong with an alpha of .92 for the clinical sample and .93 for 
the nonclinical college student sample. Test-retest reliability of the BDI-II showed a strong 
correlation (r = .93) when administered a week apart.  
Construct validity for the BDI-II is moderate with moderate relationships between the 
BDI-II and the Beck Hopelessness Scale (BHS; r = .68), the Revised Hamilton Psychiatric 
Rating Scale for Depression (HRSD-R; r =.71). Additionally, the BDI-II is more strongly related 
to the HRSD-R than the Revised Hamilton Anxiety Rating Scale (HARS-R; r = .47), showing 
evidence of discriminant validity as the BDI-II is more similar to another depression inventory 
than an anxiety inventory (Beck et al, 1988). Factor analysis of the BDI-II showed that the items 
on the BDI-II loaded onto two factors. Beck and colleagues (1996) found that Loss of Pleasure, 
Crying, Agitation, Loss of Interest, Indecisiveness, Loss of Energy, Changes in Sleeping Pattern, 
Irritability, Changes in Appetite, Concentration Difficulty, Tiredness and Fatigue, and Loss of 
Interest in Sex all loaded on the first factor, which they concluded represented the Somatic-
Affective aspect of depression. Sadness, Pessimism, Past Failure, Guilty Feelings, Punishment 
Feelings, Self-Dislike, Self-Criticalness, Suicidal Thoughts or Wishes, and Worthlessness were 
all items that loaded on the second factor which the researchers labeled as the Cognitive aspect 
of depression. Storch and colleagues (2004) conducted a confirmatory factor analysis in a sample 
of 414 nonclinical college students analyzing the factor structure Beck and colleagues (1996) 
identified and found that the scores loaded on the factors in the same way.  
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The researchers found that in both the clinical (t [498] = 2.69, p < .01) and nonclinical (t 
[118] = 2.53, p < .05) populations, women scored higher on the BDI than men. Race/ethnicity 
was not correlated with BDI-II scores; however, it should be noted that the researchers coded 
individuals as White or Non-White. As such, there may exist some differences between specific 
race/ethnicity groups had they been explored. As the clinical sample were diagnosed with 
various disorders, the researchers found that individuals diagnosed with a mood disorder scored 
significantly higher on the BDI-II than those with anxiety, adjustment, or “other” disorders (F [4, 
259] = 4.93, p < .001). 
Item nine in the BDI-II assesses suicidality, which the research assistants were trained to 
scan for. If an individual provided an answer other than “0-I do not have any suicidal thoughts or 
plans”, the RA was instructed to contact the researcher and complete a SLAP assessment 
(Florida Therapy Services, n.d.). If the participant needed to be placed under the Baker Act (the 
emotional hospitalization for safety concerns in the state of Florida; Christy, Stiles, & 
Shanmugam, 2007), CCRC protocol would have been followed and university police would have 
been called to escort the individual to the nearest hospital. No participants in the study expressed 
suicidal ideation on the BDI-II, and the protocols set in place did not have to be implemented. 
The BDI-II has been used in the research on depression and in most studies utilizing NF to 
decrease depressive symptoms. 
The Beck Anxiety Inventory  
The Beck Anxiety Inventory (BAI; Beck, & Steer, 1990) is a 21-item self-report measure 
of anxiety symptoms. The BAI was created from an 86 item pool that were drawn from extant 
anxiety scales including the Anxiety Checklist, the Physician’s Desk References Checklist, and 
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the Situational Anxiety Checklist. The authors selected the 21 items for the BAI by conducting 
numerous rounds of item analysis including reducing items based on their similarity to one 
another and their validity after conducting a factor analysis. The BAI is scored by summing the 
total numbers correlating to the responses the participants choose. The larger the sum, the more 
symptoms of anxiety present.  
The BAI psychometric properties were examined on a clinical outpatient population (N = 
1,086) that was diagnosed with mood disorders by meeting the DSM-III or DSM-III-R criteria. 
Beck and colleagues (1988) used a subsample of 160 for the reliability and validity analyses. A 
total of 243 college students were also used as a nonclinical comparison group. Thus, the 
following psychometric properties must be interpreted with that in mind. The internal 
consistency was high with an alpha of .92. Test-retest reliability was evaluated with a week 
between administrations, correlations were moderate with a correlation coefficient of .75. 
Concurrent validity was assessed by comparing the BAI to other measures of anxiety including 
the Hamilton Anxiety Rating Scale-Revised (HARS-R; Hamilton, 1956), the anxiety subscale of 
the Cognition Checklist (CCL-A; Beck, Brown, Steer, Eidelson, & Riskind, 1987), the trait and 
state subscales of the State-Trait Anxiety Inventory (STAI; Speilberger, 1983), and a seven day 
mean anxiety rating of the Weekly Record of Anxiety and Depression (WRAD; Barlow & Cerny, 
1988). The researchers found that there were moderate relationships between the BAI and the 
HARS-R (r = .51), CCL-A (r = .51), trait anxiety (r = .58), state anxiety (r = .47), and WRAD (r 
= .54). These findings support the idea that anxiety and depression may be closely related; 
however, the fact that the relationship between the BDI-II and the anxiety scales is not strong 
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suggests that the BDI-II is able to discriminate between depressive symptoms and anxiety 
symptoms.  
Beck and colleagues (1996) evaluated the discriminant validity of the BAI by assessing 
differences in BAI scores between groups of individuals diagnosed with the DSM-III-R criteria 
for Panic Disorder (with and without agoraphobia), Social Phobia, Obsessive-Compulsive 
Disorder, and Generalized Anxiety Disorder. The researchers found that BAI scores were 
different based on diagnosis with individuals diagnosed with Panic Disorders having higher BAI 
scores (F [4, 341] = 11.57, p < .001). 
Construct validity of the BAI has been evaluated in the literature and researchers have 
found that the BAI shows strong relationships with depression scales including the BDI (r = .48), 
Hamilton Psychiatric Rating Scale for Depression-Revised (r = .25), and the depression subscale 
of the CCL (r = .22; Beck & Steer, 1996). As depression and anxiety may manifest in the same 
ways, anxiety scales are often related to depression scales (Gotlib & Cane, 1989), it is expected 
that there exist some relationships between the BAI and depression scales. 
Factor analysis was conducted to determine correlations between the items on the BAI 
and how they relate to one another (Beck, Epstein, Brown, & Steer, 1988). The researchers found 
that the 21 BAI items can be clustered into four subscales: Neurophysiological, Subjective, 
Panic, and Autonomic. The Neurophysiological subscale includes the numbness or tingling, 
wobbliness in legs, dizzy or lightheaded, unsteady, hands trembling, shaky, and faint items. 
Subjective includes the unable to relax, fear of the worst happening, terrified, nervous, fear of 
losing control, and scared items. Panic includes the heart pounding or racing, feelings of 
choking, difficulty breathing, and fear of dying items. Feeling hot, indigestion or discomfort in 
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abdomen, face flushed, and sweating (not due to heat) are all included in the autonomic subscale. 
Similar to the BDI, women reported higher scores on the BAI than men (t [391] = 2.72, p <.01). 
Furthermore, younger individuals reported higher anxiety scores than older individuals (F [21, 
370] = 1.72, p < .05). 
The Self-Efficacy for Learning Form-Abridged  
The Self-efficacy for Learning Form (SELF-A; Zimmerman & Kitsantas, 2005, 2007) is a 
19-item self-report, measure of self-efficacy for self-regulated learning. That is, the SELF-A 
measures students’ perceived responsibility and ability to take control of their learning, including 
items that ask about students’ ability to take notes in class, or if they do not understand 
something, their ability to get the information they need. The answers are on a 100 point scale 
from 0—I definitely cannot do this, to 100—I definitely can do this. Respondents write the 
number that corresponds to their beliefs in their ability to complete the task. 
Zimmerman and Kitsantas (2005, 2007) have yet to complete reliability and validity 
analyses on SELF-A scale; however, they report that the communalities of the items in the factor 
analysis were all above .9, identifying that the items relate well to one another. Further, the 
authors compared students’ responses on the SELF to their teachers’ perceptions of the students’ 
self-efficacy via the Perceived Responsibility for Learning Scale (Zimmerman, & Kitsantas, 
2007) and found a strong relationship between the students’ responses and teachers’ perceptions 
(r = .71), suggesting the measure is moderately valid. The SELF-A encompasses the construct of 





Table 1. Data Collection Instrument Reliability and Validity 















α = .66 - .80 r = .85 - .95 
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r = .37 - .67 






α = .92 r = .93 Moderately 
related to  
BHS (r = .68) 
HRSD-R (r = 
.47) 
 





α = .92 r = .75 Moderately 
related to 
HARS-R (r = 
.51) 
CCL-A (r = .51) 
STAI (r = .47 - 
.58) 
WRAD (r = .54) 
 




α = .97 Not Reported Strongly related 
to PRLS (r = 
.71) 
Research Questions 
 The purpose of this study was to investigate the effect of 16 sessions of NF training on 
college students with ADHD diagnoses: (a) scores of ADHD symptoms (as measured by the 
CAARS-S:S; Conners et al, 1999), (b) depression (as measured by the BDI-II; Beck et al, 1996), 
(c) anxiety (as measured by the BAI; Beck & Steer, 1990), and (d) academic self-efficacy (as 
measured by the SELF-A; Zimmerman & Kitsantas, 2005) over time. The independent variable 
in this study was time whereas the dependent variables included (a) hyperactivity, (b) 
impulsivity, (c) inattention, (d) self-concept, (e) depression, (f) anxiety, and (g) academic self-
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efficacy. The research question was: Are there mean rank differences in college students’ scores 
on the Conner’s Adult ADHD Rating Scale (CAARS), the Beck Depression Inventory (BDI), the 
Beck Anxiety Inventory (BAI), and the Self Efficacy for Learning Form-Abridged (SELF-A) over 
time when receiving a NF intervention?  
Data Analysis 
 The Statistical Package for Social Science (SPSS) software package for Windows version 
21.0 (IBM Corp., 2012) was used to analyze the data. This study employed a quasi-experimental, 
times-series design with one independent variable (time) and seven dependent variables. As 
such, the dataset will include the following continuous dependent variables (a) inattention (as 
measured by the CAARS-S:S inattention subscale), (b) hyperactivity (as measured by the 
CAARS-S:S hyperactivity subscale), (c) impulsivity (as measured by the CAARS-S:S 
impulsivity subscale),  (d) self-concept (as measured by the CAARS-S:S self-concept subscale), 
(e) depression (as measured by the BDI-II), (f) anxiety (as measured by the BAI), and (g) 
academic self-efficacy (as measured by the SELF-A).  
To answer the research question, the researcher used SPSS to conduct a Friedman’s 
ANOVA (Friedman, 1937; Friedman, 1940; Daniel, 1990). Because the sample size was too 
small for a parametric analysis (i.e., the data were not normally distributed), the researcher 
conducted a Friedman’s ANOVA for each of the DVs. The Friedman’s ANOVA is the 
nonparametric equivalent to the repeated measures ANOVA. The Friedman’s ANOVA converts 
continuous or ordinal scores into ranked scores for each individual over time and computes a test 
statistic (X2) based on those ranked scores. If the test statistic falls above the threshold for 
statistical significance, the researcher is able to reject the null hypothesis (Daniel, 1990). Further, 
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because there were four groups (i.e., assessment time points), the researcher conducted post hoc 
tests to determine which groups had statistically significant differences (e.g. pretest-posttest, 
pretest-follow up…etc.).  
The researcher addressed the following assumptions for Friedman’s ANOVA before 
running the analyses. The data were collected from one group of subjects at four time points, the 
group of subjects randomly selected from the population to participate, the DVs are measured at 
the continuous level, and, because the Friedman’s ANOVA is a nonparametric analysis, the data 
did not need to be normally distributed (Lowry, n.d.). 
Ethical Considerations 
 The researcher took the following steps to ensure participants were treated in an ethical 
manner while participating in this study. The researcher obtained approval from the IRB before 
commencing any study related recruitment or activity. Once participants decided to participate in 
the study, they were informed of their rights while participating in the study through the 
informed consent process. Because the IRB labeled the study as exempt, participants were not 
required to sign the informed consent; however, they were made aware of the study protocol and 
potential risks and benefits. Further, participants’ identifiable information was included on the 
treatment letter verifying an ADHD diagnosis. Thus, to protect participant confidentiality, the 
researcher separated the treatment letters from the participants’ instrument packets and assigned 
participant numbers to the packets. Moreover, the researcher stored all participant data in a 
locked file cabinet in the researcher’s locked office. 
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Limitations of the Study 
A number of the limitations to this study were discussed in the threats to validity section. 
The lack of a control group is a limitation to the study design, adding a control group would 
allow the researcher to compare the scores on the assessments between the treatment and control 
group, increasing internal validity. Attrition is another limitation to the study in that internal 
validity was threatened due to a lack of completion from the participants. Further, the small and 
convenient sample is a limitation to the study as the power of the statistical results was low due 
to a small sample size. Shadish and colleagues (2002) suggest increasing the sample size in a 
study in order to increase statistical power. Moreover, data collection procedures (i.e., self-report 
measures) pose a limitation to the study as participants may respond to the questionnaires in a 
socially desirable manner. Including an observer-report measure would strengthen the validity of 
the results. Instrumentation error is also a potential limitation of the study. As some participants 
in the fall semester of data collection took longer than eight weeks to receive their 16 sessions of 
NF, treatment fidelity is threatened and serves as a limitation to the study. 
The researcher described methods incorporated to mitigate the threats to validity explored 
in the validity section. Some elements that the researcher implemented to reduce the threats to 
validity include (a) collecting data over two semesters to increase sample size, (b) ensuring 
treatment fidelity in the RA training and session notes, and (c) ensuring the statistical procedure 




 Chapter three has provided an overview of the research design and protocols for the 
proposed study. The research methods chapter described potential threats to validity (i.e., 
statistical conclusion, internal, construct, and external) in addition to mechanisms that may 
mitigate these threats. Additionally, data collection procedures including population, sample, 
recruitment, incentives, and screening criteria were described. Moreover, the reliability and 
validity of the data collection instruments used in the study were presented in addition to the data 




CHAPTER FOUR: RESULTS 
Chapter four presents the results of the current study investigating the effects of 
neurofeedback training on ADHD symptoms, depression, anxiety, and academic self-efficacy in 
college students diagnosed with ADHD. The purpose of the study was to test the hypothesis that 
after 16 sessions of neurofeedback training, participants’ scores on the Conners Adult ADHD 
Rating Scale (CAARS; Conners et al, 1999), Beck Depression Inventory-II (BDI-II; Beck et al, 
1961), and the Beck Anxiety Inventory (BAI; Beck et al, 1996) would decrease over time. 
Further, the researcher hypothesized that participant scores on the Self-Efficacy for Learning 
Form-Abridged (SELF-A, Zimmerman & Kitsantas, 2005) would increase. The current study 
incorporated a one-group time-series design to explore the effects of 16 sessions of 
neurofeedback on college students diagnosed with ADHD. 
This chapter reviews the study’s (a) research design, (b) sampling and data collection 
methods, (c) participants’ descriptive data, (d) preliminary data analysis procedures and 
explanation of statistical assumptions, (e) results of statistical analyses, and (f) a conclusion of 
the findings of the study. 
Research Design 
The current study implemented a one group, quasi-experimental time series research 
design in which 11 study participants received 16 sessions of a neurofeedback training 
intervention over eight to ten weeks. Participants’ symptoms of ADHD (CAARS:S-S; Conners, 
et al, 1999), depression (BDI-II; Beck et al, 1961), anxiety (Beck et al, 1996), and academic self-
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efficacy (SELF-A, Zimmerman & Kitsantas, 2005) were measured at four time points throughout 
the study. Time series research designs allow researchers to repeatedly test participants over the 
course of an intervention. Repeatedly assessing participants increases the internal validity of the 
study as multiple assessment points strengthens the researcher’s ability to state a causal 
relationship between the independent variable (IV) and the dependent variable (DV) (Shadish, 
Cook, & Campbell, 2002). Therefore, changes observed in scores over time can be better 
attributed to the intervention implemented rather than an external factor. 
Data Collection 
Data in the current study were collected over two rounds of data collection which 
spanned the course of nine total months (May 2016-January 2017). Participant recruitment began 
in April 2016 with the researcher recruiting participants from the pilot study and placing flyers 
around a large Southeastern University campus. Further, the researcher contacted the student 
accessibility/disability services offices at nearby colleges in the Southeastern United States with 
the hopes that the offices would share the study flyer with the students at their institutions. 
Neurofeedback sessions began in May 2016 for the first round of data collection and ended in 
July 2016. The second round of neurofeedback sessions began in September 2016 and ended in 
early December 2016. Follow up sessions were conducted in August 2016 and December 
2016/January 2017 for the first and second rounds of data collection respectively.  
Participants received 16 total sessions of neurofeedback (with the exception of one 
participant who, due to a clerical error, received 17 sessions) with 1-2 sessions of neurofeedback 
per week. Participants were scheduled for two sessions each week, however, due to unforeseen 
circumstances (i.e., Hurricane Matthew, scheduling conflicts) there were some weeks in which 
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participants received only one session. The researcher collected self-report data from the 
participants on their symptoms of ADHD, depression, anxiety, and academic-self-efficacy. 
Participants completed self-report assessments at the first session (pretest), after eight sessions of 
neurofeedback (mid), after their sixteen (or 17) total neurofeedback sessions (post), and at a four 
week follow up (follow-up). Multiple assessment points allowed the researcher to assess changes 
in scores over time. That is, the researcher was able to evaluate changes in scores based on 
whether the participants received eight (pre-mid) or sixteen sessions (pre-post). Further, the 
researcher was able to determine whether the changes in scores were lasting with the follow up 
scores. 
Sampling Procedures 
The researcher recruited participants through the dissemination of flyers at the large 
Southeastern University and surrounding colleges. Participants from the student populations at 
these institutions were randomly exposed to the recruitment flyers and self-selected to participate 
based on the information outlined on the flyer. The researcher purposefully placed flyers in the 
offices on the campuses that would most likely serve the population of students that were eligible 
for the study. These offices included Student Accessibility/Disability Services (office serving 
students with accessibility/disability needs including learning disabilities and ADHD), 
Counseling and Psychological Services (office providing free counseling and psychological 
services to college students), and the Office of Wellness and Health Promotion (office providing 
biofeedback—a similar intervention to that used in the current study—to college students).  
Potential participants who expressed interest in participating in the study called the 
researcher’s office telephone and completed a short over-the-phone screening. Inclusion criteria 
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for the study included the following: (a) over 18 years of age; (b) currently enrolled at a college; 
(c) able to provide documentation of an ADHD diagnosis from a mental health professional; (d) 
no history of psychosis or psychotic disorders—to be verified in the treatment letter from the 
mental health professional and self-report; (e) no recent emotional hospitalizations—within the 
past month, to be verified by self-report; (f) not currently pregnant; (g) did not have an implanted 
electrical medical device such as a pacemaker; (h) did not have severe skin allergies; and (i) was 
able to speak, read, and understand English as all of the assessments were in English. 
Response Rates 
The researcher recruited participants through the dissemination of flyers on Southeastern 
United States higher education institutions’ campuses. There is no method of determining how 
many individuals were exposed to recruitment flyers; thus, the researcher can no accurately 
calculate a response rate. However, 23 total individuals expressed interest in participating in the 
current study. Of the 23 interested participants, 2 individuals were not eligible to participate, 4 
individuals never showed up for their first sessions, 4 individuals could not fit the sessions into 
their schedules, 13 individuals completed at least 1 neurofeedback session, and 11 of the 13 
participants completed all 16 sessions of neurofeedback and all of the assessments. Therefore, 
the completion rate for the participants that expressed interest was 47.8%. 
Descriptive Statistics 
Participants in the current study included 11 college students who had been diagnosed 
with ADHD at some point in their lifetime. Participants in this study self-selected to participate 
in the study and provided proof of an ADHD diagnosis in the form of a treatment summary. 
Participants (n = 4) presented with Attention Deficit Hyperactivity Disorder, Combined type 
110 
 
(314.01, F90.2) as their diagnosis, one participant presented with Attention Deficit Hyperactivity 
Disorder with hyperactivity as their diagnosis, and the other six participants’ treatment 
summaries did not specify the type of ADHD.  At the outset of the study, eight participants 
reported using medication as a means by which they managed their ADHD symptoms (one 
participant reported beginning a medication regimen after the first week of NF sessions). 
Additional methods of managing ADHD symptoms for the participants included mental health 
counseling (n = 3), meditation (n = 9), and apps to help with studying and time management (n = 
1).  The sample included three participants (27%) who identified as males, and eight participants 
(73%) who identified as female. Participant ages ranged from 18 to 27 years of age. Students 
were enrolled in both the undergraduate (n = 8) and graduate (n = 3) level programs. The vast 
majority (n = 9) of the participants identified racially as White (non-Hispanic), with one 
participant identifying as Hispanic, and one participant identifying as Biracial.  
 Main concerns for the participants included issues surrounding focus/concentration, 
inattention, test anxiety, stress, memory, and time management. Participants reported 
expectations and hopes that participating in the study would help alleviate some of their 
symptoms of ADHD. Two participants mentioned a specific hope that participating in the study 
would help them to be able to reduce their need for medication for their ADHD and sleep. 
Participants also rated themselves as being in “good” (n = 8) or “average” (n = 3) physical health 
and all participants reported that they exercise and try to eat healthy as a positive thing they do to 
impact their health. Only one participant reported having migraines, sleep concerns were an issue 
for six participants, with participants reporting an average of between four and six hours of sleep 
per night. Participants also reported experiencing “blue moods” (n = 6), anxiety (n = 4), 
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difficulty concentrating (n = 11), lack of energy (n = 6), racing thoughts (n = 8), angry outbursts 
(n = 1), feelings of inferiority (n = 7), and memory problems (n = 10). 
 Participants reported conservative use of alcohol and drugs. Six participants reported 
drinking alcohol as often as several times per month and as seldom as several times per year. 
One participant reported using marijuana several times per year. No participants were in 
recovery for an addiction; however, three participants reported a family history of substance 
abuse. One participant reported having suicidal thoughts in the past; however, the participant 
reported she was not currently having suicidal thoughts and did not have a plan. Participants 
reported having “some (1-5)” (n = 7), or “many (5+)” (n = 4) supportive individuals in their 
lives. Further, participants reported activities such as reading, exercising, playing videogames, 
watching television, journaling, crafting, playing with pets, music, and engaging in prosocial 
activities around campus as positive things they do to foster their emotional health. See Table 2 
for participant demographic information. 
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Table 2. Participant Demographics 
Demographics Male Female 
Gender 3 8 
Race   
       Hispanic - 1 
       White 3 6 
       Biracial - 1 
Current Efforts to Manage ADHD 
Symptoms 
  
       Medication 2 7 
       Counseling - 2 
Physical Health Rating   
       Good 2 6 
       Average 1 2 
Number of Supports   
       1-5 Some 2 5 
       5+ Many 1 3 
Alcohol or Drug Use   
       Alcohol 1 5 
       Drugs - 1 
       None 2 2 
Frequency of Alcohol Use   
       1/2x per month 1 4 
       Several times/month - 1 





Conner’s Adult ADHD Rating Scale 
The Conner’s Adult ADHD Rating Scale Short, Self-Report form (CAARS; Conners, 
Erhardt, & Sparrow, 1999) is a 26 item, Likert-scale measure of ADHD symptoms in adults. It is 
composed of four subscales (inattention, hyperactivity, impulsivity, and self-concept) as well as 
an ADHD index. The CAARS is scored by adding the responses from each item in each subscale 
to determine a total subscale score. Further interpretation of the CAARS may include plotting 
individuals’ total subscale scores on a profile. When participants’ scores are plotted in their 
profile, T scores are provided for each subscale total score based on the individual’s age and 
gender. According to Conners and colleagues (1999), profile patterns including at least one 
clinically significant T score (> 65), are representative of marginally significant problems with 
ADHD symptoms. The more scales with clinically significant T scores, the higher the level of 
impairment. The researcher did not incorporate T scores into the analysis of the data for this 
study as raw total scores for each subscale were used instead. Using the raw scores allowed the 
researcher to analyze the data using the Friedman ANOVA. Using previously transformed data 
would have affected the interpretation and calculation of the X2 statistics in the Friedman 
ANOVAs. Thus, T scores are useful in the practical interpretation of the CAARS scores as they 
provide information on how individuals’ scores compare to a normed population; however, raw 
scores are best when running analyses on the data to compare subjects’ scores across time 
(Pallant, 2010). The following is a report of reliability data for each of the subscales included in 
the current study. 
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Total reliability coefficients for the CAARS were strong for pre (α = .922), mid (α = 
.899), post (α = .848), and FW (α = .892). Specifically, the inattention subscale of the CAARS is 
composed of five items. Instrument statistics for the CAARS inattention subscale can be found in 
Table 3. Internal consistency coefficients below .7 are considered questionable, with coefficients 
around .7 considered moderate and those above .8 considered strong (Pallant, 2010). However, 
alpha coefficients may vary depending on the number of items on the assessment and the sample 
size. That is, smaller sample sizes and less assessment items may yield lower alpha coefficients 
(Leech, Onwuegbuzie, &O’Connor, 2011; Streiner, 2003).  Coefficients for the inattention 
subscale of the CAARS were moderate to strong (pre α = .916; mid α = .785; FW α = .678) with 
the post coefficient being the most questionable (α = .585). The pre reliability coefficient from 
the current study sample is higher than that found in the norm population (α = .83; α = .80) for 
men and women respectively. The mid, post, and FW reliability coefficients are all below that of 
the norm population. 
The hyperactivity subscale of the CAARS is also composed of five items measuring 
hyperactivity and restlessness. Reliability coefficients for the hyperactivity subscale of the 
CAARS were moderate to strong for the pre (α = .694), mid (α = .728), post (α = .840), and FW 
(α = .916). The mid and post coefficients from the current study’s sample are consistent with the 
hyperactivity coefficients for males (α = .77) and females (α = .80). Pre and FW coefficients are 
lower and higher than hyperactivity reliability coefficients respectively. 
The impulsivity subscale of the CAARS is also composed of five items measuring 
impulsivity and emotional lability. Reliability coefficients for the impulsivity subscale of the 
CAARS were moderate for the pre (α = .721), mid (α = .708), post (α = .681), and FW (α = .708) 
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administrations of the CAARS. The reliability coefficients from the current study’s sample are 
lower than the hyperactivity coefficients for males (α = .80) and females (α = .77).  
Finally, the self-concept subscale of the CAARS consists of five items measuring 
problems with self-concept. Reliability coefficients for the self-concept subscale of the CAARS 
were strong for the pre (α = .838), mid (α = .817), and post (α = .881) administrations of the 
CAARS. Coefficients for the FW administration were moderate (α = .741). The coefficients for 
the sample population in the current study were slightly lower than those from the normed non-
clinical sample (α = .86) for men and women. It must be noted that the sample size in the current 
study (N = 11) was significantly smaller than the sample size from Conners and colleagues’ 
study (N = 799; Erhardt et. al., 1999). Therefore, the lower alpha coefficients (i.e., post 
inattention) may reflect differences in consistency based on the smaller sample (i.e. a wider 
range of scores from a smaller number of subjects; Conners, et. al., 1999). 
Beck Depression Inventory 
The Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) is a 21 item 
self-report Likert scale measure of depressive symptoms. Depression as a construct in the current 
study is defined as participants’ scores on the BDI-II. Descriptive statistics for the BDI-II 
including means and standard deviations can be found in Table 3. Internal consistency 
coefficients were strong for the pretest (α = .934), midpoint (α = .937), posttest (α = .920), and 
FW (α = .912) administrations of the BDI-II. The reliability coefficients in the current sample are 




Beck Anxiety Inventory 
The Beck Anxiety Inventory (BAI; Beck, & Steer, 1990) is a 21 item self-report Likert 
scale measure of symptoms of anxiety. The researcher has operationally defined anxiety as 
participants’ self-report scores on the BAI. Descriptive statistics for the BAI including means 
and standard deviations can be found in Table 3. Internal consistency coefficients were strong for 
pretest (α = .946), midpoint (α = .944), posttest (α = .895), and FW (α = .962), suggesting that 
the items on the BAI sufficiently measure anxiety. The reliability coefficients in the current 
sample are consistent with the coefficients found in a nonclinical sample of college students (α = 
.92).  
Self-Efficacy for Learning Form-Abridged 
The Self-Efficacy for Learning Form-Abridged (SELF-A; Zimmerman & Kitsantas, 
2005) is a 19 item self-report measure of academic self-efficacy in college students. The SELF-A 
assesses college students’ perceived ability to complete academic related tasks and includes 
items related to study habits, note taking, and soliciting help if need be from a classmate or the 
instructor. Academic self-efficacy was operationally defined as the total score on the SELF-A. 
As participants’ responses were measured on a scale of 0 – “I definitely cannot do this”, to 100 – 
“I definitely can do this”, higher total scores indicated higher academic self-efficacy. Descriptive 
data for the SELF-A can be found in Table 3. Internal consistency coefficients for the SELF-A 
were strong for midpoint (α = .954), posttest (α = .951), and FW (α = .944). The pretest 
reliability coefficient was questionable (α = .483), indicating a weak relationship between 
participants’ responses on each of the items, suggesting that participants may have varied in the 
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types of academic self-efficacy with which they presented. That is, participants may have 
reported high efficacy on some of the items of the SELF-A and not others, providing a level of 
inconsistency for the instrument overall. The reliability coefficients found with the current study 
sample are consistent with the communalities reported by Zimmerman and Kitsantas (i.e., > .9) 
with the exception of the pretest reliability coefficient.  
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Table 3. Statistics for the CAARS, BDI-II, BAI, and SELF-A 
Descriptive Statistics M SD Median Mean Rank Range Min. Max. 
 
CAARS—Inattention  
       
Pretest 10.55 4.204 11 3.14 12 3 15 
             Midpoint 8.73 2.867 9 2.86 9 5 14 
             Posttest 8.09 2.508 8 2.41 7 5 12 
             Follow Up 
 
7.00 2.408 7 1.59 7 4 11 
CAARS—Hyperactivity        
             Pretest 10.18 2.750 10 3.36 8 6 14 
             Midpoint 8.09 2.844 8 2.50 10 4 14 
             Posttest 7.09 2.844 7 1.86 11 3 14 
             Follow Up 
 
7.36 3.854 8 2.27 14 1 15 
CAARS—Impulsivity         
             Pretest 3.36 2.693 3 3.00 9 1 10 
             Midpoint 2.36 1.963 2 2.32 6 0 6 
             Posttest 2.45 1.916 2 2.36 6 0 6 
             Follow Up 
 
2.27 1.954 2 2.32 6 0 6 
CAARS—Self-Concept        
            Pretest 7.09 4.036 6 3.41 13 0 13 
            Midpoint 4.91 2.700 4 2.68 9 0 9 
             Posttest 3.45 2.544 4 1.77 8 0 8 
             Follow Up 
 
3.91 2.343 4 2.14 7 0 7 
BDI-II        
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             Pretest 10.55 9.658 9 3.45 27 0 27 
             Midpoint 7.09 8.584 5 2.64 28 0 28 
             Posttest 5.82 7.692 4 1.86 26 0 26 
             Follow Up 5.64 6.860 2 2.05 20 0 20 
        
BAI        
             Pretest 13.18 13.273 8 3.45 42 1 43 
             Midpoint 8.91 10.737 4 2.55 31 2 33 
             Posttest 6.91 7.176 4 1.91 21 1 22 
             Follow Up 
 
8.18 12.552 3 2.09 43 1 44 
SELF-A        
             Pretest 111.500 26.036 109 1.27 85.0 74.0 159.0 
             Midpoint 123.545 31.793 120 2.45 90.5 76.0 166.5 
             Posttest 127.455 29.874 132 2.68 85.0 84.0 169.0 
             Follow Up 132.909 29.156 134 3.59 92.0 82.0 174.0 





Friedman’s Test (Friedman, 1937; 1940) was conducted using the Statistical Package for 
the Social Sciences Version 23.0. The researcher used the Friedman’s ANOVA to answer the 
research question of: Are there mean rank differences in college students’ scores on the Conner’s 
Adult ADHD Rating Scale (CAARS), the Beck Depression Inventory (BDI-II), the Beck Anxiety 
Inventory (BAI), and the Self Efficacy for Learning Form-Abridged (SELF-A) over time when 
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receiving a NF intervention? Specifically, the researcher sought to explore differences in 
participants’ scores on the inattention, hyperactivity, self-concept, impulsivity subscales of the 
CAARS; and the total depression, anxiety, and academic self-efficacy scores over time.  
The purpose of the Friedman ANOVA is to examine mean rank differences in a 
dependent variable between three or more groups. Contrary to similar parametric analyses (i.e., 
Repeated Measures ANOVA), the Friedman ANOVA transforms the raw scores into ranked 
scores in each group and compares the ranks to one another (Daniel, 1990; Friedman, 1937). 
Comparing ranks instead of raw continuous scores allows the researcher to analyze data when 
the parametric assumption of normality is violated (Daniel, 1990). The ranks are calculated by 
assigning a number based on the rank of the individual’s score in each group. For example, if an 
individual’s highest score of the four data collection time points was the first score, the first 
score would be assigned the highest rank. And the other three scores would be assigned based on 
how they rank with one another. Individual subjects’ scores are ranked and each groups rank is 
then totaled. That is, the total rank for each assessment point is included in the analysis. If the 
difference in total ranks of each group is significant at the p < .05 level based on the critical 
value calculation, the researcher can assert that there is a difference between the groups (Lowry, 
n.d.). Further, Wilcoxon post hoc tests were conducted to determine where differences lie 
between groups in the cases where significance was found in the Friedman analyses. When the 
researcher conducted the post hoc tests, a Bonferroni adjustment was implemented because six 
post hoc tests were run on the same datasets. Bonferroni adjustments are suggested as alpha 
levels are inflated when multiple tests are run on the same data (Gall, Gall, & Borg, 2006). Thus, 
the researcher calculated a reduced alpha level of significance based on the number of tests being 
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run on the data. In the case of the current study, six post hoc tests were run for each significant 
Friedman test; therefore, the researcher divided the alpha level by six. The new alpha level used 
in the post hoc tests to determine significance was (α = .0083). Significance was also reported at 
the p < .05 level for the post hoc tests because although, statistically, the alpha level may be 
inflated, providing a larger probability for type I error; effect sizes provided support of a 
significant change in scores over time (Shadish, et. al., 2002). That is, the researcher sought to 
report the strength of the effect based on the positive and negative ranks regardless of the 
statistical significance (as determined by the Bonferonni adjusted alpha) as effects may occur in 
a sample even if statistical significance is not found (Shadish, et. al., 2002). 
The Friedman ANOVA is the nonparametric equivalent to the parametric Repeated 
Measures ANOVA analysis. The data in the current study met the assumptions necessary for the 
Friedman ANOVA in that the data were: (a) collected from one group at three or more different 
occasions; (b) collected from a random sample of a population; (c) collected with the dependent 
variables at a continuous level; and (d) do not need to be normally distributed (Lowry, n.d.). As 
the assumptions for the Friedman ANOVA are more methodological in nature rather than 
statistical, specific statistical analyses were not necessary to show that the data met the 
assumptions. The data were gathered from one group of subjects who randomly self-selected to 
participate at four different occasions with measurements yielding continuous data. Further, the 
data are not normally distributed. 
Primary Research Question 
The research question guiding this study was: Are there mean rank differences in college 
students’ scores on: (a) the Conner’s Adult ADHD Rating Scale (CAARS), (b) the Beck 
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Depression Inventory (BDI-II), (c) the Beck Anxiety Inventory (BAI), and (d) the Self Efficacy 
for Learning Form-Abridged (SELF-A) over time when receiving a NF intervention? To answer 
the research question, seven Friedman ANOVAs were run to investigate differences in scores on 
each of the dependent variables (inattention, hyperactivity, impulsivity, self-concept, depression, 
anxiety, and academic self-efficacy). In cases in which differences were found (i.e., p < .05), post 
hoc analyses were run to determine which groups were significantly different.  
Inattention 
The Conner’s Adult ADHD Self-Report Scale (CAARS; Conners, et. al., 1999) includes 
an inattention subscale which includes five items addressing problems with inattention and 
memory (e.g., I’m disorganized, I have trouble getting started on a task). A Friedman ANOVA 
was conducted on the pre, mid, post, and follow up scores on the inattention subscale for the 
CAARS. There was a significant difference in scores in the inattention subscale of the CAARS 
(X2(3) = 10.268, p = .016). Mean ranks for the groups were as follows (Pre MR = 3.14, Mid MR = 
2.86, Post MR = 2.41, and FW MR = 1.59; See Table 3). That is, the pre assessment ranks for 
inattention were highest and the ranks decreased over time.  
Post hoc Wilcoxon tests were conducted on the inattention data to examine which groups 
showed significant differences from one another. Wilcoxon analyses indicated significant 
differences at the p < .05 level in pre inattention and post inattention (M = 8.09, SD = 2.508) 
scores (Z = -2.146; p = .032) with post inattention scores lower than pre inattention scores in 
seven cases, post inattention scores higher than pre inattention scores in three cases, and one tie. 
There was also a significant difference in pre inattention and follow up (FW; N = 11, M = 7.00, 
SD = 2.408) inattention scores (Z = -2.456, p = .014) with FW inattention scores ranking less 
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than pre inattention scores in eight cases, FW inattention scores ranking higher than pre 
inattention scores in two cases, and one tie. There was also a significant difference in post 
inattention and FW inattention scores (Z = -2.047, p = .041) with FW scores ranking lower than 
post scores in six cases, FW scores ranking lower than post scores in one case, and four ties. 
Further, a difference was found at the Bonferroni corrected alpha level of p < .0083 between mid 
inattention and FW inattention scores (Z = -2.699, p = .007) with FW inattention ranking lower 
than mid inattention in nine cases, no instances of FW inattention ranking higher than mid 
inattention, and two ties.  
Post hoc analyses indicated no significant difference between the pre and mid inattention 
scores (Z = -1.692, p = .091). However, when subtracting mid inattention scores (N = 11, M = 
8.73, SD = 2.867) from pre inattention scores (N = 11, M = 10.55, SD = 4.204), mid inattention 
scores were lower than the pre inattention scores in seven cases, the mid inattention scores were 
higher than the pre inattention scores in three cases, and there was one tie. Further, there was no 
significant difference in mid inattention and post inattention scores (Z = -1.310, p = .190), yet 
post scores ranked lower than mid scores in six cases, post scores ranked higher than mid scores 
in three cases, and there were two ties. See Table 4 for statistical data. 
Table 4. Inattention Statistical Data 





CAARS—Inattention  10.268 .016*      
Pre – Mid   -1.692 .091 7 3 1 
             Pre – Post   -2.146 .032* 7 3 1 
             Pre – FW   -2.456 .014* 8 2 1 
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             Mid – Post   -1.310 .190 6 3 2 
             Mid – FW   -2.699 .007** 9 0 2 
             Post – FW   -2.047 .041* 6 1 4 
        
* p < .05; ** p < .0083 
 Effect sizes were interpreted by the magnitude of positive and negative ranks. The 
negative ranks indicate how many times the latter assessment scores ranked lower than the 
former assessments scores. On the CAARS inattention scale, the lower the score, the lower the 
presence of symptomology. The largest effect size can be seen between the mid and FW 
assessment points with FW scores ranking lower than mid scores in nine cases and no cases of 
mid scores ranking higher than FW scores.  The largest effect size suggests that the largest 
decrease in inattention scores occurred between the mid and FW assessment points. 
Hyperactivity  
The Conner’s Adult ADHD Self-Report Scale (CAARS; Conners et al, 1999) includes a 
hyperactivity subscale which includes five items addressing problems with hyperactivity and 
restlessness (e.g., I tend to squirm or fidget, I’m bored easily). A Friedman ANOVA was 
conducted on the pre, mid, post, and follow up scores on the hyperactivity subscale for the 
CAARS. Results indicated there was a significant difference in hyperactivity scores in the 
CAARS over time (X2(3) = 10.151, p = .017). Pre hyperactivity mean rank scores were highest 
(MR = 3.36), with mid hyperactivity scores second highest (MR = 2.5), FW scores third highest 
(MR = 2.27), and post scores lowest (MR = 1.86; See Table 3).  
Post hoc Wilcoxon tests indicate a significant difference between pre hyperactivity (M = 
10.18, SD = 2.750) and mid hyperactivity scores (M = 8.09, SD = 2.844; Z = -2.512, p = .012) 
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with mid hyperactivity scores ranking lower than pre hyperactivity scores in eight cases, mid 
hyperactivity scores ranking higher than pre hyperactivity scores in one case, and two ties. 
Further a significant difference exists between pre hyperactivity and post hyperactivity scores (M 
= 7.09, SD = 2.844; Z = -2.375, p = .018) with post scores ranking lower than pre scores in seven 
cases, post scores ranking higher than pre scores zero times, and four ties. A marginally 
significant difference was found (Z = -1.965, p = .049) between pre and FW hyperactivity (M = 
7.36, SD = 3.854) as well with FW hyperactivity scores ranking lower than pre scores in seven 
cases, FW ranking higher than pre scores in two cases, and two ties. 
Significant differences were not found between the mid hyperactivity scores and post 
hyperactivity scores (Z = -1.703, p = .088); however, post scores ranked lower than mid scores 
seven times, post scores ranked higher than mid scores one time, and there were three ties. There 
was also no significant difference between mid and FW hyperactivity scores (Z = -1.138, p = 
.255), but FW scores ranked lower than mid scores in five cases, FW scores ranked higher than 
mid scores in four cases, and there were two ties. Finally, there was no significant difference in 
post and FW scores (Z = -.604, p = .546) with FW scores ranking lower than post scores in three 
cases, FW scores ranking higher than post scores in four cases, and four ties. See Table 5 for 
statistical data. 
Table 5. Hyperactivity Statistical Data 





CAARS—Hyperactivity  10.151 .017*      
Pre – Mid   -2.512 .012* 8 1 2 
             Pre – Post   -2.375 .018* 7 0 4 
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             Pre – FW   -1.965 .049* 7 2 2 
             Mid – Post   -1.703 .088 7 1 3 
             Mid – FW   -1.138 .255 5 4 2 
             Post – FW   -.604 .546 3 4 4 
        
* p < .05; ** p < .0083 
 Effect sizes were interpreted by the magnitude of positive and negative ranks. On the 
CAARS hyperactivity scale, the lower the score, the lower the presence of symptomology. The 
largest effect size can be seen between the pre and mid assessment points with mid scores 
ranking lower than pre scores in eight cases and one case of pre scores ranking higher than mid 
scores.  The largest effect size suggests that the largest decrease in hyperactivity scores occurred 
between the pre and mid assessment points. 
Impulsivity  
The Conner’s Adult ADHD Self-Report Scale (CAARS; Conners et al, 1999) includes an 
impulsivity subscale which includes five items addressing problems with impulsivity and 
emotional lability (e.g., I have a short fuse/hot temper, I still throw tantrums). A Friedman 
ANOVA was conducted on the pre, mid, post, and follow up scores on the impulsivity subscale 
for the CAARS. No significant difference was found between impulsivity group scores over time 
(X2(3) = 3.284, p = .350). Mean ranks for each group were close with pre impulsivity scores at the 
highest rank (MR = 3.00), post impulsivity scores second highest (MR = 2.36), and Mid and FW 
impulsivity scores tied with the lowest scores (MR = 2.32; See Table 3). The lack of variance in 
the mean ranks and small sample size may have contributed to the lack of significant findings for 
the impulsivity dependent variable (Shadish, et. al., 2002). See Table 6 for statistical data. 
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Table 6. Impulsivity Statistical Data 
Descriptive Statistics X2 p 
CAARS—Impulsivity  3.284 .350 
   
* p < .05 
Self-Concept  
The Conner’s Adult ADHD Self-Report Scale (CAARS; Conners et al, 1999) includes a 
self-concept subscale which includes five items addressing problems with self-concept (e.g., I 
get down on myself, I wish I had greater confidence in my abilities). A Friedman ANOVA was 
conducted on the pre, mid, post, and follow up scores on the self-concept subscale for the 
CAARS. A significant difference was found for self-concept scores over time (X2(3) = 11.745, p 
= .008). Pre self-concept scores ranked the highest of all group (MR = 3.41) with mid scores 
ranking second highest (MR = 2.68), FW scores ranked third highest (MR = 2.14), and post 
scores ranked the lowest (MR = 1.77; See Table 3).  
Post hoc Wilcoxon tests indicate a significant difference between pre self-concept (M = 
7.09, SD = 4.036) and mid self-concept scores (M = 4.91, SD = 2.700; Z = -1.973, p = .049) with 
mid self-concept scores ranking lower than pre self-concept scores in seven cases, mid self-
concept scores ranking higher than pre self-concept scores in one case, and three ties. 
Additionally, a significant difference exists between pre self-concept and post self-concept 
scores (M = 3.45, SD = 2.544; Z = -2.609, p = .009) with post scores ranking lower than pre 
scores in nine cases, post scores ranking higher than pre scores in one case, and one tie. A 
significant difference was found (Z = -2.403, p = .016) between pre and FW hyperactivity (M = 
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3.91, SD = 2.343) as well with FW self-concept scores ranking lower than pre scores in eight 
cases, FW ranking higher than pre scores in two cases, and one tie. 
No significant differences were found between mid self-concept and post self-concept 
scores (Z = -1.690, p = .091). However, post self-concept scores ranked lower than mid scores in 
eight cases, post scores ranked higher than mid scores in two cases, and there was one tie. 
Moreover, there was no significant difference between mid and FW self-concept scores (Z = -
1.502, p = .133); yet, FW scores ranked lower than mid scores in seven cases, FW scores ranked 
higher than mid scores in three cases, and there was one tie. Finally, there was no significant 
difference between post and FW self-concept scores (Z = -.843, p = .399) with FW scores 
ranking lower than post scores in two cases, FW scores ranking higher than post scores in four 
cases, and five ties. See Table 7 for statistical data. 
Table 7. Self-Concept Statistical Data 





CAARS—Self-Concept  11.745 .008*      
Pre – Mid   -1.973 .049* 7 1 3 
             Pre – Post   -2.609 .009* 9 1 1 
             Pre – FW   -2.403 .016* 8 2 1 
             Mid – Post   -1.690 .091 8 2 1 
             Mid – FW   -1.502 .133 7 3 1 
             Post – FW   -.843 .399 2 4 5 
        
* p < .05; ** p < .0083 
Effect sizes were interpreted by the magnitude of positive and negative ranks. On the 
CAARS self-concept scale, the lower the score, the lower the presence of issues related to self-
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concept. The largest effect size can be seen between the pre and post assessment points with post 
scores ranking lower than pre scores in nine cases and one case of pre scores ranking higher than 
post scores.  The largest effect size suggests that the largest decrease in self-concept impairment 
scores occurred between the pre and post assessment points. 
Depression 
The Beck Depression Inventory-II (BDI-II; Beck, et. al., 1996) total scores were used to 
evaluate participants’ levels of depression over time during a neurofeedback treatment. A 
Friedman ANOVA was conducted on the pre, mid, post, and FW BDI-II scores to investigate 
differences in scores between groups. A significant difference was found in depression scores 
over time (X2(3) = 13.165, p = .004) with pre BDI-II scores ranking highest (MR = 3.45), mid 
BDI-II scores ranking second highest (MR = 2.64), FW BDI-II scores ranking third highest (MR 
= 2.05), and post BDI-II scores ranking lowest (MR = 1.86; See Table 3).  
Post hoc Wilcoxon tests were conducted to examine specific differences between groups. 
A significant difference existed between the pre BDI-II (M = 10.55, SD = 9.658) and mid BDI-II 
scores (M = 7.09, SD = 8.584; Z = -2.196, p = .028) with mid depression scores ranking lower 
than pre scores in seven cases, mid scores ranking higher than pre scores in two cases, and two 
ties. Pre depression scores were different from post depression (M = 5.82, SD = 7.692) scores as 
well (Z = -2.194, p = .028) with post scores ranking lower than pre scores in nine cases, post 
scores ranking higher than pre scores in one case, and one tie. The final significant difference 
was found between the pre and FW (M = 5.64, SD = 6.860) groups (Z = -2.194, p = .028), with 




No significant differences were found between the mid depression and post depression 
groups (Z = -1.612, p = .107); however, post scores ranked lower than mid scores in six cases, 
post scores ranked higher than mid scores in one case, with four ties. Further, no difference was 
found between mid scores and FW scores (Z = -.509, p = .611); yet, FW scores ranked lower 
than mid scores in five cases, FW scores ranked higher than mid scores in two cases, and there 
were four ties. Finally, no difference was found between post and FW scores (Z = -.135, p = 
.893) with FW scores ranking lower than post scores in two cases, FW scores ranking higher 
than post scores in three cases, and six ties. See Table 8 for statistical data. 
Table 8. Depression Statistical Data 





BDI-II  13.165 .004*      
Pre – Mid   -2.196 .028* 7 2 2 
             Pre – Post   -2.194 .028* 9 1 1 
             Pre – FW   -2.194 .028* 9 1 1 
             Mid – Post   -1.612 .107 6 1 4 
             Mid – FW   -.509 .611 5 2 4 
             Post – FW   -.135 .893 2 3 6 
        
* p < .05; ** p < .0083 
 Effect sizes were interpreted by the magnitude of positive and negative ranks. On the 
BDI-II, the lower the score, the lower the presence of depressive symptoms. The largest effect 
size can be seen between the pre and post, and pre and FW assessment points with post and FW 
scores ranking lower than pre scores in nine cases and one case of pre scores ranking higher than 
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post and FW scores. The largest effect size suggests that the largest decreases in depression 
scores occurred between the pre and post, and pre and FW assessment points.   
Anxiety  
The Beck Anxiety Inventory (BAI; Beck & Steer, 1990) total scores were analyzed to 
examine differences in participants’ self-reported levels of anxiety over time. A Friedman 
ANOVA was conducted to investigate differences in anxiety scores between the pre, mid, post, 
and FW groups. A significant difference was found in anxiety scores over time (X2(3) = 10.078, p 
= .018) with pre BAI scores ranking highest (MR = 3.45), mid BAI scores ranking second 
highest (MR = 2.55), FW BAI scores ranking third highest (MR = 2.09), and post BAI scores 
ranking lowest (MR = 1.91; See Table 3).  
Post hoc Wilcoxon tests were conducted to examine specific differences between groups. 
A significant difference existed between the pre BAI (M = 13.18, SD = 13.273) and mid BAI 
scores (M = 8.91, SD = 10.737; Z = -2.501, p = .012) with mid anxiety scores ranking lower than 
pre scores in nine cases, mid scores ranking higher than pre scores in one case, and one tie. Pre 
anxiety scores were different from post anxiety (M = 6.91, SD = 7.176) scores as well (Z = -
2.407, p = .016), with post scores ranking lower than pre scores in nine cases, post scores ranking 
higher than pre scores in two cases, and no ties. The final significant difference was found 
between the pre and FW (M = 8.18, SD = 12.552) groups (Z = -2.308, p = .021) with FW scores 
lower than pre scores in eight cases, FW scores ranking higher than pre scores in two cases, and 
one tie. 
No significant differences were found between the mid anxiety and post anxiety groups 
(Z = -1.367, p = .172); however, post scores ranked lower than mid scores in seven cases, post 
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scores ranked higher than mid scores in two cases, and there were two ties. Further, no 
significant difference was found between mid scores and FW scores (Z = -.665, p = .506); yet, 
FW scores ranked lower than mid scores in seven cases, FW scores ranked higher than mid 
scores in three cases, with one tie. Finally, no difference was found between post and FW scores 
(Z = -.178, p = .858), with FW scores ranking lower than post scores in four cases, FW scores 
ranking higher than post scores in five cases, and two ties. See Table 9 for statistical data. 
Table 9. Anxiety Statistical Data 





BAI  10.078 .018*      
Pre – Mid   -2.501 .012* 9 1 1 
             Pre – Post   -2.407 .016* 9 2 0 
             Pre – FW   -2.308 .021* 8 2 1 
             Mid – Post   -1.367 .172 7 2 2 
             Mid – FW   -.665 .506 7 3 1 
             Post – FW   -.178 .858 4 5 2 
        
* p < .05; ** p < .0083 
 Effect sizes were interpreted by the magnitude of positive and negative ranks. On the 
BAI, the lower the score, the lower the presence of symptomology. The largest effect size can be 
seen between the pre and mid assessment points with mid scores ranking lower than pre scores in 
nine cases and one case of pre scores ranking higher than mid scores. The largest effect size 




Academic Self-Efficacy  
The Self-Efficacy for Learning Form-Abridged (SELF-A; Zimmerman & Kitsantas, 
2005) total scores were used to evaluate differences in participants’ academic self-efficacy over 
time throughout the intervention. When inputting the SELF-A scores to the dataset, the 
researcher transformed the raw scores (each item was on a scale from 0-100%) to scores from 0-
10. That is, if a participant reported 67% confidence on an item, the researcher input the score as 
6.7 and total scores were computed by totaling the item responses for all 19 items. There was a 
significant difference in self-efficacy scores over time (X2(3) = 18.361, p < .001). The mean ranks 
for each group increased over time (Pre MR = 1.27, Mid MR = 2.45, Post MR = 2.68, FW MR = 
3.59; See Table 3), suggesting that academic self-efficacy improved over time.   
Post hoc Wilcoxon tests were conducted to examine specific differences between groups. 
A significant difference existed between the pre SELF-A (M = 111.5, SD = 26.0356) and mid 
SELF-A scores (M = 123.545, SD = 31.7934; Z = -2.179, p = .029) with mid efficacy scores 
ranking lower than pre scores in two cases, mid scores ranking higher than pre scores in nine 
cases, and no ties. Differences were also found between the mid and FW groups (Z = -1.989, p = 
.047), with FW scores ranking lower than mid scores in two cases, FW scores ranking higher 
than mid scores in eight cases and one tie. The final significant difference was found between the 
post and FW groups (Z = -2.146, p = .032), with FW scores ranking lower than post scores in 
two cases, FW scores ranking higher than post scores in nine cases, and no ties. Differences were 
found at the Bonferroni corrected alpha level of p < .0083 between pre efficacy and post efficacy 
scores (M = 127.455, SD = 29.8743; Z = -2.759, p = .006), with post scores ranking lower than 
pre scores in one case, and post scores ranking higher than pre scores in ten cases. Moreover, a 
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significant difference was found between pre and FW (M = 132.909, SD = 29.1563) groups (Z = 
-2.934, p = .003), with FW scores ranking higher than pre scores in all 11 cases. 
No difference was found between the mid efficacy and post efficacy groups (Z = -1.176, 
p = .240); yet, post scores ranked higher than mid scores in six cases, post scores ranked lower 
than mid scores in four cases, and one tie. See Table 10 for statistical data. 
Table 10. Academic Self-Efficacy Statistics 





SELF-A  18.361 .000      
Pre – Mid   -2.179 .029* 2 9 0 
             Pre – Post   -2.759 .006** 1 10 0 
             Pre – FW   -2.934 .003** 0 11 0 
             Mid – Post   -1.176 .240 4 6 1 
             Mid – FW   -1.989 .047* 2 8 1 
             Post – FW   -2.146 .032* 2 9 0 
        
* p < .05; ** p < .0083 
 Effect sizes were interpreted by the magnitude of positive and negative ranks. On the 
SELF-A, the higher the score, the higher the level of academic self-efficacy. The largest effect 
size can be seen between the pre and FW assessment points with FW scores ranking higher than 
pre scores in all 11 cases. The largest effect size suggests that the largest increase in academic 





Chapter four has provided an overview of the study design, recruitment and sampling 
procedures, descriptive demographic statistics of the sample population, descriptive data on each 
of the instruments, and data analysis procedures and findings. The researcher found that there 
were significant changes in scores over time in the inattention, hyperactivity, self-concept, 
depression, anxiety, and academic self-efficacy constructs. No significant changes were found in 
the impulsivity construct. Post hoc analyses indicated differences between pre inattention, 
hyperactivity, self-concept, depression, anxiety, and academic self-efficacy scores and mid, post, 
and follow up scores for the same constructs. Differences in mid scores and post scores were 
found in the academic self-efficacy construct. Additionally, a significant difference between post 
and follow up academic self-efficacy scores was found. The implications of these findings and a 





CHAPTER FIVE: DISCUSSION 
Chapter five presents a discussion about the results of the current study and implications for 
future research. The results of the study identified that after 16 sessions of neurofeedback, 
college student participants reported a significant decrease in their levels of inattention, 
hyperactivity, negative self-concept, depression, and anxiety. Further, participants’ scores in 
academic self-efficacy increased significantly over time; however, no significant changes were 
identified in participants’ impulsivity symptom scores. This chapter provides an overview of the 
study and presents the study’s (a) discussion, (b) limitations, and (c) implications and 
recommendations for future research. 
Overview 
College students diagnosed with ADHD are at higher risk for depression, anxiety, and low 
academic achievement as compared to individuals without ADHD diagnoses (Buchannan, 2011; 
Gaultney, 2014). Further, college students with ADHD diagnoses face challenges to access and 
adherence when pursuing pharmacological intervention for their ADHD symptoms. Adverse side 
effects to stimulant medications used to treat ADHD symptoms include headache and changes in 
appetite. Consequently, college students may seek alternative treatment options to manage their 
symptoms including counseling and/or drugs such as marijuana to avoid the adverse side effects 
related to stimulant medication (Combs et. al., 2015; Cunill et. al., 2016). Neurofeedback is a 
drug-free, non-invasive intervention that has shown efficacy in reducing problematic symptoms 
associated with ADHD (i.e., inattention, hyperactivity) as well as depression and anxiety 
(Escolano et. al., 2014; Hammond, 2005; Moore, 2000). Further, the side effects of 
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neurofeedback are minimal to non-existent (Zengar, 2013). The Zengar Institute, the 
manufacturers of the NeurOptimal system used in the current study, report that side effects may 
include feeling tired after a session. Neurofeedback may be a promising intervention to use with 
college students with ADHD to decrease their ADHD symptoms as well as anxiety and 
depression, without severe adverse side effects. Therefore, neurofeedback may be a viable 
treatment option for college students with ADHD as an alternative to medication. 
Summary of Study 
The purpose of the current study was to examine the effects of 16 sessions of 
neurofeedback training on college students’ (a) inattention, (b) hyperactivity, (c) impulsivity, (d) 
self-concept, (e) depression, (f) anxiety, and (g) academic self-efficacy. Eleven college students 
completed sixteen sessions of neurofeedback training and were assessed at four time points (i.e., 
pre, mid, post, and follow-up) throughout the study to evaluate changes in symptomology over 
time. The researcher used the Conners Adult ADHD Rating Scale (CAARS; Conners et al, 1999), 
Beck Depression Inventory-II (BDI-II; Beck et al, 1961), Beck Anxiety Inventory (BAI; Beck et 
al, 1996), and the Self-Efficacy for Learning Form-Abridged (SELF-A, Zimmerman & Kitsantas, 
2005) to measure participants’ levels of ADHD symptoms, depression, anxiety, and academic 
self-efficacy, respectively. 
Constructs of Interest 
ADHD 
Characteristics of Attention Deficit-Hyperactivity Disorder include symptoms of 
inattention, hyperactivity, and impulsivity in children and adults (American Psychiatric 
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Association, 2013). Although ADHD is more prevalent in children (Faraone et.al, 2016), 
children with ADHD diagnoses often retain the symptoms of ADHD into adulthood (Karam et. 
al., 2015). College students with ADHD diagnoses are at higher risk of suicidality, depression, 
test anxiety, generalized anxiety, and substance use/dependence (Buchannan, 2011; Combs et. 
al., 2015; Gaultney, 2014). Research findings identify the efficacy of neurofeedback in 
mitigating ADHD symptoms in children (Escolano et. al., 2014); however, less research has 
examined the effects of neurofeedback on ADHD symptoms in early adulthood (college 
students). For the purposes of the current study, symptoms of ADHD were measured by the 
Conner’s Adult ADHD Rating Scale (Conners, et. al., 1999). 
Depression 
Depression is a mood disorder characterized by persistent sadness and a notable lack of 
energy (American Psychiatric Association, 2013). College students with ADHD are more likely 
to suffer from symptoms of depression and suicidality (Harrison et. al., 2013). Further, suicidal 
ideations and behaviors have been shown to have a positive relationship with ADHD symptoms 
(Patros et. al., 2013). Existing research shows promise for the efficacy of neurofeedback in 
mitigating the symptoms of depression in adult samples (Hammond, 2005); however, the current 
study is unique in that it provides support of the efficacy of neurofeedback in a sample of college 
students diagnosed with ADHD. 
Anxiety 
Anxiety is often characterized by excessive fear or worry. College students with ADHD 
are more likely to suffer from anxiety. Specifically, adults and college students with ADHD have 
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higher prevalence of test anxiety or anxiety related to work or academic achievement. The Beck 
Anxiety Inventory (Beck et al, 1996) was used in the current study to measure participants’ 
generalized symptoms of anxiety. Neurofeedback has shown positive results with individuals 
with anxiety (Moore, 2000). Existing literature on neurofeedback’s efficacy with anxiety focuses 
on specific diagnoses related to anxiety (i.e., Obsessive Compulsive Disorder, Post Traumatic 
Stress Disorder, etc.) and do not specifically focus on anxiety symptoms in college students with 
anxiety.  
Academic Self-Efficacy 
Individuals with ADHD are at risk for exhibiting lower academic self-efficacy and 
consequently, lower academic achievement. Academic self-efficacy, for the purpose of the 
current study, is defined as individuals’ belief in their ability to complete a list of academic 
related tasks (i.e., ratings on the SELF-A). Children with ADHD are more likely to struggle 
academically due to the inattention and hyperactivity associated with ADHD (Major et. al., 2012; 
Tabassam & Grainger, 2002). Therefore, low academic self-efficacy is reinforced in childhood 
by low academic achievement and persists into adulthood in college, leading to higher rates of 
failed classes, course withdrawal, and dropping out in college students with ADHD. The current 
study is unique in that it evaluates the effects of neurofeedback on academic self-efficacy, which 
has not before been evaluated.  
Participants 
 Participants were recruited on the campuses of Southeastern United States Universities 
with flyers, and classroom announcements. The researcher was contacted by a total of 23 
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interested potential participants; however, 10 participants were either ineligible, did not show up 
for their initial sessions, or could not fit the sessions into their schedules. Of the 13 eligible 
participants, 11 participants completed all 16 sessions and all of the accompanying assessments. 
The 11 subjects who completed all stages of the study consisted of 3 males and 8 females. The 
majority of participants in the study identified as White (n = 9; 81%), with one (9.1%) participant 
identifying as Biracial, and one (9.1%) participant identifying as Hispanic. Participants’ ages 
ranged from 18 to 27 with a mean age of 22.6. 
Data Collection 
Participants received 16 total sessions of NF during the course of the study. One 
participant was scheduled for a 17th session as the result of a scheduling error; therefore, 
completed 17 sessions. Participants were scheduled for two NF sessions each week. Due to 
unforeseen circumstances (i.e., inclement weather, scheduling issues), there were some weeks in 
which participants received only one session. Neurofeedback training lasted 15 minutes for 
participants’ first sessions, and 33.5 minutes for each subsequent session. Further, in the initial 
session, participants were administered a psychosocial assessment, as well as the CAARS, BDI-
II, BAI, and SELF-A. Participants completed assessments after the eighth and sixteenth sessions, 
as well as at a four-week follow-up after the last NF session. Participants received an incentive in 
the form of a $10 gift card at the first, eighth, sixteenth, and follow-up sessions. Funding for the 
current study was provided through the Association for Assessment and Research in Counseling 





Participants in the current study included 11 total college students. Other studies 
incorporating NF with a college student population included larger populations (N = 32, Fritson 
et. al., 2007) and as few as one in case studies (i.e., Decker et. al., 2014). Small samples are 
common in studies incorporating NF as an intervention with adults; however, larger samples are 
seen mostly in randomized control trials with children with ADHD (i.e., N = 112, Jansen et al, 
2016). The most reported reason for small sample sizes in NF studies is attrition (Bink et al, 
2015). Adults and college students are likely to have less flexible schedules due to employment 
and class obligations and may be more likely to discontinue participating in a study due to 
scheduling conflicts. Moreover, asking college students to make a commitment to the NF 
research investigation for 12 weeks is significant and contributes to attrition. Shadish and 
colleagues (2002) explain that researchers may prevent attrition by changing the intervention to 
meet the expectations of the participants; that is, if participants are not expecting to spend a lot of 
time participating in the study, researchers can shorten the intervention to decrease the 
probability of attrition. However, in the current study, the length of the intervention (16 NF 
sessions) was inherent in the research question and could not be shortened as the researcher 
explained the expectations and time commitments of the participants at the outset of the study. 
Future research may offer larger amounts of monetary incentives to encourage participants to 
complete the study. In the current study, eight participants identified as females, and three 
participants identified as males. Gall and colleagues (2007) express that “females are more likely 
than males to volunteer for research in general” (p. 187). A majority female sample can be found 
142 
 
in similar studies investigating inattention within college student populations (i.e., Fritson, 2007). 
Further, Rasey and colleagues’ study included an equal number of men (n = 2) and women (n = 
2). NF investigations examining anxiety and depression often include more women than men 
(Baehr et. al., 2001; Cheon et. al., 2015; Kerson et. al., 2009; Kluetsch et. al., 2014). A rationale 
for the majority of the samples being female in studies examining depression and anxiety may be 
because females are diagnosed significantly more with depression and anxiety as compared to 
males (Nemeth, Harrell, Beck, & Neigh, 2013). Further, studies examining ADHD symptoms in 
which the targeted population is not college students includes fewer female participants (Mayer 
et al, 2016; White et. al, 2005), suggesting that females with ADHD are more likely to 
participate in a NF study if they are a college student. Thus, the population in the current study is 
similar to other studies incorporating NF as an intervention with college students. 
Further, the majority (n = 9; 81%) of participants identified as White and female (n = 8, 
73%), with one participant identifying as Biracial, and one participant identifying as Hispanic. 
Therefore, the sample for the current study was not as diverse as the student demographic 
makeup at the large Southeastern University in which the study was conducted. Although the 
majority (50%) of students at the Southeastern University identify as White, 23% of students 
identify as Hispanic/Latino and 11.1% of students identify as African-American. With a larger 
sample, the demographics in the current study sample may have more closely mirrored that of 
the student population at the large Southeastern University. As such, the results of the current 
study are not generalizable to students from backgrounds not represented in the current study 
(i.e., Black, Asian, etc.). Future research may include individuals from more diverse 
backgrounds and a larger sample size to improve the external validity and generalizability of the 
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study. However, a small sample of minority participants is not abnormal in research, with 
researchers examining ways to increase minority recruitment and retention in research (Levkoff 
& Sanchez, 2003; Shavers, Lynch, & Burmeister, 2002). Individuals from underrepresented 
backgrounds may be less likely to participate in research due to historical events (Corbie-Smith, 
1999; Freimuth, Quinn, Thomas, Cole, & Duncan, 2001).  For example, the Tuskegee Syphilis 
Study was a study in which hundreds of Black farmers were infected with Syphilis and not 
properly treated, resulting in the Syphilis-related deaths of over 100 Black men, thus negatively 
affecting African Americans’ views of research. Green and colleagues (1997) found that African 
Americans who had knowledge of the Tuskegee Syphilis Experiment reported being less willing 
to engage in health related research or health education. Therefore, recruiting and retaining 
participants from minority backgrounds is difficult for researchers. Additionally, cultural 
considerations should be acknowledged when recruiting minority participants. Similar studies 
utilizing NF rarely reported racial demographic data-with most studies only reporting inclusion 
criteria (i.e., diagnosis) rather than racial demographic information. As such, future research 
should examine potential differences in the effects of NF based on race by implementing 
culturally sensitive recruitment strategies to retain participants from minority backgrounds.  
All 11 participants in the current study had received ADHD diagnoses from a mental 
health professional (i.e., counselor, psychologist, psychiatrist, etc.). Similar studies confirmed 
ADHD symptom severity or ADHD diagnosis through a structured clinical interview or 
screening assessment (Mayer et. al., 2016; White et. al., 2005). As the participants in the current 
study had all received diagnoses and provided proof of the diagnoses, the researcher did not seek 
to validate participants’ ADHD diagnoses further. Participants in the current study were also all 
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above the age of 18. Other research studies have been conducted with children (Escolano et. al., 
2014; Gonzalez-Castro et. al., 2016) and adolescents (Duric et. al., 2012) including children as 
young as seven years old. The mean age of college students (M = 22.6) in the current study is 
similar to the ages of college student participants in similar studies (Fritson et. al., 2007). The 
current study sample differs from samples in similar investigations with college students in that 
the current study included both graduate students and undergraduate students. College student 
participants in similar studies (Fritson et. al., 2007; Rasey et. al., 1995) were all undergraduate 
students. Although, the current study includes graduate level students as well as undergraduate 
students, the mean age of the sample is similar to that of studies only including undergraduate 
students. Future research may investigate potential differences between ADHD symptomology 
and manifestation in undergraduate and graduate students. 
Instrument Descriptive Statistics 
CAARS  
The Conner’s Adult ADHD Rating Scale (Conners et. al., 1999) is a 26-item self-report 
measure of ADHD symptomology for adults. Items on the CAARS are four point Likert scale 
ranging from 0-Not at all, never; to 3-Very much, very frequently. Respondents select the 
number that corresponds to their level of experiencing the problem outlined in the item. The 
CAARS measures ADHD symptomology in the domains of inattention, impulsivity, 
hyperactivity, and self-concept through four subscales, each consisting of five items. Total scores 
for each subscale determine the intensity of symptomology in each area. That is, higher scores in 
each subscale indicate higher levels of symptomology. The Conner’s Adult ADHD Rating Scale 
(Conners et. al., 1999) can be found in Appendix G.  
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 When examining the reliability coefficients of the CAARS, the researcher identified 
adequate alpha coefficients for the overall total scores for pre (α = .922), mid (α = .899), post (α 
= .848), and FW (α = .892). According to Leech and colleagues (2011), reliability of scores on 
an instrument indicates how consistent the instrument will produce the same results over time 
and conditions. Internal consistency reliability refers to the likelihood of scores to be replicated 
across time, and conditions. That is, do the items on the scale measure the constructs across 
times, settings, and other conditions (Leech, et. al., 2011). In the current study, the researcher 
calculated Chronbach’s α to determine the reliability of each of the subscales of the CAARS. 
Therefore, the following α coefficients represent the degree to which participants’ scores on each 
subscale of the CAARS are likely to be replicated. Coefficients for the inattention subscale of the 
CAARS were moderate to strong (pre α = .916; mid α = .785; FW α = .678) with the post 
coefficient being the most questionable (α = .585). Therefore, the alpha coefficients for the 
CAARS inattention subscale suggest that participants answered more consistently in the pre 
assessment, and least consistently in the post assessment. A potential explanation for this 
phenomenon may be that participants’ levels of inattention changed at an inconsistent rate over 
time, thus, creating inconsistencies in participants’ reports of inattention. That is, participants 
may have experienced a high level of inattentive symptoms on each item of the inattention 
subscale at the outset of the study; however, as time went on, participants may have experienced 
changes in inattentive symptoms measured by certain items on the inattention subscale. 
The reliability coefficients for the hyperactivity subscale of the CAARS were moderate to 
strong for the pre (α = .694), mid (α = .728), post (α = .840), and FW (α = .916) administrations 
of the CAARS; suggesting that respondents’ scores became more consistent over time. 
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Reliability coefficients for the impulsivity subscale of the CAARS were moderate for the pre (α 
= .721), mid (α = .708), post (α = .681), and FW (α = .708) administrations of the CAARS; 
suggesting that respondents’ scores remained moderately consistent at each administration of the 
assessment. Reliability coefficients for the self-concept subscale of the CAARS were strong for 
the pre (α = .838), mid (α = .817), and post (α = .881) administrations of the CAARS and 
moderate (α = .741) for the FW administration. Self-concept reliability coefficients remained 
relatively stable over time, suggesting that the current study participants’ scores on the self-
concept subscale of the CAARS were consistent at each administration.  
 Anastopoulos and colleagues (2015) examined the impact of a group intervention on 
college students diagnosed with ADHD. The researchers included the inattention, hyperactivity, 
and total ADHD symptoms subscales of the CAARS Long version to determine changes in 
symptomology in the study sample (N = 43). The researchers found improvements in inattention 
(t = 4.81, d = .76, p <.001), hyperactivity (t = 1.99, d = .31, p < .06), and total ADHD scores (t = 
3.80, d =.60, p < .15). The researchers failed to include reliability data in the article; however, 
the findings are congruent with the current study findings in that significant differences were 
found in the inattention and hyperactivity subscales of the CAARS. The sample in the 
Anastopoulos study was similar to the sample in the current study in that the majority of 
participants were female (n = 27; 63%). Participants in the Anastopoulos study (2015) had an 
average age of 20.3 years; whereas participants in the current study had a mean age of 22.6 
years. Although the participants in the Anastopoulos study and the current study are similar in 
gender and age, the Anastopoulos study included more diversity in the sample, with 37% of the 
sample being of Hispanic, African American, or multiracial backgrounds. However, as both the 
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Anastopolous study and the current study produced similar findings, both studies increase the 
generalizability of the CAARS assessment.  
 Moreover, Anastopoulos and colleagues (2016) evaluated the prevalence of comorbidity 
in college freshmen with ADHD. The sample included college freshmen with ages ranging 
between 18 and 22 (M = 18.2). The researchers compared a group of freshmen with ADHD 
diagnoses to a comparison group without ADHD diagnoses. Mean T scores on the inattention 
and hyperactivity subscales of the CAARS for the ADHD group were 78.6 (SD = 12.4) and 63.5 
(SD = 13.5), respectively. Participants presented with the following mean scores for inattention 
pre (M = 67.45; SD = 13.545), and hyperactivity pre (M = 61.91; SD =8.927); thus, the current 
study sample differed slightly from the clinical sample population of college students in the 
Anastopoulos (2016) study. Participants in the current study presented with lower levels of 
inattention and hyperactivity symptoms than the participants in the Anastopoulos study, 
suggesting that the current study sample was slightly less clinical than comparable samples. 
However, according to Conner’s and colleagues (1999), T scores greater than 65 indicate 
significant problems with ADHD. Therefore, although the current study sample presented with 
lower scores on average than a comparable population, the participants still presented with 
clinically significant levels of distress related to their ADHD symptomology as evidenced by a T 
score higher than 65 in at least one of each of the subscales for each participant. Moreover, a 
floor effect is more likely to occur if scores at the outset of the study are lower than average; 




The Beck Depression Inventory-II (Beck, Ward, Mendelson, Mock, & Erbaugh 1961; 
Beck, Steer, & Brown, 1996) is a 21-item, self-report measure of depressive symptoms. 
Respondents complete the BDI-II by marking the appropriate number that corresponds with the 
statement with which they identify most. Items on the BDI-II include sadness, self-dislike, past 
failure guilty feelings, and loss of interest. Corresponding statements range from 0 – not 
experiencing the symptom, to 3 – severely experiencing the symptom. Higher scores on the BDI-
II indicate higher levels of depressive symptoms. Sample items for the BDI-II can be found in 
Appendix H. 
Internal consistency reliability for the sample in the current study were strong for the 
pretest (α = .934), midpoint (α = .937), posttest (α = .920), and FW (α = .912) administrations of 
the BDI-II. The consistent reliability coefficients suggest that participants responded consistently 
on the BDI-II at each administration of the assessment. Therefore, the probability that 
participants’ scores on the BDI-II were a result of measurement error are low (Shadish et al, 
2002). 
Cheon and colleagues (2016) also examined the effects of NF on depressive symptoms in 
adults. Similar to the current study, the researchers found a significant decrease in BDI-II scores 
in an adult sample. Further, the sample in the Cheon study were similar in gender makeup to the 
current study sample in that there were 16 women in the study and 4 men. Although the sample 
was similar in gender to the current study, the sample in the Cheon study were significantly older 
with a mean age of 43.25, than the college students in the current study (M = 22.6). Choi and 
colleagues’ (2011) sample was more comparable in age (M = 28.46) to that of the current study 
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and also included more females than males, similar to the current study. The current study’s 
findings are consistent to similar studies conducted with alike samples.  
The current study sample presented with lower levels of depression than similar studies. 
Scores on the BDI-II are categorized as minimal (0-13), mild (14-19), moderate (20-28), and 
severe (29-63). The sample in Cheon and colleagues’ (2016) study presented with moderate 
levels of depression (M = 25.25, SD = 7.91), while the current study sample presented with 
minimal levels of depression (M = 10, SD = 9.658). Therefore, although current study 
participants’ scores significantly decreased over time, the sample included in the study on 
average did not present with clinical levels of depression; suggesting that NF may be effective in 
decreasing depressive symptoms in clinical and subclinical populations. 
BAI 
The Beck Anxiety Inventory (BAI; Beck, & Steer, 1990) is a 21 item self-report Likert 
scale measure of symptoms of anxiety. Respondents complete the BAI by selecting the 
corresponding number to identify the extent to which they experience symptoms of anxiety such 
as numbness or tingling, hands trembling, and fear of dying. Answer options range from 0 – not 
at all, to 3 – severely, it bothered me a lot. Higher total scores on the BAI indicate more severe 
levels of anxiety symptoms. Sample items for the BAI can be found in Appendix I. 
 Internal consistency coefficients for the BAI scores were strong for pretest (α = .946), 
midpoint (α = .944), posttest (α = .895), and FW (α = .962), suggesting that participants in the 
current study responded consistently on the BAI at each administration of the assessment. 
Further, strong internal consistency coefficients suggest that the probability of participants’ 
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scores being the results of measurement error are low. That is, participants’ scores on the BAI 
are more likely to be consistent across time and settings. 
Surprisingly, many studies examining the effect of NF on anxiety symptoms did not 
include the BAI; rather, researchers used the State-Trait Anxiety Inventory (STAI; Speilberger, 
1983). Not using the BAI may be a result of researchers seeking to examine potential differences 
in state and trait anxiety over time with a NF intervention. Cheon and colleagues (2016), 
however, incorporated the BAI in their study examining the effects of NF on depressive 
symptoms in adults with Major Depressive Disorder. The sample in the Cheon study presented 
with moderate levels of anxiety (M = 19.75, SD = 12.76), while the current study sample 
presented with mild levels of anxiety (M = 13.18, SD = 13.27). However, the large standard 
deviations in both samples indicate that participants in both the current study and the Cheon 
study varied greatly in their levels of anxiety. Similar to the findings of the current study, Cheon 
and colleagues found a significant difference in BAI scores (p = .01); however, the researchers 
reported the difference in BAI scores as approaching significance as the p value failed to meet 
their Bonferroni adjusted significance value of .005. The current study adds to the anxiety and 
NF literature by providing support for the use of the BAI with college students with ADHD. 
SELF-A 
The Self-Efficacy for Learning Form-Abridged (SELF-A; Zimmerman & Kitsantas, 
2005) is a 19 item self-report measure of academic self-efficacy in college students. The SELF-A 
assesses college students’ perceived confidence in their ability to complete academic related 
tasks such as note taking, asking classmates for help, or practicing effective study habits. 
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Respondents provide a number on a scale of 0 - “I definitely cannot do this”, to 100 – “I 
definitely can do this”, higher total scores indicated higher academic self-efficacy.  
Internal consistency coefficients for the SELF-A scores were strong for midpoint (α = 
.954), posttest (α = .951), and FW (α = .944), with pretest reliability as the most questionable (α 
= .483). These reliability coefficients indicate that participants’ scores on the pretest 
administration of the SELF-A were less consistent than the mid, post, and FW administration 
scores were. A potential explanation for the lower reliability in the pretest SELF-A scores may 
be that participants may have presented with varying levels of academic self-efficacy. That is, 
participants may have felt efficacious in some areas (i.e., note taking), but not in other areas (i.e., 
soliciting help from a classmate or instructor). Finally, self-efficacy is a construct that may vary 
within an individual, thus causing seemingly inconsistent scores on an assessment. It appears that 
participants’ scores on the SELF-A were more reliable at the mid, post, and FW assessments; 
suggesting that participants responded more consistently at the mid, post, and FW 
administrations of the SELF-A. The mid, post, and FW reliability coefficients are similar to the 
reliability reported in Major and colleagues’ (2012) examination of academic self-efficacy in 
adolescents with ADHD (α = .97). It should be noted that the researchers used the long version 
of the SELF, which included 57 items rather than the abridged version (used in the current study) 
which included only 19 items.  
The sample in the current study presented with self-efficacy scores that are comparable to 
scores found in similar samples. Major and colleagues (2012) compared self-efficacy in 
adolescents with ADHD and a comparison group of adolescents without ADHD diagnoses. 
Female adolescents with ADHD diagnoses (n = 13) presented with a mean SELF score of 50.11 
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(SD = 14.62), with male adolescents (n = 18) presenting with a mean SELF score of 63.54 (SD = 
12.97). Males in the current study (n = 3) presented with on average less academic self-efficacy 
(M = 49.83) than the adolescent males in the Major study. However, females in the current study 
(n = 8) presented with higher levels of academic self-efficacy than males in the current study and 
females in the Major study (M = 62.01). Further, both males and females in the current study 
presented with lower levels of academic self-efficacy than the comparison group of male (M = 
68.63) and female (M = 76.42) adolescents without ADHD diagnoses in the Major study. The 
slight differences in scores between the sample in the Major study and the current sample may 
not be significantly different, and may be the result of measurement error rather than actual 
differences within the study samples. 
Research Question 
The research question guiding the current study was: Are there mean rank differences in 
college students’ scores on: (a) the Conner’s Adult ADHD Rating Scale (CAARS), (b) the Beck 
Depression Inventory (BDI-II), (c) the Beck Anxiety Inventory (BAI), and (d) the Self Efficacy 
for Learning Form-Abridged (SELF-A) over time when receiving a NF intervention? To answer 
the research question, the researcher compared scores on the aforementioned assessments from 
11 participants who received 16 sessions of NF. Assessments were administered at four time 
points, allowing the researcher to observe changes in scores in four-week intervals (pre, mid, 
post, and four week FW). The researcher conducted a Friedman ANOVA on each of the 
constructs of interest (inattention, hyperactivity, impulsivity, self-concept, depression, anxiety, 
and academic self-efficacy) to examine if changes in scores occurred over time.  
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 The results of the current study indicate that there were significant improvements in 
scores in inattention (X2(3) = 10.268, p = .016), hyperactivity (X
2
(3) = 10.151, p = .017), self-
concept (X2(3) = 11.745, p = .008), depression (X
2
(3) = 13.165, p = .004), anxiety (X
2
(3) = 10.078, p 
= .018), and academic self-efficacy (X2(3) = 18.361, p < .001) over time. A significant difference 
in scores was not found in the participants’ impulsivity scores (X2(3) = 3.284, p = .350).   
 On the inattention subscale of the CAARS, mean rank scores for each assessment point 
consistently declined (Pre MR = 3.14, Mid MR = 2.86, Post MR = 2.41, and FW MR = 1.59; See 
Table 2), suggesting that participants’ scores steadily improved over time. Significant differences 
were found between the pre and post, pre and FW, mid and FW and post and FW assessment 
times. The largest effect size was found between the mid and FW assessment times, suggesting 
that the majority of participants had the most significant improvement in scores between the 
eighth session and four week FW assessments. Mayer and colleagues (2012) also found medium 
(d = -.56) to large (d = -.73) effect sizes when exploring the effects of a NF intervention on 
ADHD symptoms in adults.  
Further, the participants’ mean pretest score for the inattention subscale was the highest 
mean score for all of the CAARS subscales; indicating that the sample in the current study 
experienced the most distress in the domain of inattention. Rasey and colleagues (1995) found 
that three of four college students improved in attention scores as measured by the Integrated 
Variables of Attention (IVA). The current study builds upon the existing literature by including a 
larger sample in which, overall, mean scores for inattention decreased over time. Thus, similar to 
the findings of Rasey and colleagues, inattention improved after receiving a NF intervention over 
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time. Moreover, the measure of inattention used in the current study was designed to assess 
inattention in adults with ADHD – the study population. The population in the Rasey study were 
college students that had not been diagnosed with ADHD. Therefore, the significant difference in 
scores in the current study may have been the result of the sample presenting with clinical levels 
of inattention at the outset of the study. Nevertheless, the current study builds upon existing 
research, providing further support for NF in reducing inattention in college students with 
ADHD. 
 On the hyperactivity subscale of the CAARS, mean rank scores declined, yet FW scores 
increased slightly. Participants scores were highest at the outset of the study (Pre MR = 3.36), 
reduced significantly (p = .012) at the midpoint (MR = 2.5), reduced more from mid to post (MR 
= 1.86), and increased slightly at follow up (MR = 2.27). Although participants’ scores increased 
slightly at the FW assessment point, the scores were not as high as they were at the midpoint 
assessment, suggesting that participants may have begun to experience hyperactivity symptoms 
after completing the NF sessions. However, the symptoms of hyperactivity were not as severe as 
they were at the outset or midpoint of the study. Another follow up assessment would allow the 
researcher to determine whether the participants’ symptoms of hyperactivity increased, 
decreased, or plateaued after the participants finished the 16 sessions of NF. The largest effect 
size was found between the pre and mid assessment points, suggesting the largest change in 
scores occurred after the first eight sessions. These findings contribute to the hyperactivity and 
NF literature, identifying that after as little as eight sessions, adults with ADHD may experience 
significant changes in hyperactive symptoms.  
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 Self-concept, as it relates to ADHD, has not been examined in the NF literature. Similar 
to symptoms of hyperactivity, participants’ scores on self-concept improved from pre to mid and 
from mid to post; however, a slight increase was found between post and FW. Follow-up scores 
were not as high as midpoint scores, suggesting that participants experienced a slight increase in 
problems with self-concept after completing 16 sessions of NF, yet their problems with self-
concept were significantly lower (p = .016) than they were at the outset of the study. Further, five 
of eleven participants’ scores were the same from post to FW, suggesting that for almost half of 
the participants, problems with self-concept remained the same over four weeks after NF 
sessions ceased. The current study adds to the literature by providing support that college 
students with ADHD experienced a significant reduction in problems with their self-concept as it 
relates to their ADHD diagnoses over time with a NF intervention. Moreover, the findings of the 
current study provide empirical support to the assertions made by researchers that using 
neuroplasticity to alter brain physiology may change individuals’ self-perception 
(Brenninkmeijer, 2010; Linden, 2008). 
 On the BDI-II, participants’ scores declined from pre to mid, and mid to post, with a 
slight increase from post to follow up. Although participants’ scores ranked slightly higher from 
post to FW, more than half (n = 6) of participants’ scores remained the same from post to follow 
up, suggesting that more than half of participants reported neither higher nor lower levels of 
depression four weeks after NF sessions were over. The results of the current study differ slightly 
from Baehr and colleagues’ (2001) findings. Participants in the Baehr study included three adults 
had received at least 27 sessions of NF and were assessed with the BDI (Beck, Steer, & Garbin, 
1988) one, three, and five years post their final NF session. Participants’ reports of their 
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depressive symptoms remained stable one, three, and five years after receiving NF, suggesting 
that NF may provide stable effects as long as five years. As the participants in the current study 
only received 16 sessions of NF, the slight increase in depressive symptoms may be a result of 
not receiving enough NF sessions for a sustained reduction in depressive symptoms. The current 
study supports the existing literature that identified that NF is effective in reducing depressive 
symptoms in adults (Baehr et al, 2001; Cheon et al, 2016; Cheon et al, 2015) and contributes to 
the literature that college students’ scores on the BDI-II reduced significantly after 16 session of 
a NF intervention. 
 Participants’ scores on the BAI reduced from pre to mid and from mid to post, with a 
slight increase from post to FW. As with other constructs in the current study (i.e., depression, 
hyperactivity, self-concept), scores at FW were still not as high as they were at the midpoint or at 
the outset of the study. However, almost half (n = 5) of participants’ scores were higher at FW 
than they were at post, suggesting that almost half participants experienced an increase in 
symptoms of anxiety after concluding NF sessions. A longer FW assessment would allow the 
researcher to determine whether participants’ reports of anxiety symptoms would steadily 
increase or plateau. The slight increase in reporting of anxiety symptoms after not having NF 
sessions may be due to the sense of calmness that the NF sessions provide. Gracefire and Durgin 
(2012) found that participants report feeling more calm as a result of as little as one session of 
NF; however, reports of symptoms of anxiety do not change after one session. That is, 
individuals may experience a calmness associated with receiving NF, which may interfere with 
reports of symptoms of anxiety. As the BAI includes items focusing on both somatic and 
emotional symptoms of anxiety, participants may have experienced a reduction in the somatic 
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symptoms of anxiety as a result of feeling calmer after NF sessions. However, after ending NF 
sessions, the somatic symptoms of anxiety may have returned. Further, Kerson and colleagues 
(2009) found that in eight subjects, both state and trait anxiety were significantly reduced as a 
result of an average of 28.75 sessions of a NF intervention. Kerson and colleagues found that 
after a six-month follow-up, participants’ scores improved significantly from the pre assessment, 
suggesting that NF is effective in reducing anxiety in adults with lasting results. Again, as with 
depressive symptoms, the participants in the current study may have shown more lasting results 
at follow-up if they had received more NF sessions. The results of the current study add to the 
NF and anxiety literature by providing support for NF with college students with ADHD and 
comorbid anxiety symptoms.  
 The researcher also found a steady increase in mean rank scores over time in academic 
self-efficacy. An increase in scores on the SELF-A indicate an improvement in self-reported 
efficacy in academic tasks. Therefore, the study findings identified that participants’ academic 
self-efficacy increased from pre to mid, mid to post, and post to FW. Specifically, the largest 
effect size was observed between the pre and FW assessment times as all 11 participants scored 
higher at FW than they did at the outset of the study. The results of the current study add to the 
literature on self-efficacy and NF as no other studies have examined differences in academic 
self-efficacy with a NF intervention in college students with ADHD. Fritson and colleagues 
(2007) included a self-efficacy scale in their study examining the effects of a NF intervention on 
cognitive abilities and emotions in a nonclinical college student sample. The researchers did not 
find a difference in self-efficacy scores based on their population and self-efficacy measures. The 
current study differs from Fritson and colleagues’ study in that the sample included college 
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students who are at higher risk of having low academic self-efficacy, also, the measure used in 
the current study assessed academic self-efficacy rather than generalized self-efficacy in college 
students. Academic self-efficacy may be more relevant to the college student population; 
therefore, may be more accurately reported by the college student sample in the current study. 
The results of the current study add to the NF literature on college students and self-efficacy by 
providing support that academic self-efficacy can improve with 16 sessions of a NF intervention. 
The researcher found that pre and post impulsivity scores ranked the highest, while mid 
and FW scores ranked the lowest. A significant difference was not found between scores at each 
assessment point, suggesting that participants’ scores on impulsivity were not different from one 
another over time. Specifically, participants presented with a mean score of 3.36 (SD = 2.69) of a 
total possible 15 on the impulsivity subscale of the CAARS. The findings are consistent with 
research on impulsivity and hyperactivity in adults with ADHD as adults are less likely to report 
symptoms of hyperactivity or impulsivity than children (Millstein et al., 1997). Therefore, 
because the participants in the current study were all adults, they were inherently less likely to 
report symptoms of impulsivity. As such, a floor effect may have occurred with participants 
reporting low impulsivity scores at the outset of the study, leaving limited room for the scores to 
decrease. 
Limitations of the Study 
As is the case with all research, the current study contains inherent limitations. These 
limitations include issues with the research design and the population/study sample. Potential 
study limitations were hypothesized in the design phase of the study and the researcher attempted 
159 
 
to mitigate the possibilities of specific limitations. The following sections explore the limitations 
of the study, and how these limitations affect the interpretation of the study results.   
Research Design 
The current study implemented a one group, time series, quasi-experimental design. 
Inherent in a one group quasi-experimental design is the limitation of the lack of a control group. 
Shadish and colleagues (2002) note that designs without a comparison group lack the ability to 
state a causal relationship between the intervention and the results. Therefore, the researcher 
cannot state that the intervention in the current study (i.e., neurofeedback) caused a decrease in 
ADHD symptomology, depression, anxiety; or an increase in academic self-efficacy. With a 
control group, the researcher would be better able to assert that changes in scores were the result 
of the intervention rather than other external factors. Moreover, restriction of range is another 
limitation of the current study. Restriction of range is a type of threat to statistical conclusion 
validity in which the ability of the researcher to determine statistical significance is impeded by a 
lack of variance in scores in the data. Specifically, restriction of range was evident in the current 
study as the variance in scores on the impulsivity subscale was not large enough to determine 
statistical significance. That is, a floor effect occurred in which participants reported consistently 
low scores on the impulsivity subscale of the CAARS. A potential explanation for the 
consistently low scores on the CAARS involves the wording of the questions in the impulsivity 
subscale of the CAARS. Some items of the impulsivity subscale such as “I still throw temper 
tantrums”, may have been worded in a way that may have not been relatable to the participants in 
the sample. As adult college students, the study participants may not have identified with the 
“temper tantrum” terminology as it may have reminded participants of childish behaviors. 
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Although the CAARS was developed for adults, the term “temper tantrums” may be altered to be 
more relatable to adults. Additionally, a limitation of the study also includes the fact that all of 
the data collection instruments were self-report; therefore, limiting the data to self-report only 
measures. The CAARS comes in an observer report form, which may have yielded more 
substantial results, especially with ADHD symptomology as participants may not have noticed 
changes in their behaviors that observers may have noticed. Additionally, participants may have 
responded in a socially desirable manner.    
Finally, history is a threat to internal validity in experimental research involving the 
possibility of alternative external factors contributing to the changes in the dependent variables. 
Thus, the researcher may not be able to attribute changes in the dependent variables to the 
intervention. In the current study, external events may have impacted participants’ responses on 
the instruments. For example, one participant began taking medication after being in the study 
for approximately two weeks. When asked about changes they noticed since beginning the study, 
they reported that they had noticed improvement; however, they were unsure as to whether the 
improvement was a result of the new medication regimen or the NF sessions. The researcher 
cannot determine whether the improvement in scores was due to the medication or the 
intervention, threatening the internal validity of the study. 
Sampling 
Participants in the current study were recruited by flyers posted on campus, emails sent to 
student listservs, and the researcher made announcements in undergraduate and graduate level 
classrooms explaining the study. Convenient sampling may be a limitation in the current study as 
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it reduces the researcher’s ability to generalize the results of the study. Because the majority of 
the study participants were students at the large Southeastern University at which the researcher 
collected data (with one participant being a student from a nearby community college), the 
researcher cannot generalize the results of the current study to students outside of the two 
institutions represented. 
Twenty-three individuals expressed interest in the study with 11 participants completing 
all of the required sessions and paperwork. The small sample in the current study is a limitation 
as studies with small sample sizes are likely to have low statistical power. That is, the probability 
of making Type II error (falsely accepting the null hypothesis) is higher in studies with low 
power. Nonparametric statistical procedures are often used in small sample sizes as 
nonparametric analyses are valid and as powerful as their parametric counterparts despite having 
minimal or weak assumptions (Gibbons & Chakraborti, 2011). However, although the sample 
size in the current study may not affect the power of the statistical analysis, small sample sizes 
make it difficult for the researcher to determine whether or not the sample is a representation of a 
normal distribution in the population. That is, the sample may not be an accurate representation 
of the population. Specifically, in the current study, a larger sample may have provided more 
variance in scores on the assessments, thus, providing different results and conclusions about a 
larger more accurate representation of the population. 
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Implications and Recommendations 
Implications 
The current study provides implications for the counseling profession, public policy, and 
counselor education. Recently, the counseling profession has gained an increased focus on 
neuroscience and neurocounseling, with increased focus on the physiological and biological 
aspects of psychotherapy (Myers & Young, 2012; Russel-Chapin, 2016). Researchers have found 
connections between talk therapy and neurophysiology; specifically, research findings identify 
that counseling has the potential to alter brain physiology through neuroplasticity (Linden 2008). 
Functional Magnetic Resonance Imaging (fMRI) studies have shown changes in 
neurophysiology as a result of engaging in psychotherapy (Brenninkmeijer 2012). The 
Neurocounseling Interest Network became an official interest network in ACA in March 2015 
with the purpose of connecting counselors who use neurocounseling in their counseling work. 
Neurocounseling is described as the practice of incorporating neuroscience and brain-based 
concepts into individuals’ practical counseling work (Russel-Chapin, 2016). Many practitioners 
utilize neuroscience in practice and scholars have stressed the importance of integrating 
neuroscience-based interventions and concepts in counseling practice (Badenoch, 2008; Marci, 
Ham, Moran, & Orr, 2007; Montgomery, 2013; Myers & Young, 2012; Wheeler & Taylor, 
2016). The current study provides implications for the counseling profession by adding to the 
literature on neuroscience-based interventions that counselors may learn more about and 
implement into their clinical practice. Moreover, the current study contributes to the counseling 
outcome based intervention research. Ray and colleagues (2011) note that only six percent of 
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articles published in counseling journals explored the efficacy of counseling interventions; 
therefore, the current study contributes to the counseling literature on intervention efficacy.  
Although there is much literature on integrating neurobiology and neuroscience-focused 
counseling techniques in counseling practice, limited literature exists on incorporating 
neurocounseling as a counselor educator. The Council for Accreditation of Counseling and 
Related Educational Programs (CACREP, 2016), however, stresses the importance of focusing 
on the “biological, neurological, and physiological factors that affect human development, 
functioning and behavior” (p. 9). Therefore, counselor education programs should be 
implementing neurocounseling and principles of neuroscience in the classroom. Miller and 
Barrio-Minton (2016) provide a framework by which counselor educators may integrate 
Interpersonal Neurobiology into their courses. Further, Russo and Stevens (2016) explained in a 
periodical how the University of Texas at San Antonio (UTSA) implements neurocounseling; 
specifically, neurofeedback information is integrated into their counselor course. The faculty and 
students at UTSA collect data on clients receiving NF sessions as part of the counseling students’ 
practicum experience to expand the NF literature in counseling and provide practical experience 
with both research and NF for their students. The current study provides implications for 
counselor educators as the results of the study provide evidence that participants’ maladaptive 
symptoms decreased after receiving a neurofeedback intervention. Counselor educators may use 
the results of the current study to expand counseling students’ knowledge of brain-based 
interventions. 
Public policy implications of this study begin with providing evidence of the efficacy of 
neurofeedback as a treatment for ADHD symptoms in college students. Empirical support for NF 
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as an intervention may lead to policy changes as neurofeedback may be offered as a viable 
supplement to counseling and medication for college students diagnosed with ADHD. 
Eventually, college students diagnosed with ADHD, anxiety, or depression may be offered an 
NF as an alternative intervention to manage their symptoms in conjunction with medication 
and/or counseling. Additionally, empirical evidence supporting NF as a treatment for ADHD 
symptoms in adults may provide an evidence base for insurance companies, which may allow 
counselors to be reimbursed for providing NF as an intervention. Moreover, providing further 
evidence for NF may increase the opportunities for children with ADHD to receive alternative 
services such as NF as the long term effects of stimulant medications on the developing brain are 
still unknown (Craig, et al, 2015). 
 Finally, the current study adds to the NF literature and the literature on college students 
with ADHD. As NF is a novel intervention in the counseling profession, and most research on 
NF and individuals with ADHD focus on children, the current study supports and builds upon the 
existing research in the field. Further, the current study provides a platform on which future 
research in the area of NF and neurocounseling may expand. 
Recommendations for Future Research 
There were numerous limitations to the internal and external validity of the current study. 
Some threats to validity may not have been controlled for (i.e., attrition), while others may have 
been intentionally sacrificed to increase other forms of validity in the study (i.e., sacrificing the 
ability to generalize across treatment outcomes for treatment fidelity). Future research may 
address the limitations of the current study by including a larger study sample. Although the 
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sample in the current study was sufficient to answer the research question posed, a larger, more 
diverse sample would allow the researcher to be able to generalize the results to a larger 
population. Further, a larger, more diverse sample would allow for further complex statistical 
analyses examining differences within characteristics of participants (i.e., gender race, education, 
SES, and other forms of managing symptoms). That is, the researcher would be able to examine 
whether differences exist in how ADHD symptoms change over time with a NF intervention or 
not between groups. Moreover, future research should include a control group for comparison. 
As the current study incorporated a one-group design and causality could not be asserted, 
incorporating a control group to the study design would allow the researcher to compare changes 
in scores over time between the treatment and control groups. Thus, the researcher would be able 
to assert causality with a treatment and control group.  
 Future research may also include multiple methods of defining the constructs of interest. 
A threat to validity that the current study possesses is the threat of monomethod bias, in which 
researchers use one operational definition of a construct of interest. In the current study, 
depression, anxiety, and academic self-efficacy were operationally defined as the total score of 
the respective assessments. The problem with defining a construct solely by scores on one 
assessment is that the assessments used may not encompass multiple aspects of the construct. For 
example, anxiety is a multifaceted construct; however, the BAI does not measure specific aspects 
of anxiety that may be more relevant to the participants in the study. As college students with 
ADHD are more likely to suffer with test anxiety (Nelson et. al., 2014; Prevatt et. al., 2015), 
future research should include an anxiety assessment that specifically measures test anxiety in 
college students. As academic self-efficacy was also a construct measured in the current study, 
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with results suggesting an improvement in academic self-efficacy over time, future research may 
expand these results by including students’ grades, as an additional facet of an academic 
achievement construct. Including students’ grades in future research may provide a connection 
between NF and academic achievement in addition to academic self-efficacy.  
Moreover, future research may seek to explore differences in the effects of NF training 
based on the number of sessions provided to participants. For the constructs of interest examined 
in the current study, the largest effect sizes ranged between each of the assessment points. That 
is, participants experienced the largest changes in symptomology between different assessment 
points (i.e., pre to mid, pre to post, mid to FW…etc.) for each construct. Future research may 
examine changes in symptomology after eight, 16, and more sessions with follow up assessments 
to determine the ideal number of sessions needed to create long lasting changes as a results of 
NF training. Additionally, Fuchs and colleagues (2003) compared the effects of NF training to 
medication and found no differences between the groups. A lack of differences between the 
effects of NF and medication suggests that NF training is as effective as methylphenidate in 
managing ADHD symptoms in children. Future research may compare the effects of NF training 
to medication in adults to determine whether NF training is as effective as medication in adults 
as it is with children. Moreover, similar research may be conducted comparing the effects of NF 
training to other evidenced based counseling therapies (i.e., Cognitive Behavioral Therapy) to 
examine whether NF training is just as effective as current evidence based interventions. 
The current study was novel and essential to the growing interest and research in the 
neurocounseling field. Due to the novelty of the intervention in the current study, future research 
in this area may take many forms. On a larger level, future research incorporating NF in 
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counseling may include studies examining counselors and counseling students’ attitudes toward 
neurofeedback, counselor educators’ use of neurocounseling in their courses, and more efficacy 
studies examining NF efficacy in various populations. 
Conclusion 
The purpose of the current study was to examine the effects of 16 sessions of a 
neurofeedback training intervention on college students’ symptoms of ADHD (inattention, 
hyperactivity, impulsivity, and self-concept), depression, anxiety, and academic self-efficacy. A 
one-group time series design was implemented to explore changes in participants’ 
symptomology over the course of 12 total weeks. Participants’ scores on assessments measuring 
ADHD, depression, anxiety, and academic self-efficacy were analyzed to examine differences 
from the outset of the study, to after eight sessions, to after 16 sessions, to a four week follow up.  
 Key findings of the study identified that participants experienced significant reductions in 
symptomology for the constructs of (a) inattention, (b) hyperactivity, (c) self-concept, (d) 
depression, (e) anxiety, and (f) academic self-efficacy. No significant changes occurred in 
participants’ self-reported levels of impulsivity. Further, results indicate that for inattention and 
academic self-efficacy, participants continued to experience a reduction in symptomology after 
ending NF sessions. A slight increase in symptomology occurred between the post and follow up 
assessment points for hyperactivity, self-concept, depression, and anxiety. Although participants 
reported a slight increase in symptoms after ending NF sessions, levels of symptomology were 
still lower at follow up than at the pre and midpoint assessments. 
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 The results of the current study provide support for the efficacy of NF in reducing 
symptoms of ADHD, depression, and anxiety in college students with ADHD. Additionally, the 
results identified that NF is effective in increasing academic self-efficacy in college students 
with ADHD. These results provide implications for the counseling and counselor education 
professions by providing evidence of an intervention to assist adults and college students with 
ADHD, depression, anxiety, or issues with academic self-efficacy. Further, the results of the 
current study may provide implications for policy by providing empirical support for the efficacy 
of NF, thus increasing the likelihood that NF may become an evidence-based intervention that is 
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An Investigation of the Effects of Neurofeedback Training on Attention Deficit Hyeractivity 
Disorder (ADHD) Symptoms in College Students. 
Informed Consent  
Principal Investigator(s):   Shaywanna Harris, M.A. 
Gulnora Hundley, M.D., Ph.D. 
Glenn Lambie, Ph.D.       
Investigational Site(s):  University of Central Florida Community Counseling and Research  
Center (CCRC) 
Introduction:  You are being invited to take part in a research study which will include about 15 
people at UCF. You have been asked to take part in this research study because you are a college 
student with a diagnosis of ADHD. You must be 18 years of age or older to be included in the 
research study. The individuals conducting this research are faculty members and graduate 
students in the UCF Department of Child, Family, and Community Sciences.  
What you should know about a research study: 
 A research assistant will explain this research study to you.  
 A research study is something you volunteer for.  
 Whether or not you take part is up to you. 
 You should take part in this study only because you want to.   
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 You can choose not to take part in the research study.  
 You can agree to take part now and later change your mind.  
 Whatever you decide it will not be held against you. 
 Feel free to ask all the questions you want before you decide. 
Purpose of the research study:  Neurofeedback is a drug free, non invasive training process that may 
increase brain efficiency. Several research studies provide encouragement that Neurofeedback has the 
potential to reduce ADHD symptoms in college students. The purpose of this study is to further the 
research on therapeutic outcomes of Neurofeedback Training and explore the efficacy of Neurofeedback 
Training on ADHD symptoms in college students. 
What you will be asked to do in the study: In this study, you will be asked to complete an initial 
intake paperwork session which includes reviewing this consent form and completing the 
psychosocial inventory and the 4 study assessments. Assessment of your eligibility in the study 
will be continuous in that if you show evidence of meeting exclusion criteria at any time during 
the study, you may be informed that you are no longer eligible to participate in the study.  
Baseline Visit: 
Each participant will attend a baseline initial visit at the CCRC. In this session, you will be 
given an overview of the study process and sign the informed consent. Additionally, you will 
complete the psychosocial inventory, 4 assessments, and 15 minutes of neurofeedback training. 
This may take approximately one hour.  
Neurofeedback training sessions will be conducted as follows: 
 In each session, you will be seated in a chair in a private room in the CCRC. A 
trained research assistant will then attach tiny sensors near your scalp and on your 
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ears with medical grade adhesive. Much like an EKG or ECG, the sensors are 
simply reading the electric signals from your brain activity, there is nothing 
invasive involved with the training process. The Neurofeedback system being 
used does not “push” the brain in any particular direction rather, it merely cues 
the central nervous system to do what is naturally most efficient for the brain. 
During the training session, the research assistant will provide you with earbuds 
and begin the program. You will then listen to music during which you may 
notice a brief pause in the sound. The precise timing of these interruptions give 
the brain the vital information it needs to operate optimally. You need not do 
anything else during these sessions, you may read or close your eyes, but nothing 
else is required of you during the neurofeedback training sessions. After the 
session, it is highly unlikely that you will experience any side effects but due to 
the relaxing nature of the session, you may feel tired. To address this, you are 
encouraged to remain in the waiting room for 10 minutes after each session. In 
sessions when you will complete paperwork, you will do so before beginning the 
neurofeedback training session. 
Location:  The UCF Community Counseling and Research Center  
Time required:  We expect that you will commit to participate in this research study for 12 
weeks. You will be required to come to the UCF Community Counseling and Research Center 
twice a week for approximately one hour sessions. Total, you will be asked to complete 8 weeks 
of neurofeedback training for a total of 16 sessions with a follow up assessment 4 weeks after the 
final neurofeedback session. Every 4 weeks you will be asked to complete 4 assessments; these 
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assessments should take approximately 20 minutes to complete. Four weeks after your last 
Neurofeedback session, you will be asked to complete a follow up assessment packet including 
the same assessments you completed during your neurofeedback sessions. 
Audio or video taping:  Although there are cameras in the CCRC rooms for training purposes, 
the Neurofeedback sessions for this study will not be recorded. 
Risks: Risks in this study are minimal. Participants may feel tired following a neurofeedback 
session. To mitigate risks involved, we will recommend each participant stay in the waiting room 
for approximately 10 minutes following a session. If participants experience emotional discomfort 
throughout the process, the researchers will provide referrals to the UCF Counseling Center, 
Counseling and Psychological Services (CAPS), or Crisis Services for the participants at the 
client’s request or at the clinical discretion of the research assistant. As the research assistants are 
also trained counselors, they will be available to minimize risks associated with immediate 
emotional discomfort during session. Taking part in this research study may lead to added costs to 
you as you will be required to provide your own transportation to and from the UCF Community 
Counseling and Research Clinic. However, participants are not required to pay nor will you be 
asked to pay to participate in research related activities. In rare occasions, some individuals with 
severe skin allergies to cosmetics or lotions may experience irritation as a result of using the 
conductor paste. If you have a severe skin allergy, please inform the research team.  
Benefits:  We are unable to promise any benefits to you or others from your taking part in this 
research. However, possible benefits include reduced stress, increased relaxation and optimism, 
and increased focus and concentration. 
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Compensation or payment:  You will be given a $10 gift card at your first, 8th, 16th, and follow 
up sessions.  
Confidentiality:  We will limit the personal data collected in this study to people who have a need to 
review this information, for example the IRB and other representatives of UCF may have access to the 
data collected in this study however, your participation in this study is confidential. Your name or other 
identifying information will not be attached to any of the information gathered in this project. All 
electronic data will be password protected on laptops and stored with your documentation in a locked file 
cabinet, behind a locked door, in the CCRC which is password locked at all times. The only document 
that will contain your name is your treatment summary as proof of an ADHD diagnosis. However, your 
treatment summary will have your name redacted and a client identification number will replace it to 
ensure privacy, all materials will be locked in a locked file cabinet, behind a locked door, in the CCRC 
which is locked. The data collected will be used for statistical analyses and no individuals will be 
identifiable from the pooled data. The information obtained from this research may be used in future 
research and published. However, your right to privacy will be retained, i.e. your personal details will not 
be revealed. Results of assessments will be stored in a password protected computer accessible only by 
the research team. Per UCF IRB policy, human resesearch records will be stored for 5 years after the 
study has closed. Your identifiable information will not be attached to these records. 
The information provided during the research process will be kept strictly confidential, except for those 
reasons required by law. These exceptions include the following: 
1. When there is a serious threat to your health and safety or the health and safety of another 
individual or the public. Information will only be shared with a person or organization that is 
able to help prevent or reduce the threat.  
2. When there is suspected abuse or neglect of a child, elderly person, resident of an institution, 
or a disabled person. 
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3. As a result of any lawsuit against the counselor and/or legal/court proceedings. 
4. If a law enforcement official requires a release. 
5. When you (the client) explicitly request in writing that information be shared with a third party. 
 
(ACA Code of Ethics [2005], Section B.2; Chapter 491, state of Florida law governing the practice of 
Clinical, Counseling, and Psychotherapy Services [2010], Section 491.0147) 
 
Study contact for questions about the study or to report a problem: If you have questions, 
concerns, or complaints, or think the research has harmed you, talk to Shaywanna Harris, Doctoral 
Student and Principal Investigator, College of Education and Human Performance, (407) 823-
4778, s.harris@knights.ucf.edu or Gulnora Hundley, Co-Investigator, College of Education and 
Human Performance, (407) 823-1652 or by email at Gulnora.hundley@ucf.edu.  
IRB contact about your rights in the study or to report a complaint:    Research at the University of 
Central Florida involving human participants is carried out under the oversight of the Institutional Review 
Board (UCF IRB). This research has been reviewed and approved by the IRB. For information about the 
rights of people who take part in research, please contact: Institutional Review Board, University of Central 
Florida, Office of Research & Commercialization, 12201 Research Parkway, Suite 501, Orlando, FL 
32826-3246 or by telephone at (407) 823-2901. You may also talk to them for any of the following:  
 Your questions, concerns, or complaints are not being answered by the research team. 
 You cannot reach the research team. 
 You want to talk to someone besides the research team. 
 You want to get information or provide input about this research.  
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Withdrawing from the study:Your participation in this research project is entirely voluntary. 
You do not have to participate. You do not have to answer any question(s) that you do not wish 
to answer. Please be advised that you may choose not to participate in this research study, and 
may withdraw from the study at any time without consequence. Whatever you decide will not be 
held against you in any way. If at any time within the duration of the study you meet any of our 
exclusion criteria, you may be disqualified from participating in the study. 




























My name is Shaywanna Harris, I’m a doctoral student in the Counselor Education program at UCF. I’m 
currently working on my dissertation study using an intervention that previous research has shown may 
potentially mitigate symptoms of ADHD in college students. This study will be held in the Community 
Counseling and Research Center in the Education Complex on UCF’s Campus. The purpose of this study 
is to explore the impact of neurofeedback training on Attention Deficit Hyperactivity Disorder (ADHD) 
symptoms in college students. Neurofeedback works by “listening” to your brains waves and notifying 
your brain when the waves are out of the mean range of functioning by providing a small interruption in 
the music playing. There have been numerous studies showing the efficacy of neurofeedback in children 
with ADHD, this study seeks to expand these results to an adult population. Participant incentives will be 
provided in the form of gift cards. 
  
If you have an ADHD diagnosis and are interested in participating, please see the attached flyer and 












Information Given Below is For Research Purposes Only 
 
The information supplied below is for use in our research study only and will be kept confidential. Please answer 
each question as fully and honestly as you can. If you have any questions at any time, feel free to ask the research 
assistant and they will be happy to assist you or provide clarification. 
PERSONAL IDENTIFICATION DATA 
Today’s Date: _______________________ 
Best Phone Number to Reach You: _____________________ May We Leave a Message at This Number?_______ 
Best Time to Contact You: Mornings:___ Afternoons:____ Evenings:______  
Email Address: ___________________________________Gender: _______ Date of Birth: ______________  
Age: _______  
Primary racial/cultural background:   
___ Asian  ___ Black/African American ___ White/Caucasian   ___ Native 
American 
___ Hispanic/Latino ___ Biracial/bicultural   ___ Other: _________________________ 
 
BRIEFLY ANSWER THE FOLLOWING QUESTIONS (use the back of this page if necessary) 
1. What are your main concerns as it pertains to your ADHD (what brings you here)? 
_____________________________________________________________________________________________ 
_____________________________________________________________________________________________ 













Circle any of the following words which you feel best describe you: 
active ambitious     self-confident     persistent nervous     hardworking    impatient     impulsive     moody  
excitable     imaginative     calm     serious     easygoing     shy     good-natured     introvert     often-blue   extrovert 
likeable     leader     quiet     hard-boiled     submissive     self-conscious     lonely     sensitive    passive    indifferent 
 




Rate your physical health:  ___Very Good  ___Good  ___Average  ___Declining  ___Other (please explain below): 
_____________________________________________________________________________________________ 







Do you currently have a pacemaker or other electric medical implanted device? ___Yes  ___No  (If yes, please 
describe)______________________________________________________________________________________ 
______________________________________________________________________________________ 
Have you used drugs for other than medical purposes? ___Yes  ___No  (If yes, please describe) 
_____________________________________________________________________________________________ 
Are you presently taking any medication(s) for physical reasons?  ___Yes  ___No (If yes, please describe)  
_____________________________________________________________________________________________ 





Have you ever had a severe emotional upset that resulted in hospitalization? ___Yes  ___No  (If yes, please 
explain)  
_____________________________________________________________________________________________ 




What was the outcome of any prior counseling? 
_____________________________________________________________________________________________
__________________________________________________________ 
How many supportive people (those on whom you can depend) do you currently have in your life?    
___ None (0)  ___Some (1-5)  ___ Many (5+) 








Do you experience such things as (check all that apply):                                Is this current or in the past (or 
both)? 
Migraines     ___Yes  ___No  ___ Current ___ Past 
Stomach Problems    ___Yes  ___No  ___ Current ___ Past 
Trouble Sleeping     ___Yes  ___No  ___ Current ___ Past 
How many hours of sleep do you get each night? _____ 
Sexual Difficulties    ___Yes  ___No  ___ Current ___ Past 
Frequent Crying     ___Yes  ___No  ___ Current ___ Past 
“Blue” moods     ___Yes  ___No  ___ Current ___ Past 
Anxiety/panic attacks    ___Yes  ___No  ___ Current ___ Past 
Difficulties concentrating    ___Yes  ___No  ___ Current ___ Past 
Hallucinations (visual/auditory/tactile)  ___Yes  ___No  ___ Current ___ Past 
Lack of energy     ___Yes  ___No  ___ Current ___ Past 
Racing thoughts     ___Yes  ___No  ___ Current ___ Past 
Angry outbursts     ___Yes  ___No  ___ Current ___ Past 
Eating related issues    ___Yes  ___No  ___ Current ___ Past 
Feelings of inferiority    ___Yes  ___No  ___ Current ___ Past 
Flashbacks (Reliving traumatic events)  ___Yes  ___No  ___ Current ___ Past 
Avoiding places, activities or people 
that remind you of a traumatic event  ___Yes  ___No  ___ Current ___ Past 
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Overwhelming Guilt or Shame   ___Yes  ___No  ___ Current ___ Past 
Memory Problems    ___Yes  ___No  ___ Current ___ Past 
Always Being on Guard    ___Yes  ___No  ___ Current ___ Past 
Addictive behaviors    ___Yes  ___No  ___ Current ___ Past 









Do you drink alcohol or use any drugs? 
___Alcohol   ___Drugs   ___Both   ___I do not drink alcohol or use drugs 
 
If you use alcohol or drugs, what kind do you use? Check all that apply. 
___ Beer/Wine    ___ Liquor  ___ Amphetamines/Speed/Meth/etc 
___ Marijuana/Pot/Hash/etc  ___ Cocaine/Crack/etc ___ Hallucinogens/Acid/Ecstasy/etc 
___ Inhalant/Huffing/Whipits/etc  ___ Opioids/Heroin/Opium/etc 
___ Phencyclidine/Mushrooms/etc ___ Sedatives/valium/etc 
___ Over the counter/prescription medications   ___ Other: ___________________ 
 
If you use alcohol or drugs, how often do you use them? 
___ Every day    ___ Several times per week 
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___ Several times per month  ___ Once or twice a month 
___ Several times per year  ___ Once a year 
___ Other: _______________________________ 
 
If one of the above substances has been checked: 
Have you ever felt like you should cut down on your alcohol or other drug use (including prescription 
drugs)? ___Yes  ___No  (If yes, please describe) 
___________________________________________________ 
______________________________________________________________________________________ 
Has a friend or relative discussed concerns about your use? ___Yes  ___No  (If yes, please describe) 
______________________________________________________________________________________ 
Have you ever felt guilty about your drinking or drug use? ___Yes  ___No  (If yes, please describe) 
______________________________________________________________________________________ 
Have you ever had to take a drink or use a drug the next day to steady your nerves? ___Yes  ___No  (If 
yes, please describe) 
______________________________________________________________________________ 
Are you in recovery from any addictive behavior? ___Yes  ___No  (If yes, please describe) 
______________________________________________________________________________________ 
Is there a history of problems with alcohol or drug use in your family (immediate or extended)?  
___Yes  ___No  (If yes, please describe) 
__________________________________________________________  
Do you engage in any of the following behaviors in such a way that it may be an issue for concern? 
___ Gambling    ___ Sexuality 
___ Spending    ___ Eating (overeating, restricting, binging/purging) 
___ The Internet    ___ Exercise 
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___ Other: _______________________________ 
Sometimes when people feel depressed or overwhelmed, they think that they’d be better off dead. Have you 
ever thought about suicide? ___Yes   ___No (If yes, explain) 
_____________________________________________________________________________________________ 
_____________________________________________________________________________________________ 




EDUCATIONAL HISTORY  
What is the highest grade you have completed? 
___ Some high school    ___ GED    ___ Special High School Diploma    
___ High School Diploma ___ Some College  ___ AA/AS Community College  
___ Bachelor’s degree   ___ Master’s degree ___ Specialist’s degree 
___ Doctorate degree 
RELATIONSHIP INFORMATION  
Relationship Status:  ___Single  ___Engaged    ___Married   ___ Cohabitating and unmarried 
___ Partnered  ___Separated   ___Divorced   ___Widowed 
Name of spouse/partner: ________________________________________________  
Spouse's/partner’s occupation: __________________________________________________ 
Have either of you ever filed for divorce? ___Yes ___No (if yes, please describe when): 
________________________ 
Have you ever been separated?  ___Yes ___No (if yes, describe when and for how long) 
_____________________________________________________________________________________________ 
Rate your satisfaction in your current relationship:   ___Unhappy  ___Average  ___Happy   ___Very Happy 
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Do you have any children? ___Yes____No 
If so, how many? ______ 
 
This concludes the psychosocial portion of your intake process. Thank you for taking the time to complete this 
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